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Summary  
	   Sphingolipids regulate crucial biological processes, such as stress 
response and apoptosis. The budding yeast Saccharomyces cerevisiae has been 
pivotal to uncover the impact of sphingolipid dynamics on eukaryotic cell 
physiology and metabolism. The bioactive sphingolipid ceramide can be generated 
by the de novo biosynthetic pathway or through the hydrolysis of complex 
sphingolipids, the last catalysed by the inositol phosphosphingolipid phospholipase 
C protein, Isc1p (the yeast orthologue of the mammalian neutral sphingomyelinase 
2). Cells lacking Isc1p display shortened chronological lifespan (CLS), oxidative 
stress sensitivity and severe mitochondrial dysfunctions, which are associated with 
iron overload, enhanced oxidative damage to biomolecules and increased cell 
death by Yca1p-mediated apoptosis. Previous results demonstrated that the 
PP2A-like phosphatase Sit4p and the MAPK kinase Hog1p are activated in 
response to increased ceramide levels displayed by isc1Δ cells during aging and 
contribute to mitochondrial dysfunction, hydrogen peroxide hypersensitivity and 
shortened chronological lifespan of isc1∆ cells. 
 In this thesis, the role of the nutrient-sensing Target Of Rapamycin 
Complex 1 (TORC1) and its downstream effector, the AGC protein kinase Sch9p, 
in isc1Δ phenotypes was assessed. This work demonstrates that the TORC1-
Sch9p pathway is activated in cells lacking Isc1p. The deletion of TOR1 or SCH9 
abolishes the premature aging, oxidative stress sensitivity and mitochondrial 
dysfunctions displayed by isc1Δ cells and this is correlated with alterations in 
autophagic activity and flux. The protective effect of TOR1 deletion is not 
associated with the attenuation of Hog1p hyperphosphorylation, which was 
previously implicated in isc1Δ phenotypes. Importantly, Hog1p activation is 
responsive to ceramide by Sch9p-dependent mechanisms. Our data support a 
model in which Isc1p regulates mitochondrial function and chronological lifespan in 
yeast through the TORC1-Sch9p pathway, although Isc1p and TORC1 also seem 
to act through independent pathways, as isc1Δtor1Δ phenotypes are intermediate 
to those displayed by isc1Δ and tor1Δ cells. We then provide evidence the 
TORC1-Sch9p signalling pathway acts as a central axis to integrate upstream 
Isc1p-driven ceramide signalling signals to downstream effectors Sch9p and Sit4p. 
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 Macroautophagy plays an important regulatory role in mitochondrial 
function, stress response and aging. Since these processes are impaired in Isc1p-
deficient cells, we aimed to investigate how Isc1p-driven ceramide signalling 
regulates macroautophagy and other mitochondrial quality control mechanisms, 
namely mitochondrial dynamics and the selective degradation of mitochondria by 
mitophagy. The results show that Isc1p deficiency reduces autophagic flux by 
primarily impairing vesicular trafficking, vacuolar proteolysis, acidification and 
morphology. These phenotypes are suppressed by downregulation of TORC1 and 
its downstream effectors, Sch9p and Sit4p, which integrate nutrient and stress 
signals from TORC1 with ceramide signalling from Isc1p. We show that the 
deletion of ISC1 leads to hyperactivation of mitophagy, presumably as an adaptive 
response to mitochondrial dysfunction, and this was correlated with loss of cell 
viability of isc1Δ cells. Isc1p-deficient cells also displayed higher levels of the 
mitochondrial fission protein Dnm1p associated with unbalanced mitochondrial 
fission, contributing to mitochondrial fragmentation, oxidative stress sensitivity and 
shortened lifespan. The deletion of TOR1, SCH9, SIT4 and HOG1 attenuated the 
induction of mitophagy in respiratory conditions, and this was correlated with the 
suppression of mitochondrial fragmentation and improvement of mitochondrial 
function. We further show that Isc1p and Dnm1p physically interact in vitro, further 
supporting a possible regulatory role for Isc1p in mitochondrial dynamics.  
 The deletion of SIT4 extends lifespan in yeast by boosting mitochondrial 
function (mitochondrial catabolic derepression) and stress response. Although 
Sit4p functions downstream of Isc1p, the phosphatase is downregulated by 
TORC1 and was recently shown to control the turnover of complex sphingolipids in 
a Npr1p-dependent manner. However, how TORC1 effector Sit4p integrates 
nutrient and sphingolipid signalling is not yet fully understood. Our results 
demonstrate that Sit4p regulates the sphingolipid biosynthetic pathway by a 
transcriptional regulatory mechanism involving the ceramide synthase LAG1 and 
ceramidase YPC1. An increased LCBPs/LCBs ratio is observed in sit4Δ cells and 
ceramide metabolism is preferably shunted towards the synthesis of α-
hydroxylated phytoceramide species, which have been implicated on proper 
mitochondrial function. Importantly, overall decreased ceramide production in 
sit4Δ cells is correlated with reduced activation of the TORC2-Pkh1p-Ypk1p 
pathway and decreased Orm phosphorylation. Moreover, the Pkh1/2p-Sch9p 
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pathway is downregulated in sit4Δ cells by a Snf1p-dependent mechanism. The 
downregulation of this pathway is associated with improved mitochondrial fitness 
and extended CLS upon Sit4p deficiency. Given the regulatory role of Sit4p in 
nutrient signalling and the regulation of the activation of the Pkh1/2p-Sch9p 
pathway, our results provide evidence that Sit4p is not only an effector but also a 
key regulator of sphingolipid metabolism and is involved in a regulatory network of 
interacting pathways that integrate signals from TORC1-mediated nutrient sensing 
with sphingolipid dynamics to regulate cell growth and longevity in yeast.  
 In conclusion, the work described in this thesis provides new insights on the 
molecular mechanisms by which cellular signalling pathways are activated in 
response to alterations in sphingolipid metabolism and the impact on crucial 
cellular functions and metabolism. This clarification is pivotal to understand 
sphingolipid functions in more detail and define new strategies to improve human 
health and extend lifespan.  
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Sumário  
 
 Os esfingolípidos regulam processos biológicos cruciais, tais como a 
resposta ao estresse e apoptose. A levedura Saccharomyces cerevisiae tem sido 
crucial para definir o impacto da dinâmica do metabolismo dos esfingolípidos na 
fisiologia e metabolismo celular dos eucariontes. O esfingolípido bioactivo 
ceramida pode ser gerado pela via biossintética de novo ou através da hidrólise 
dos esfingolípidos complexos, sendo que o último processo mencionado é 
catalisado pela proteína Isc1p (inositol phosphosphingolipid phospholipase C 
protein), que é ortóloga à proteína esfingomielinase neutra tipo 2 em mamíferos. 
As células deficientes na proteína Isc1p apresentam envelhecimento cronológico 
prematuro, sensibilidade aumentada ao estresse oxidativo e disfunção 
mitocondrial severa, os quais estão associados com o excessivo influxo de ferro, 
aumento dos danos oxidativos a biomoléculas e aumento de morte celular por 
apoptose mediado pela metacaspase Yca1p. Estudos anteriores demonstraram 
que a proteína fosfatase da família das proteínas fosfatases tipo 2A e a proteína 
da via das proteínas cínases activadas por mitogénios (MAPK) Hog1p são 
activadas em resposta ao aumento dos níveis de ceramida exibidos pelas células 
deficientes na proteína Isc1p durante o envelhecimento, contribuindo, desta 
forma, para a disfunção mitocondrial severa, sensibilidade aumentada ao estresse 
oxidativo e envelhecimento cronológico prematuro apresentadas por este 
mutante.  
 Nesta tese, o papel desempenhado pela via de sinalização mediada por 
nutrientes, a via Target Of Rapamycin Complex 1 (TORC1) e a sua proteína 
efectora, a proteína cínase Sch9p, nos fenótipos de células deficientes na 
proteína Isc1p foi analisado. Este trabalho demonstra que a via sinalizadora 
TORC1-Sch9p está mais activa no mutante isc1Δ. A deleção dos genes TOR1 e 
SCH9 suprime o envelhecimento cronológico prematuro, sensibilidade aumentada 
ao estresse oxidativo e disfunção mitocondrial severa ostentadas pelo mutante 
isc1Δ e tal está associado com a supressão do defeito na autofagia exibido pelo 
mutante. O efeito protector promovido pela deleção do gene TOR1 não está 
relacionado com a activação da via sinalizadora mediada pela proteína Hog1p, a 
qual está associada aos fenótipos exibidos pelas células deficientes na proteína 
Isc1p. Por outro lado, a activação de Hog1p em resposta a ceramida ocorre por 
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mecanismos dependentes de Sch9p. Os dados apresentados neste trabalho 
suportam um modelo segundo o qual a proteína Isc1p regula a função 
mitocondrial e o envelhecimento cronológico em levedura através da via 
sinalizadora TORC1-Sch9p, embora existam também mecanismos independentes 
entre Isc1p e TORC1, uma vez que os fenótipos apresentados pelo mutante 
isc1Δtor1Δ são intermédios àqueles exibidos pelas células mutantes isc1Δ e 
tor1Δ. Neste sentido, o trabalho oferece uma nova perspectiva segundo a qual a 
via sinalizadora TORC1-Sch9p actua como um eixo central que integra 
sinalização derivada da ceramida gerada pela proteína Isc1p e a transmite às 
proteínas efectoras Sch9p e Sit4p.   
 A macroautofagia desempenha um papel importante na regulação da 
função mitocondrial, resposta ao estresse e longevidade. Dado que estes 
processos estão desregulados nas células deficientes na proteína Isc1p, este 
trabalho pretende investigar de que forma a sinalização derivada da ceramida 
gerada por intermédio da proteína Isc1p regula a macroautofagia e outros 
mecanismos de controlo de qualidade mitocondrial, nomeadamente a dinâmica 
mitocondrial e a degradação selectiva de mitocôndrias pelo processo de 
mitofagia. Os resultados demonstram que a ausência de Isc1p reduz o fluxo 
autofágico ao comprometer primariamente o tráfego vesicular, a proteólise, 
acidificação e morfologia vacuolar. Estes fenótipos são suprimidos pela 
diminuição na actividade do complexo proteico TORC1 e das proteínas efectoras, 
Sch9p e Sit4p, as quais integram sinalização por nutrientes e estresse derivada 
de TORC1 com a sinalização por ceramida gerada por Isc1p. Por outro lado, foi 
demonstrado que a deleção do gene ISC1 promove a hiperactivação da mitofagia, 
presumivelmente em resposta à disfunção mitocondrial, e tal está associado com 
a perda de viabilidade celular do mutante isc1Δ. As células deficientes na proteína 
Isc1p também exibem níveis aumentados da proteína mitocondrial de fissão 
Dnm1p e tal está relacionado com fissão mitocondrial excessiva, contribuindo, 
desta forma, para a fragmentação da rede mitocondrial, sensibilidade aumentada 
ao estresse oxidativo e envelhecimento cronológico prematuro. De forma notável, 
a deleção dos genes TOR1, SCH9, SIT4 e HOG1 atenuam a indução da 
mitofagia, em condições respiratórias, e tal está correlacionado com a supressão 
da fragmentação mitocondrial e melhoramento da função mitocondrial. Este 
trabalho também demonstra que as proteínas Isc1p e Dnm1p interagem 
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fisicamente in vitro, o que suporta um possível papel regulatório da proteína Isc1p 
no processo de dinâmica mitocondrial.  
 A deficiência do gene SIT4 estende a longevidade em levedura ao 
melhorar a função mitocondrial (desrepressão catabólica da mitocôndria) e a 
resposta ao estresse. Embora a proteína Sit4p seja efectora da proteína Isc1p, a 
fosfatase é inibida pelo complexo TORC1 e recentemente foi demonstrado que a 
proteína controla o metabolismo dos esfingolípidos complexos por um processo 
dependente da proteína cínase Npr1p. Contudo, ainda é desconhecido de que 
forma a proteína Sit4p integra a sinalização mediada por nutrientes e 
esfingolípidos para regular a longevidade celular. Desta forma, este trabalho 
pretende estabelecer uma associação funcional entre Sit4p e o metabolismo dos 
esfingolípidos e avaliar o seu impacto na longevidade. Os resultados demonstram 
que a proteína Sit4p regula a via biossintética por um mecanismo que envolve a 
transcrição dos genes que codificam para as proteínas ceramide sintetase LAG1 
e ceramidase YPC1. O rácio (bases esfingóides fosforiladas /bases esfingóides) 
encontra-se aumentado em células deficientes na proteína Sit4p e o metabolismo 
é preferencialmente desviado para a síntese de metabolitos de fitoceramida α-
hidroxilados, os quais têm sido implicados na regulação da função mitocondrial. 
Em particular, a diminuição dos níveis totais de ceramida observada no mutante 
sit4Δ está correlacionada com uma activação reduzida da via de sinalização 
TORC2-Pkh1p-Ypk1p e com a fosforilação diminuída das proteínas Orm. Além 
disso, a activação da via sinalizadora Pkh1/2p-Sch9p está diminuída nas células 
deficientes em Sit4p por um mecanismo dependente da proteína Snf1p. A 
reduzida activação desta via de sinalização está associada com o melhoramento 
da função mitocondrial e com a extensão da longevidade promovia pela ausência 
da proteína Sit4p em levedura. Dado o papel regulatório da proteína Sit4p na 
sinalização mediada por nutrientes e na activação da via sinalizadora Pkh1/2p-
Sch9p, os resultados demonstram que a proteína Sit4p se comporta, não só como 
efectora, mas como um regulador crucial do metabolismo dos esfingolípidos e 
como tal, está integrada numa rede regulatória de vias de sinalização que actuam 
de forma coordenada para integrar sinalização derivada de nutrientes transmitida 
pelo complexo TORC1 com o metabolismo dos esfingolípidos e desta forma 
regular o crescimento celular e a longevidade.  
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 Em conclusão, o trabalho descrito nesta tese fornece informação adicional 
em relação aos mecanismos moleculares pelos quais vias de sinalização 
celulares são activadas em resposta a alterações no metabolismo dos 
esfingolípidos e o seu impacto em funções celulares cruciais e no metabolismo 
celular. Tal clarificação é crucial para entender as funções dos esfingolípidos mais 
detalhadamente e desta forma, definir novas estratégias que contribuam para 
melhorar a saúde humana e estender a sua longevidade.  
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                             General Introduction 
 
 
 
 
 
 
 
 
 
 
 
 There is a single light of science, and to brighten it anywhere is to brighten 
it everywhere. 
            Isaac Asimov 
CHAPTER I 
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1.1. Yeast as an eukaryote biological model system 
 
Yeast is an unicellular fungus of the phylum Ascomycetes, class 
Hemiascomycetes and separated into the main order Saccharomycetales (Guarro 
et al., 1999). Single cells may undergo budding (eg. Saccharomyces) or direct 
division (fission, eg. Schizosaccharomyces) and can even grow as simple irregular 
filaments (mycelium) (Guarro et al., 1999). In sexual reproduction, most yeasts 
form asci, which contain up to eight haploid ascospores (Guarro et al., 1999). For 
the past decades, the budding yeast Saccharomyces cerevisiae has been widely 
used for much of molecular and cellular research because basic aspects of 
replication, cell division and overall cellular metabolism are highly conserved 
between yeast and higher eukaryotes, including mammals (Petranovic et al., 2010, 
Botstein & Fink, 2011). Fundamental processes such as cell cycle (Cross et al., 
2011), secretory pathway (Papanikou & Glick, 2009), autophagy (Loewith & Hall, 
2011), apoptosis (Carmona-Gutierrez et al., 2010) and the endoplasmic reticulum 
(ER) unfolded protein response (UPR) (Mori, 2009) have been extensively 
characterized in yeast. The new insights obtained in yeast have served in many 
ways to foster our understanding about the role of such cellular processes in 
human health and disease.  
Among all eukaryotic model organisms, S. cerevisiae combines several 
advantages. It can be cultured in different media, it has a short doubling time and 
convenient experimental tractability, due to simple and inexpensive growth 
conditions and easy genetic manipulations (Franssens et al., 2013). The complete 
sequencing of its genome in 1996 was extremely useful for a comprehensive study 
of genes in human genome and other higher eukaryotes. Furthermore, the ease of 
genetic manipulation in yeast allows its use for conveniently analyzing and 
functionally dissecting gene products from other eukaryotes (Franssens et al., 
2013). The development of DNA transformation has made yeast particularly 
suitable for gene cloning and genetic engineering techniques (Winzeler et al., 
1999). The identification of genes corresponding to virtually any genetic trait can 
be identified by complementation from plasmid libraries (Hu et al., 2007). Plasmids 
can be introduced into yeast cells either as replicating elements or by 
chromosomal integration into the genome (Forsburg, 2001, Hu et al., 2007, 
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Dunham & Fowler, 2013). The phenotypes arising after either deletion or 
overexpression of yeast genes have significantly contributed to our understanding 
of proteins function in vivo. These techniques have been extensively exploited for 
the analysis of gene regulation, structure-function relationships of proteins, 
chromosome structure, and other general questions in cell biology (Forsburg, 
2001, Dunham & Fowler, 2013). This is illustrated by the fact that the identification 
of genes in yeast usually precedes the discovery of human orthologs 
(approximately 25% of all yeast gene deletions can be complemented by the 
corresponding human orthologs and 60% of yeast genes have significant 
homology with at least one conserved domain of human genes) and mammalian 
genes can be introduced into yeast for systematic analyses of the functions of the 
corresponding gene products (Foury, 1997, Forsburg, 2001, Smith & Snyder, 
2006, Dunham & Fowler, 2013). More recently, heterologous expression of non-
natural occurring proteins in yeast has provided novel insights into human age-
associated and neurodegenerative diseases, including Alzheimer´s and 
Parkinson´s diseases (Zhang et al., 1994, Outeiro & Lindquist, 2003, Vanhelmont 
et al., 2010, Sampaio-Marques et al., 2012, Dunham & Fowler, 2013, Franssens et 
al., 2013). 
As the first available eukaryal genome  (http://www.genome.gov/10000510), 
comprehensive functional, genomic and proteomic methodologies have been 
firstly established in yeast, which allowed the discovery of a complex array of 
interacting pathways at a transcriptional and regulatory level (Botstein & Fink, 
2011, Dunham & Fowler, 2013). Ultimately, it became the basis of several used 
technologies, such as yeast two-hybrid, high-throughput screening, microarrays 
and ChIP (Dunham & Fowler, 2013). Moreover, high-throughput data obtained 
from functional and genomic tools, such as transcriptome, proteome, metabolome 
and flux analysis, interactome and locasome analysis are currently compiled in 
well-curated bioinformatic databases (Botstein & Fink, 2011, Karathia et al., 2011) 
that provide overall information about protein-protein interactions, genetic 
interactions, protein function and predicted orthologs in higher eukaryotic 
organisms (Botstein & Fink, 2011). On this regard, yeast is utterly the eukaryote 
organism with the most complete experimental database and S. cerevisiae has 
become essential in systems biology by providing a global mapping of gene and 
protein interaction within the cell and a comprehensive understanding of 
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eukaryotic cellular processes (Mustacchi et al., 2006). 
As any model system, yeast also presents some limitations as a working 
biological system. One major problem is the fact that yeast is unicellular and much 
less complex than mammalian cells (Karathia et al., 2011, Zakrajsek et al., 2011). 
In order to understand the etiology of multifactorial diseases, such as diabetes or 
metabolic syndrome, studies in yeast are limited due to the absence of multi-
organic integration signalling imposed by multicellularity during evolution. For 
instance, assessing the role of intercellular interactions and systemic mechanisms, 
such as endocrine and hormone regulation, lies beyond the scope of yeast as a 
biological system. In neurodegenerative disease, the study of basic aspects 
associated with synaptic transmission and glial-neuronal processes are hindered 
(Khurana & Lindquist, 2010). Another important disadvantage is the occurrence of 
gene duplications, which may difficult the identification of new genes due to 
redundancy effects (van der Klei & Veenhuis, 2006).  
There are also specific aspects related to yeast physiology, such as the cell 
wall and associated signalling pathways (eg. the CWI pathway) (Levin, 2011). For 
instance, the lipid and protein composition of cell surface greatly varies between 
yeast and mammals and therefore response to stimuli may produce distinct effects 
on cell physiology and metabolism. In pharmacotoxicologic studies, yeast usually 
require higher concentrations of the compound that is often required to produce a 
toxic effect in mammalian cell systems, presumably due to the barrier presented 
by the cell wall and various efflux pumps (Matuo et al., 2012). Importantly, 
mammalian cells have diversified, from an evolutionary point of view, to include 
cellular specialization and compartmentalization without homology in yeast. Yeast 
mitochondria, for example, lack a typical complex I although it possesses a 
structurally simpler complex named external NADH dehydrogenase 2 (Ndh2p, also 
known as Nde2p) (Luttik et al., 1998). In this regard, studies assessing the effect 
of loss-of-function of complex I, such as in Parkinson´s disease (Kosel et al., 1996, 
Keeney et al., 2006), are limited. 
 In the scope of this study, the elucidation of sphingolipid metabolism and 
dynamics and their route of synthesis were primarily done in yeast cells and have 
been important to uncover new functions of sphingolipids and to understand the 
mechanisms for sphingolipid homeostasis in human health and disease (Dickson, 
2008, Huang et al., 2013). The budding yeast has been used to identify nearly all 
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of the genes that encode for sphingolipid metabolic enzymes and many of these 
were critical in identifying mammalian homologs (Rego et al., 2014). Since yeast 
and mammals share many similarities in sphingolipid metabolism and signalling 
(Dickson, 2008, Rego et al., 2014), S. cerevisiae is considered a valuable model 
organism to study sphingolipid functions and regulation.  
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1.2. Aging and disease 
 
 Aging is a biological process characterized by a progressive loss of 
metabolic and physiological integrity of an organism, which leads to a gradual 
deterioration of biomolecules and impairment of stress resistance mechanisms. 
Aging has become the primary risk factor for the development of many 
pathological conditions, including cancer, neurodegenerative diseases, diabetes, 
cardiovascular disorders, sarcopenia and liver dysfunction (Kirkwood, 2005, 
Tosato et al., 2007, Newgard & Pessin, 2014). 
Several hypotheses have been proposed to explain the etiology of the 
aging process. It was firstly proposed that aging is stochastic rather than 
programmed due to a decrease in forces of natural selection for maintenance in 
the post-reproductive phase of life (reviewed in (Kirkwood, 2008)). From an 
evolutionary point of view however, biological processes that slow or counteract 
the deleterious effects of aging are more advantageous and therefore expected to 
be preferentially selected in individuals to prolong life and give rise to more 
progeny. As a result of this conception, the notion of gerontogenes (genes that 
increase lifespan when overexpressed or mutated) and lifespan extension 
mechanisms have emerged and became the basis for the theory of antagonistic 
pleiotropy (Williams, 2001, Williams & Day, 2003). It was postulated the existence 
of positive evolutionary selection of genes in early life stages that confers 
advantageous effects but possibly adverse effects later in life (at post-reproductive 
phase) (Williams, 2001, Williams & Day, 2003). 
Cells are constantly exposed to a harmful environment throughout life. In 
particular, early work on DNA damage has established it as a main cause of aging 
due to gradual impairment of DNA repair processes and DNA loss of integrity 
(Chen et al., 2007). From this, aging would be genetically determined by 
deleterious changes on repair and maintenance mechanisms under the genetic 
control (Chen et al., 2007, Kirkwood, 2008, Rodriguez-Rodero et al., 2011). The 
disposable soma theory predicts that stochastic accumulated damage and decline 
of maintenance and repair systems cause aging in somatic tissues, whereas the 
germ line is carefully maintained and kept immortal (Kirkwood & Holliday, 1979). 
However, several studies have demonstrated that aging is not fully genetically 
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programmed and also relies on the interaction with environmental factors, raising 
to the general notion that aging is a multifactorial phenomenon characterized by a 
time-dependent decline in physiological function (Kirkwood & Melov, 2011).  
Over recent years, the unprecedented advance in genomics and several 
other ´omic´ areas has provided crucial evidence on the nature and the underlying 
mechanisms governing the aging process. These approaches include the 
discovery and identification of key genes and pathways, genetic studies of 
heritable diseases with common denominators with premature aging and 
physiological and metabolic profiling that relates cellular and organismal 
alterations with hallmarks of aging (Mair & Dillin, 2008, Kirkwood & Melov, 2011, 
Rodriguez-Rodero et al., 2011, Lopez-Otin et al., 2013, Newgard & Pessin, 2014). 
Importantly, advances in human genetics and cellular biology allowed to scrutinize 
the sources of aging-related changes, the maintenance and repair mechanisms 
responsible for cell homeostasis, the outcome resulting from the intersection 
between deleterious changes and lifespan-promoting processes and finally the 
ability to ameliorate and retard normal aging (hormetic regulation of aging) and 
hence extend healthy lifespan. On this regard, aging can be envisioned as a 
biological process determined by the interconnectedness between genetic and 
biochemical processes, usually conserved in evolution, and environmental factors. 
Over a lifetime, this leads to a gradual accumulation of detrimental changes in 
molecules, cells and tissues associated with a general decline in stress tolerance 
functions, therefore limiting the ability of an organism to maintain homeostasis. As 
a result, individuals present higher risk to develop age-related diseases (cancer, 
cardiovascular and neurodegenerative disorders) and premature mortality (Lopez-
Otin et al., 2013). 
On the scope of this thesis, some hallmarks of aging will be described, 
namely genomic and telomere instability, epigenetic alterations, loss of 
proteostasis, impaired nutrient sensing and stem cell exhaustion. 
 
1.2.1. Genomic instability and telomere shortening 
 
Senescence is a complex process involving genetic and environmental 
factors affecting most physiological pathways. Among species, the average 
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lifespan is very wide, which indicates that maximum lifetime is partially determined 
by specific aspects of species genotypes and ultimately the individual´s genotype.  
Over a lifetime, DNA is exposed to several physical and chemical factors 
(e.g. phthalates and UV radiation) and biological agents (viruses) that compromise 
genomic stability and integrity (Rodriguez-Rodero et al., 2011). In addition, 
increased damage promoted by reactive oxygen species (ROS), gradual 
impairment of DNA repair mechanisms and the accumulation of DNA replication 
errors during life correlates with cell senescence and aging (Rodriguez-Rodero et 
al., 2011). It can encompass genomic alterations (point mutations and 
polymorphisms), loss (or gain) of repeated DNA sequences, telomere shortening, 
mitogenic signals (oncogenes), gene disruption promoted by transposons and 
rearrangements in chromosome number (aberrant euploidy and aneuploidy) 
(Burhans & Weinberger, 2007, Vijg & Suh, 2013).  
Importantly, the identification of genes and mutations responsible for age-
related monogenic hereditary disorders (progeroid syndromes) has been critical to 
uncover the function of a specific group of genes in an individual’s lifespan. 
Progerias are characterized by a premature aging phenotype and have become a 
model to study aging-associated genetic changes (Rodriguez-Rodero et al., 2011). 
It includes Cockayne syndrome, Werner, Fanconi anemia, Bloom, Rothmund-
Thomson and Hutchinson-Gilford syndromes, ataxia-telangiectasia and xeroderma 
pigmentosum, which are characterized by accelerated aging promoted by 
mutations in genes implicated in genetic stability and DNA repair (Rodriguez-
Rodero et al., 2011).  
The genomic stability also includes specific mechanisms responsible for the 
maintenance and functionality of telomeres. Telomeres are DNA-protein 
complexes that cap and stabilize the ends of linear DNA strands, thus preventing 
chromosome instability. A correlation between telomere shortening and somatic 
stem cell decline during aging has been established in the past few decades (Vijg 
& Suh, 2013, Townsley et al., 2014). It has been shown that repetitive DNA 
sequences at chromosome ends shortens with age, as observed in fibroblasts and 
lymphocytes, due to the lack of adequate telomerase activity (Bodnar et al., 1998), 
but also in hematopoietic stem cells (HSC), making cells more susceptible to 
mutation, apoptotic cell death and reduced ability to self-renewal (Lansdorp, 
1995). In fact, telomere shortening or lengthening is associated with shortened 
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and extended lifespan in mice, respectively (Bernardes de Jesus et al., 2012). 
Telomerase deficiency has also been associated with age-associated diseases, 
such as pulmonary fibrosis, dyskeratosis congenita and aplastic anemia, due to 
replicative senescence and decreased regenerative capacity in tissues (Townsley 
et al., 2014).  
 
1.2.2. Epigenetic alterations 
 
The emergence of human epigenetics as a key regulator in gene 
expression and integrity has become the basis for the so-called epigenetic theory 
of aging (Berdasco & Esteller, 2012). It postulates that non-adaptive epigenetic 
alterations in cells and tissues contribute to aging. Epigenetic regulation includes 
alterations in the methylated state of genes and regulatory DNA sequences, 
covalent modifications of histones, chromatin remodeling and the expression of 
regulatory non-coding RNAs (Berdasco & Esteller, 2012).  
Some studies have demonstrated that epimutations accumulate throughout 
life, leading to activation of genes normally downregulated epigenetically. In 
particular, some modifications, such as histone H4K16 acetylation (Dang et al., 
2009), H4K20 (Sarg et al., 2002) and H3K4 trimethylation (Greer et al., 2011) and 
reduced H3K9 methylation or H3K27 (Sidler et al., 2014), have been associated 
with increased aging. Age-related epigenetic alterations also include the formation 
of nuclear regions called senescence-associated heterochromatin foci (SAHF) 
(Narita et al., 2003). At these regions, heterochromatin proteins and 
Retinoblastoma (Rb) protein are recruited to E2F-dependent promoters of 
proliferative genes, therefore repressing E2F target genes (Narita et al., 2003).  
The activity of DNA methyltransferases, deacetylases and histone 
demethylases and protein complexes involved in chromatin remodeling is altered 
with aging (Berdasco & Esteller, 2012). Importantly, the activity of the NAD-
dependent deacetylase SIRT1, which belongs to the sirtuin family, decreases 
throughout life (Berdasco & Esteller, 2012) and Herranz et al. have shown that the 
overexpression of SIRT1 improves healthy lifespan but does not extend longevity 
(Herranz et al., 2010). Although the mechanisms are rather complex, it affects 
genome stability by modifying chromatin and repressing the transcription of 
integrated reporter genes through its intrinsic acetylase activity (Vaquero et al., 
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2004). Another anti-aging factor that has come to the foreground of research area 
in recent years is the NAD-dependent deacetylase SIRT6. This protein contributes 
to genomic stability (DNA repair) and regulates H3K9 and H3K56 deacetylation in 
telomeric regions, which is involved in NF-kB-dependent modulation of gene 
expression, apoptosis, and cellular senescence (Kawahara et al., 2009, Yuan et 
al., 2009). SIRT6-deficient cells are characterized by enhanced genomic instability 
due to non-clonal chromosomal aberrations and breakage as well as 
hypersensitivity to γ-irradiation and age-related alterations (cachexia, kyphosis, 
and osteopenia) (Mostoslavsky et al., 2006), and also the hyperacetylation of the 
H3K9 locus that enhances NF-kB signalling, which ultimately leads to cell death 
and aging (Kawahara et al., 2009). On the other hand, increased expression of 
SIRT6 prolongs life by mechanisms involving reprogramming of aging cells and 
alterations in metabolism, such as reduced signalling through the serum insulin-
like growth factor (IGF-1) and other members of the IGF signalling pathway (Kanfi 
et al., 2012), whose activities are known to be lowered in long-lived mutants 
(Kenyon, 2010).  
The DNA methylation pattern of individuals with progerias is altered and 
resembles the ones in aged cells. More recently, a number of disorders have been 
documented and associated to genetic imprinting, including cancer and 
syndromes involving chromosomal instabilities, namely Angelman, Prader-Willi 
and Beckwith-Wiedemann syndromes (Adams, 2008). These disorders are caused 
by abnormal activation or silencing of genes by epigenetic mechanisms, usually 
resulting in non-adaptive alterations of the epigenetic landscape and disease 
(Adams, 2008, Berdasco & Esteller, 2012).  
 
1.2.3. Loss of protein homeostasis (proteostasis) 
 
During evolution, organisms have developed stress response mechanisms 
to adapt to harsh environmental conditions and intrinsic stress. In particular, 
perturbations on protein homeostasis or proteostasis, associated with changes in 
calcium concentration, glucose deprivation, redox changes or ischemia, impair the 
function of protein control quality mechanisms and the fidelity of the protein folding 
(Salminen & Kaarniranta, 2010, Taylor & Dillin, 2011). As a result, the 
accumulation of unfolded proteins and damaged components has severe 
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consequences for cell physiology and metabolism and contributes to aging and 
development of age-related and neurodegenerative diseases, such as Alzheimer´s 
and Parkinson´s disease (Taylor & Dillin, 2011). This observation is the 
biochemical basis for a wide variety of diseases termed ER storage or 
conformational diseases (Rutishauser & Spiess, 2002).  
In order to adapt to such hostile environment, the cell has evolved an 
adaptive and coordinated response to limit the accumulation of unfolded proteins 
called unfolded protein response (UPR) (Schröder & Kaufman, 2005, Kimata et al., 
2006, Mori, 2009). In this mechanism, the ER-located transmembrane protein 
endoribonuclease IRE1 is autophosphorylated and catalyzes the cytoplasmic 
splicing of the XBP1 mRNA. The spliced version of this mRNA is translated into 
the transcription factor XBP1 that induces various genes to alleviate the ER stress 
condition (Mori, 2009). At this stage, the folding demand is decreased by 
downregulating the transcription of genes encoding secretory proteins (Travers et 
al., 2000), and by promoting the clearance of slowly folding or misfolded proteins 
through the activation of the ER-associated degradation (ERAD), ubiquitin 
proteasome system and autophagy (Randolph Y, 2002, Nishikawa et al., 2005, 
Mori, 2009). Each of these proteostastic mechanisms are capable of eliminating 
damaged proteins or triggering a more global response, such as cell cycle arrest 
or apoptosis upon severe proteotoxic stress. To enhance the folding capacity of 
the ER, the expression of ER resident molecular chaperones and foldases is 
enhanced (Nishikawa et al., 2005) and the ER increases in size in order to dilute 
enhanced unfolded protein load, and alleviate the folding capacity and the 
accumulation of misfolded proteins (Schuck et al., 2009).  
The aging process is characterized by the gradual impairment of ER 
function and proteostasis, eventually leading to the accumulation of harmful 
protein modifications, misfolding and aggregation of proteins, disturbances in Ca2+ 
homeostasis and impairment in global protein synthesis (Squier & Bigelow, 2000, 
Kregel & Zhang, 2007, Lindner & Demarez, 2009, Jones, 2010). Moreover, the 
decline in autophagic and proteasomal degradation with aging compromises 
protein quality control and promotes the accumulation of misfolded and oxidized 
proteins. Many of the key components of the UPR such as the chaperones and 
enzymes display reduced expression and activity, resulting in a dysfunctional ER 
(Salminen & Kaarniranta, 2010). Unresolved and sustained ER stress leads to a 
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more deleterious outcome with increased protein accumulation, loss of ER 
function and activation of apoptotic cascades that ultimately contribute to cell 
death and aging (Tabas & Ron, 2011).  
 
1.2.4. Impaired nutrient signalling 
 
 The ability to utilize substrates and nutrients to fuel energy production for 
the homeostatic maintenance of cell-intrinsic processes is a characteristic of all 
living organisms. This is dictated by coordinated nutrient-sensing systems that are 
able to integrate metabolic and physiological signals to maintain cell and 
organismal homeostasis. It is well documented that these pathways become 
increasingly less efficient and dysfunctional, making cells more prone to develop 
disease. In fact, core metabolic pathways such as glycolysis, fatty acid oxidation, 
amino acid oxidation, lipogenesis, and ketogenesis become less efficient with 
aging (Newgard & Pessin, 2014). Crucial sensing protein complexes have 
received attention in the past few years in the field of aging, namely the nutrient 
and growth factors sensing mammalian Target Of Rapamycin Complex 1 
(mTORC1), the AMP-dependent protein kinase (AMPK) and sirtuins (Newgard & 
Pessin, 2014). 
 
 1.2.4.1. mTORC1 signalling 
 
 The mTORC1 is a highly conserved serine/threonine protein kinase 
complex activated by growth factors, mitogens and nutrients that is involved in the 
temporal control of cell growth by promoting transcription, ribosome biogenesis, 
nutrient transport, and inhibiting autophagy (Laplante & Sabatini, 2012, Johnson et 
al., 2013). The downregulation of mTORC1 activity, either pharmacologically 
(upon treatment with rapamycin) or genetically, extends the lifespan of several 
organisms, ranging from yeast (Medvedik et al., 2007, Pan et al., 2011), flies 
(Bjedov et al., 2010), nematodes (Vellai et al., 2003) alongside with mammals 
(Harrison et al., 2009, Miller et al., 2011). It also partly mediates the beneficial 
effects of calorie restriction (CR), which is currently the classic paradigm for 
studying the role of metabolism in aging (Blagosklonny, 2010, Sharp & Strong, 
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2010). There is increasing evidence showing that mTORC1 and the protein kinase 
S6K, one of mTORC1 effectors, contribute to aging and age-related diseases, 
such as type II diabetes mellitus and cancer (Manning, 2004, Inoki et al., 2005). It 
has been recently shown that the role of mTORC1-S6K1 signalling in the 
regulation of longevity is associated with insulin and IGF-1 signalling (Manning, 
2004). In mouse models of reduced IGF1 signalling, namely haploinsufficiency of 
IGF-1 receptor and deletion of insulin receptor substrate-1 (IRS-1), lifespan 
extension was correlated with reduced mTORC1–S6K1 signalling (Holzenberger 
et al., 2003, Selman et al., 2008). Moreover, caloric restriction (CR) prolongs 
lifespan in several models in part due to overlapping effects of reduced mTORC1-
S6K1 activity and diminished IGF-1 signalling pathway (reviewed in (Fontana et 
al., 2010)).  
 Although the mechanisms involved in the anti-aging effects of 
downregulation of mTORC1 activity are rather complex and interconnected, some 
studies have provided evidence that it may promote survival by reducing overall 
mRNA translation rate and protein synthesis. It would then relieve ER stress, 
preventing the accumulation of mistranslated and misfolded proteins and loss of 
proteostasis (Cornu et al., 2013, Johnson et al., 2013). The inhibition of mTORC1 
activity also induces macroautophagy (Johnson et al., 2013), which promotes the 
clearance of damaged biomolecules (DNA, proteins, lipids) and organelles that 
can be detrimental and induce pathological changes (Cornu et al., 2013, Johnson 
et al., 2013). mTORC1 inhibition also improves stem cell function and therefore 
the ability of tissue self-renewal (see 1.2.5.). 
 
 1.2.4.2. AMPK signalling 
 
 AMP-activated protein kinase (AMPK) is a highly conserved sensor of AMP 
and ADP levels (Mihaylova & Shaw, 2011). In glucose sensing, AMPK stimulates 
energy generation from glucose and fatty acids during stress and inhibits energy-
consuming processes, such as protein, cholesterol and glycogen synthesis 
(Hardie, 2007, Mihaylova & Shaw, 2011). Compelling evidence has demonstrated 
however that the function of AMPK is not restricted to the maintenance of energy 
metabolism but also in the regulation of several homeostatic mechanisms, such as 
autophagy (Alers et al., 2012) and general stress response by improving tissue 
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stress resistance (Greer et al., 2009). For instance, the activation of AMPK 
reduces oxidative stress by increasing thioredoxin expression (Li et al., 2009) and 
can suppress deleterious effects promoted by ER stress and inflammation (O'Neill 
& Hardie, 2013).  
 The role of AMPK in the regulation of aging process is supported by the 
general observation that proper energy metabolism is required for adequate 
organismal homeostasis whereas excessive consumption of energy promotes 
aging and contribute to pathology. It is therefore not surprising that AMPK activity 
is increased and mediates some of the anti-aging effects of CR (Canto & Auwerx, 
2011). Importantly, the beneficial effects of CR may be related to the 
downregulation of mTORC1 by AMPK, increased induction of autophagy by 
inhibiting mTOR and increasing ULK1 signalling and AMPK-induced stimulation of 
FoxO/DAF-16, Nrf2/SKN-1, and SIRT1 pro-longevity signalling pathways, which 
improve cellular stress resistance (Salminen & Kaarniranta, 2012). On the other 
hand, nutritional overload seems to impair AMPK activity and concurrently induce 
insulin resistance and inflammation in many tissues, thus increasing the propensity 
to develop obesity, diabetes and cardiovascular diseases (Gauthier et al., 2011). 
 Several studies have indicated a potentially important role of AMPK 
orthologues in regulating aging, although the specific mechanisms are not yet fully 
understood. For instance, loss of the yeast AMPK homolog Snf1p shortens yeast 
replicative lifespan (Ashrafi et al., 2000). The activation of AAK-2 (AMP-activated 
kinase-2 in C. elegans) and AMPK by metformin or its overexpression extends 
lifespan (Apfeld et al., 2004, Onken & Driscoll, 2010). The knockout of AMPKα2 
has a detrimental effect on health and lifespan in mice. In contrast, metformin 
treatment in rodents prevents cancer incidence and cardiovascular diseases and 
extends lifespan (Viollet et al., 2003). More recently, the upregulation of AMPK in 
the adult Drosophila nervous system was shown to induce autophagy both in the 
brain and the intestinal epithelium and this was linked to reduced IGF-1 signalling 
and systemic activation of dFOXO, eventually contributing to slow organismal 
aging (Ulgherait et al., 2014).  
 The responsiveness of AMPK activation declines during the aging process, 
presumably due to decreased ability to tolerate metabolic stress. Importantly, the 
impairment of AMPK signalling has been consistently associated with age-
associated diseases, namely cardiovascular diseases and metabolic syndrome. 
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For instance, Qiang et al. reported that impaired AMPK activation and inhibited 
insulin-stimulated glucose uptake into muscles during aging could enhance the 
development of metabolic syndrome (Qiang et al., 2007). Turdi et al. reported that 
reduced AMPK activity aggravated aging-driven myocardial dysfunction through 
impaired mitochondrial function and ROS production (Turdi et al., 2010). Recent 
associations drawn between the metabolic syndrome and the suppression of 
AMPK-regulated pathways at a cellular level support that therapeutic activation of 
AMPK may be beneficial to treat diabetes and obesity (Ruderman et al., 2013). 
Overall, decreased AMPK activation can decrease cellular autophagy, increase 
cellular stress and promote inflammation, leading to senescence and aging. 
 
 1.2.4.3. Sirtuins 
 
 Sirtuins belong to a conserved family of nicotinamide adenine dinucleotide 
(NAD+)-dependent protein deacetylases that regulate lifespan in some organisms, 
including yeast and mice (Nakagawa & Guarente, 2011). The role of sirtuins in 
aging came from early studies in yeast and worms showing that the deletion of 
SIR2 gene severely shortens lifespan in S. cerevisiae, while its overexpression 
extends lifespan (Kaeberlein et al., 1999). Moreover, the sirtuins activator 
resveratrol mimics CR by enhancing Sir2p activity, which in turn increases DNA 
stability and promotes yeast lifespan extension by 70% (Howitz et al., 2003). The 
overexpression of Sir-2.1, the homologue of yeast Sir2p, increases lifespan in C. 
elegans and Drosophila. Importantly, Banerjee et al. found that deletion of dSir2 
abrogates the lifespan-extending effect by starvation, demonstrating that dSir2 
expression is required for longevity in starvation conditions (Banerjee et al., 2012). 
More recently, an interplay between sirtuins, ROS signalling and aging has 
emerged (Merksamer et al., 2013). Upon activation, the (NAD+)-dependent 
deacetylases SIRT1 and SIRT3 deacetylate some proteins, namely superoxide 
dismutase SOD2, and increase the expression of oxidative stress genes including 
glutathione peroxidase (GPx1), catalase, and manganese SOD (MnSOD), which 
mediate some beneficial effects of CR by decreasing ROS levels and oxidative 
damage (Merksamer et al., 2013). 
 The importance of SIRT1 is demonstrated by the observation that a high-fat 
diet leads to cleavage of SIRT1 induced by inflammation in mice (Chalkiadaki & 
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Guarente, 2012), and obesity produces similar effects in humans (Pedersen et al., 
2008). Similarly, loss of sirtuin activity contributes to metabolic syndrome and 
diabetes in mice and humans whereas transgenic overexpression of SIRT1 
attenuates the onset of these age-related diseases. For instance, the mild 
overexpression of SIRT1 in mice on a high-fat diet and diabetic mice causes a 
significant reduction in blood glucose and plasma insulin levels (Li et al., 2011). 
The protective effect of SIRT1 also appears to be related to the mitigation of pro-
inflammatory responses, since the overexpression of SIRT1 diminishes hepatic 
steatosis and adipose tissue–specific inflammation (Li et al., 2011). In addition, 
histone deacetylation has been shown to decrease the induction of pro-
inflammatory genes (Nakagawa & Guarente, 2011) and SIRT1 seems to play an 
important role. In fact, decreased SIRT1 levels are linked with the onset and 
progression of inflammatory-associated disease and the activation of SIRT1 may 
prevent acute events following induction of inflammation (Nakagawa & Guarente, 
2011).  
 Another sirtuin protein involved in aging is SIRT6. Mice deficient in SIRT6 
exhibit severe metabolic defects and premature aging (Mostoslavsky et al., 2006), 
whereas the overexpression of SIRT6 promotes longevity in male mice (Kanfi et 
al., 2012). Conversely, SIRT6 overexpression protects from obesity with enhanced 
glucose tolerance and reduced fat storage (Kanfi et al., 2010). The effect seems to 
be, in part, mediated by the downregulation of the IGF-1 signalling pathway, which 
contributed to extend lifespan in male mice (Kanfi et al., 2012). Nevertheless, the 
protective effect of SIRT6 (and SIRT1) could also be related to DNA damage 
response, genome integrity	   and telomere maintenance, as previously discussed 
(Nakagawa & Guarente, 2011) (see 1.2.2.). 
 
1.2.5. Stem cell exhaustion 
 
 Aging is determined by alterations in differentiated cells, such as neurons, 
and partly by changes in mitotic cells, including stem cells and restricted 
progenitors. Stem cells persist throughout life in numerous mammalian tissues and 
contribute to maintain organismal homeostasis due to the regenerative role in 
tissues. However, the decline in stem cell function with aging is well documented, 
including in blood cells, forebrain, skeletal muscle, and skin cells (Lopez-Otin et 
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al., 2013, Oh et al., 2014). Therefore, age-related changes in the function of stem 
cells and other progenitors may contribute to some aspects of disease and aging.  
 The attrition of stem cell regenerative capacity is usually associated with 
DNA damage, telomere shortening and mitochondrial damage with aging (Oh et 
al., 2014). These are examples of how the decline of stem cell function emerges 
as an integrative consequence of overall cellular damage in the organism. In fact, 
mitochondrial activity, tissue growth, and metabolic rates during development 
influence the rates of cellular growth and proliferation and stem cells must be able 
to adapt their function to match the demands of tissues throughout life (Lopez-Otin 
et al., 2013). Therefore, stem cell quiescence during aging derives from the 
interactions between cell-intrinsic (proliferation, frequency, differentiation) and    
cell-extrinsic mechanisms (nutrient sensing, inflammation) (Oh et al., 2014).  
 
 
Figure 1.1. The hallmarks of aging. The main causes of the aging process are depicted 
and currently the major challenge is to establish the interconnection between these 
hallmarks and define new strategies to improve healthy lifespan and prevent the onset of 
age-related diseases, such as cancer, neurodegenerative, cardiovascular, liver and 
inflammatory diseases. The Figure was adapted from López-Otín et al., 2013.   
 
 Importantly, some anti-aging interventions, such as CR or administration of 
rapamycin (inhibition of mTOR), have been shown to improve stem cell aging in 
the epidermis, hematopoietic system and intestine (reviewed in (Ramos & 
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Kaeberlein, 2012)). Parabiosis experiments, which involve the exposure to 
systemic and humoral factors from a young parabiont (sharing circulation with an 
old mouse), also proved to restore proper stem cell function (Conboy et al., 2013). 
 Taking altogether, aging is dictated by the impairment of several genetic 
and cellular mechanisms and disruption of signalling pathways with time that 
culminates in the progressive inability to maintain organismal homeostasis and the 
emergence of age-related disease and premature mortality (Figure 1.1). 
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1.3. Oxidative stress and mitochondrial dysfunction in the 
aging process 
 
1.3.1. The mitochondrial free radical theory of aging 
  
Mitochondria are eukaryotic organelles involved in various functions, 
namely amino acid and nitrogen metabolism, apoptosis, ion and metabolite flux, 
intermediate metabolism (Krebs cycle), lipid metabolism, nucleic acid metabolism, 
mitochondrial DNA (mtDNA) inheritance, signal transduction, stress response and 
most importantly ATP production through the respiration chain/oxidative 
phosphorylation process (Hajnoczky & Hoek, 2007, Pereira et al., 2008, Vendelbo 
& Nair, 2011). The mitochondrial matrix is the site of metabolic processes such as 
the Krebs cycle, fatty-acid oxidation, Fe-S biogenesis, and heme synthesis 
(Pereira et al., 2008, Lill et al., 2012). Mitochondrial protein folding and 
degradation (mitochondrial unfolded protein response, mtUPR), mtDNA 
replication, transcription and translation also occur in the matrix (Pellegrino et al., 
2013). The inner membrane contains protein complexes necessary for electron 
transport and ATP synthesis, metabolite transporters, and factors involved in 
mitochondrial turnover. Cytochrome c is the most abundant component in the 
intermembrane space, which also includes mitochondrial fusion proteins, import 
proteins and redox enzymes (Westermann, 2010, Pellegrino et al., 2013). The 
outer membrane includes protein transporters, and factors involved in metabolite 
influx/efflux, mitochondrial fission and fusion and apoptosis (Pereira et al., 2008, 
Westermann, 2010).  
The recognition of the importance of oxidative stress in longevity pathways 
has become the hallmark of the free radical theory of aging firstly proposed by 
Harman in 1956 (Harman, 1956). It is proposed that cumulative damage to 
biological macromolecules by ROS leads to irreversible cell damage and overall 
functional decline. Later on, the free-radical theory was refined in 1972 to include 
mitochondria, as they constitute a major site for ROS production (Harman, 1972).  
ROS are byproducts formed resulting from the electron leakage in complex 
I and complex III, where oxygen is reduced to arise the superoxide radical. 
Superoxide dismutases convert superoxide radicals into hydrogen peroxide, which 
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can be further reduced to hydroxyl radicals by Fe2+. All together, these ROS are 
key contributors to oxidative damage (Vendelbo & Nair, 2011) (Figure 1.2). 
Numerous studies provide evidence for the impact of oxidative imbalance in aging, 
mostly using animal models.  
The involvement of mtDNA in longevity pathways has received 
considerable attention (Shokolenko et al., 2014). Indeed, it presents a higher 
mutation rate, which is attributed to its close proximity to the electron transport 
chain. Unlike nuclear DNA, mtDNA does not present the protective effect of 
histones against oxidative damage but instead forms protein-DNA complexes 
(nucleoids) in the mitochondrial matrix (Shokolenko et al., 2014). Although this 
nucleoid formation makes mtDNA more impervious to oxidative damage, it 
remains more susceptible to ROS-mediated damage than nuclear DNA 
(Shokolenko et al., 2014).  
During lifetime, the random accumulation of age-related somatic mtDNA 
mutations contributes to aging (Shokolenko et al., 2014). However, an alternative 
hypothesis has emerged, claiming that most of the mutations are created as 
replication errors during embryogenesis and then undergo clonal expansion and 
cause a mosaic respiratory chain dysfunction in different tissues. Mosaic 
respiratory chain deficiency caused by clonal expansion of mtDNA mutations is 
ubiquitously observed in human aging (Larsson, 2010). In an elegant work, 
Bonawitz et al. demonstrated that in yeast expressing a deficient mitochondrial 
RNA polymerase amino-terminal domain (ATD) mutant (which has efficient but 
imbalanced mitochondrial translation), defective coupling of transcription to 
translation leads to increased ROS production and inhibition of respiration in the 
stationary phase, ultimately limiting CLS (Bonawitz et al., 2006).  
Therefore, life-long exposure to ROS likely results in a preferential 
accumulation of mtDNA damage and accelerated aging. Nowadays, the refined 
mitochondrial free radical theory of aging states that the mitochondrial production 
of ROS, such as superoxide and H2O2, results in the accumulation of damage to 
macromolecules and stress resistance protein systems, which in turn overwhelm 
the capacity of biological systems to repair themselves, resulting in an inevitable 
functional decline. The cumulative increase of ROS production and aging-
associated mutations and alterations in mtDNA stability and integrity can impair 
the function of the respiratory chain and enhance ROS production. This can 
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subsequently leads to exponentially increasing levels of mtDNA damage and 
oxidative stress in the cell, which ultimately culminates in cell death and aging 
(Shokolenko et al., 2014).  
More recently, the mitochondrial free radical theory of aging has been 
challenged. Some recent studies have demonstrated that altered ROS signalling 
can either have no significant or can even be beneficial for longevity. For instance, 
increased ROS production can extend lifespan in yeast (Pan et al., 2011) and C. 
elegans (Lee et al., 2010). In yeast, enhanced ROS levels during growth produce 
a hormetic effect and activate adaptive stress response mechanisms, pre-
conditioning cells to better survive the stationary phase and to extend CLS (Pan et 
al., 2011).  
 
1.3.2. ROS scavenging systems 
 
To live in an oxygen-containing environment, organisms had to evolve 
efficient antioxidant defense systems to cope with the production of ROS. Such 
mechanisms comprise either non-enzymatic and enzymatic components to 
scavenge ROS. ROS-scavenging pathways from different cellular compartments 
act coordinately to avoid the deleterious effects of toxic oxygen products and 
oxidative damage to lipids, proteins, and nucleic acids.  
 
1.3.2.1. Non-enzymatic components of the antioxidant defense system 
 
I. Glutathione  
 
The tripeptide glutathione (γ-glutamyl-cysteinyl-glycine, GSH) is a low 
molecular weight thiol with an important regulatory role against oxidative damage 
(Davies, 2000) (Figure 1.2). It has been detected virtually in all cellular 
compartments such as cytosol, ER, lysosome, and mitochondria. Due to the 
presence of a free thiol group that can transfer two electrons, it can effectively 
neutralize ROS. During ROS scavenging, two molecules of glutathione are 
oxidized to render glutathione disulfide (GSSG) (Davies, 2000, Circu & Aw, 2012). 
The balance between GSH and GSSG is crucial to maintain cell´s redox state and 
the activity of glutathione reductase, a NADPH-dependent enzyme, is required to 
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preserve this balance (Davies, 2000, Circu & Aw, 2012). Due to its reducing 
power, GSH plays an important role in diverse biological processes, including cell 
growth/division, signal transduction, conjugation of metabolites, enzymatic 
regulation, synthesis of proteins and nucleic acids, detoxification of xenobiotics 
and the expression of stress-responsive genes (Aquilano et al., 2014). This 
relevance is supported by the fact that glutathione exist in cells at high 
concentrations (1-10 mM) (Circu & Aw, 2012). 
 
II. Natural Antioxidants: Vitamins and Polyphenols 
 
Diet is an important non-genetic factor for the control of some diseases. 
More specifically, fruits and vegetables have been reported to have a protective 
effect due to high content of vitamins A, C, and E and polyphenol, which present 
antioxidant activity (Landete, 2013). Due to their ability to scavenge ROS, they 
slow or prevent the oxidation of other molecules by removing free radical 
intermediates and inhibiting other oxidation reactions (Landete, 2013). Although 
some inconsistencies on the importance of exogenous antioxidants in vitro and in 
vivo have been reported, it is generally accepted that endogenous homeostatic 
repair mechanisms are unable to prevent global oxidative damage, particularly 
with aging, thereby making sources of dietary antioxidants especially important to 
ameliorate the impact of cumulative oxidative stress overtime (Landete, 2013). 
 
1.3.2.2. Enzymatic components of the antioxidant defense system 
 
I. Superoxide dismutase (SOD) 
 
Superoxide dismutase plays a central role in defense against oxidative 
stress in all aerobic organisms. The enzyme SOD belongs to the family of 
metalloenzymes and catalyzes the dismutation of O2•− to O2 and H2O2 (Figure 1.2) 
(Davies, 2000, Fukai & Ushio-Fukai, 2011). It is present in most of the subcellular 
compartments that generate activated forms of oxygen. In eukaryotic cells, three 
isozymes of SOD are known, namely SOD1, a copper/zinc SOD (Cu/Zn-SOD), 
SOD2, a manganese SOD (Mn-SOD), and SOD3, an extracellular SOD (EC-SOD) 
that contains copper and zinc (Fukai & Ushio-Fukai, 2011). Mn-SOD is localized in 
Chapter I 
	   	   51	  
mitochondria, whereas SOD1 is found in the cytosol, and peroxisome and 
mitochondria (Fukai & Ushio-Fukai, 2011). S. cerevisiae possesses a Cu/ZnSOD 
(Sod1p), predominantly cytosolic, and a mitochondrial form of Mn-SOD (Sod2p) 
(Gralla, 1997).  
Superoxide anions can also be eliminated by metallothioneins, which are 
small and ubiquitous Cys-rich proteins known to be involved in ROS scavenging 
and metal homeostasis (Babula et al., 2012).  
 
II. Catalase and peroxidases 
 
Among antioxidant enzymes, catalase was the first enzyme to be identified 
and characterized in detail. It is a ubiquitous tetrameric heme-containing enzyme 
that catalyzes the dismutation of two molecules of H2O2 into water and oxygen 
(Davies, 2000) (Figure 1.2). It has high specificity for H2O2, but weak activity 
against organic peroxides. Catalases break down hydrogen peroxide by a two-
stage mechanism in which hydrogen peroxide alternately oxidizes and reduces the 
haem iron at the active site. In the first step, one hydrogen peroxide molecule 
oxidizes the haem to an oxyferryl species. In the second step, a second hydrogen 
peroxide molecule is used as a reductant to regenerate the enzyme, producing 
water and oxygen (Gralla, 1997). Catalase is located in the cytosol and the matrix 
of peroxisomes and mitochondria in eukaryotic cells (Gralla, 1997). Interestingly, 
alterations in catalase subcellular localization have been observed in association 
with disease and stress conditions (Zhou & Kang, 2000). In S. cerevisiae, two 
forms of catalase exist, namely the cytosolic catalase Ctt1p and the 
peroxisomal/mitochondrial catalase Cta1p (Gralla, 1997).  
Glutathione peroxidase belongs to the peroxidase family whose main 
biological role relies on the ability to prevent oxidative stress by reducing lipid 
hydroperoxides to their corresponding alcohols and free hydrogen peroxide to 
water (Arthur, 2000, Circu & Aw, 2012, Aquilano et al., 2014). Several isozymes 
were identified in mammals and are encoded by different genes, which vary in 
cellular location and substrate specificity. Glutathione peroxidase 1 (GPx1) is the 
most abundant form of GPx and is mostly located in the cytosol of virtually any 
mammalian tissue (Figure 1.2). 
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Figure 1.2. Cellular ROS production. Mitochondria (and ER) constitute the major source 
of ROS production in cells. The reduction of oxygen to water through the respiratory chain 
proceeds via one electron flow. In the mitochondrial respiratory chain, Complex IV 
(cytochrome c oxidase) retains all partially reduced intermediates until full reduction is 
achieved. However, the redox centers in the electron transport chain may leak electrons 
to oxygen, partially reducing this molecule to superoxide anion (O2•−). Dismutation of O2•− 
produces hydrogen peroxide (H2O2), which in turn may be fully reduced to water or 
partially reduced to hydroxyl radical (OH•) by the Fenton reaction. Several antioxidant 
defense mechanisms contribute to attenuate oxidative damage to biomolecules, namely 
glutathione (GSH), glutathione peroxidases (GPx), catalase and superoxide dismutase 
(SOD).  
 
Glutathione peroxidase 2 (GPx2) is an gastrointestinal and extracellular 
enzyme, while glutathione peroxidase 3 is extracellular, especially abundant in the 
plasma. Eight different isoforms of glutathione peroxidase (GPx1-8) have been 
identified in humans and they require selenium for optimal catalytic and antioxidant 
activity (Arthur, 2000). 
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1.3.3. Yeast as a model to study the role of mitochondria in aging 
 
S. cerevisiae has been crucial to unravel the mechanisms by which cells 
respond to mitochondrial dysfunction and oxidative stress. This involves functional 
and structural alterations in mitochondrial morphology and turnover in response to 
metabolic and environmental cues elicited by cellular signalling pathways. In this 
section, the importance of general cell signalling pathways and mitochondrial 
quality control mechanisms (mitochondrial dynamics, macroautophagy and 
mitophagy) will be introduced as an emerging link to the aging process. 
 
1.3.3.1. TORC1-Sch9p and RAS/PKA pathways in the regulation of 
mitochondrial function, stress response and aging 
 
 Aging in yeast is monitored by counting the number of daughter cells 
generated by an individual mother cell (replicative lifespan, RLS) or by evaluating 
the survival of a population of post-mitotic cells (chronological lifespan, CLS) 
(Fabrizio & Longo, 2003). In S. cerevisiae, glucose, aminoacids and other 
nutrients can activate the responsive Target of Rapamycin (TOR) and the serine 
threonine kinase Sch9p and the Ras/PKA signalling pathways (Fontana et al., 
2010) with significant impact on longevity. 
  An important signalling pathway involved in the regulation of cell growth 
and survival is the highly conserved TOR pathway (Dann & Thomas, 2006). This 
pathway is highly conserved among organisms, ranging from flies, nematodes, 
protozoa alongside with mammals. In S. cerevisiae, the TOR pathway is controlled 
by two Ser/Thr protein kinases, Tor1p and Tor2p, which assemble into two protein 
complexes with distinct subunit composition and regulatory roles (Loewith et al., 
2002, Dann & Thomas, 2006, Kim & Guan, 2011, Loewith & Hall, 2011). The 
rapamycin-sensitive TOR complex 1 (TORC1) contains either Tor1p or Tor2p and 
is mostly associated with the regulation of cell growth (nutrient sensing), 
autophagy, ribosomal and protein turnover and cell proliferation (Evans et al., 
2011, Kim & Guan, 2011). The TOR complex 2 (TORC2) contains Tor2p, but not 
Tor1p, and mediates the proper maintenance of the cell cytoskeleton (Cybulski & 
Hall, 2009) and was recently implicated in the regulation of ceramide biosynthesis 
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by a Ypk2p-dependent mechanism (Aronova et al., 2008). Furthermore, TORC2 
indirectly modulates the sphingomyelinase Isc1p activity through the 
phosphorylation and activation of Slm1p and Slm2p (Tabuchi et al., 2006). 
 Some studies have linked the TORC1 pathway to the regulation of 
mitochondrial function and yeast CLS (Bonawitz et al., 2007, Pan et al., 2011). In 
fact, the deletion of TOR1 or pharmacological inhibition of TORC1 with rapamycin 
promote oxidative stress resistance and extends CLS in yeast and other 
organisms (Powers et al., 2006, Bonawitz et al., 2007, Kaeberlein & Kennedy, 
2011) (Figure 1.3). TORC1 is active during early stages of growth and represses 
the induction of stress responses and entry into the stationary phase, in part by 
inhibiting the Rim15p protein kinase (Wanke et al., 2005, Wei et al., 2008). 
Reducing TORC1 signalling at early stages of growth extends CLS by an intrinsic 
mechanism involving enhanced mitochondrial membrane potential and superoxide 
production (Pan et al., 2011). This in turn induces an adaptive response that 
contributes to decrease ROS production in the stationary phase and promote 
longevity in yeast. Associated with improved mitochondrial function, TOR1 deletion 
leads to increased translation of mtDNA-encoded subunits of the oxidative 
phosphorylation system, which increases oxygen consumption and may limit 
intracellular oxygen availability to produce ROS (Bonawitz et al., 2007). As 
observed in yeast, administration of rapamycin leaded to the downregulation of the 
mTOR-S6K pathway and reduction in ROS levels and oxidative DNA damage in 
mammalian cells (Halicka et al., 2012). 
 Some authors have identified downstream targets of TORC1 involved in the 
regulation of stress response and aging, namely the AGC protein kinase Sch9p. 
Like other AGC proteins, Sch9p has several conserved domains: a central kinase 
catalytic domain, an activation loop, a turn motif (TM) and a C-terminal regulatory 
domain, which contains a hydrophobic motif (HM) that is phosphorylated by 
TORC1 (Urban et al., 2007). At the N-terminal side of the activation loop, Sch9p 
has a calcium-dependent C2 domain with unknown function (Urban et al., 2007). 
Sch9p acts as a signalling mediator, relaying upstream signals from intracellular 
and extracellular cues, to downstream targets by phosphorylating them on serine 
and/or threonine residues (Voordeckers et al., 2011, Halicka et al., 2012, Huang et 
al., 2012). 
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Figure 1.3. The yeast major regulatory signalling pathways of CLS and 
mitochondria function. The nutrient-sensing pathways controlled by TORC1, Sch9p and 
Ras/PKA converge on the protein kinase Rim15p, which in turn regulates the activation of 
Msn2/4p and Gis1p stress-responsive transcription factors. Pkh1/2p also regulates Sch9p 
activity in response to sphingolipids (long chain sphingoid bases, LCBs). The 
downregulation of Ras/PKA and TORC1-Sch9p pathways partly mediate the anti-aging 
effects of CR. 
 
 Sch9p has a pivotal role in oxidative stress resistance, CLS and 
mitochondrial function. In fact, the deletion of SCH9 gene leads to improved 
mitochondrial function, which contributes to oxidative resistance and CLS 
extension in yeast (Fabrizio et al., 2001, Wei et al., 2008, Wei et al., 2009) (Figure 
1.3). Apart from sensing nutrient and stress signals from TORC1, Sch9p also 
regulates CLS and mitochondria function by integrating signals from long chain 
sphingoid bases (LCBs), a sphingolipid species (Figure 1.3). In addition to 
phosphorylation in the C-terminus mediated by TORC1, Sch9p is phosphorylated 
in a Thr570 residue in the activation loop by Pkh1/2p protein kinases, homologs of 
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mammalian phosphoinositide-dependent protein kinase 1 (PDK1), in response to 
LCBs (Voordeckers et al., 2011, Huang et al., 2012). Huang et al. have recently 
demonstrated that the downregulation of sphingolipid synthesis induced by 
myriocin (an inhibitor of the first step of de novo sphingolipid biosynthetic pathway) 
or the deletion of PKH2 enhances CLS and improves mitochondrial function and 
oxidative stress resistance by Sch9p-dependent mechanisms, which involves a 
decrease in the activation of the Pkh1/2p-Sch9p pathway (Huang et al., 2012). 
 Another important signalling pathway in the regulation of mitochondrial 
function and CLS in yeast is the Ras/PKA pathway. S. cerevisiae contains 2 RAS 
genes, RAS1 and RAS2, which present significant homology to the mammalian 
Ras. Both Ras1p and Ras2p function to activate adenylate cyclase (Tamaki, 
2007). Adenylate cyclase converts ATP into cAMP, which then binds the Bcy1p 
protein, a regulatory subunit of protein kinase A (PKA) (Tamaki, 2007). Three 
genes, TPK1, TPK2, and TPK3, encode the catalytic subunit of protein kinase A. 
When cAMP is hydrolyzed by phosphodiesterases encoded by the PDE1 and 
PDE2 gene, PKA is inactivated due to binding of Bcy1p to the catalytic protein 
complex (Tamaki, 2007). 
 The TORC1-Sch9p and the RAS/cAMP/PKA pathways regulate 
mitochondrial function and longevity by overlapping mechanisms (Wei et al., 2008, 
Galdieri et al., 2010) (Figure 1.3). In fact, the downregulation of both pathways 
extends longevity and increases stress resistance partly through the Rim15p 
protein kinase (Wei et al., 2008, Wei et al., 2009). Rim15p is inhibited by Sch9p, 
Ras/PKA and TORC1 during growth. Mechanistically, inactivation of TORC1 
results in dephosphorylation of the phospho-Thr1075 located in a 14-3-3-binding 
site of Rim15p, thereby causing the release of Rim15p from the cytoplasmic 14-3-
3 anchoring protein Bmh2p (Galdieri et al., 2010). For the remaining signalling 
effectors (PKA and Sch9p) involved in the inactivation of Rim15p, the mechanism 
is not yet known.  
 When these signalling pathways are downregulated, Rim15p becomes 
activated and increases the expression of a variety of genes involved in G0 entry 
and stress response through the translocation of transcription factors Msn2/4p and 
Gis1p into the nucleus (Wei et al., 2008, Galdieri et al., 2010) (Figure 1.3). The 
core of the post diauxic shift (PDS)-element and stress responsive element 
(STRE)-element genes, whose expression is induced by these transcription 
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factors, are important in response to a variety of stresses, including nutrient 
limitation and oxidative stress and also in trehalose and glycogen accumulation, 
which are required to survive under nutrient starvation (during stationary phase) 
and longevity in yeast (Galdieri et al., 2010). The transcription factors 
Msn2p/Msn4p upregulate genes encoding for antioxidant defense mechanisms, 
including SOD2, CTT1, SOD2, GLR1, HSP12 and DDR2, as well as the 
nicotinamidase PCN1 (Jamieson, 1998, Zhang et al., 2009, Galdieri et al., 2010). 
Pcn1p is involved in the NAD salvage pathway and favors Sir2p activation to 
suppress the formation of toxic replicative ribosomal DNA (rDNA) (Lesur & 
Campbell, 2004). Gis1p-regulated genes include stress response (HSP26, SIP18 
and GRE1), the pentose phosphate pathway (TKL2, GND2), glutamate synthesis 
(IDP2, GDH3) and the glyoxylate cycle (MLS1, ICL1) genes (Zhang et al., 2009).  
 Moreover, Msn2/4p and Rim15p are required for the induction of autophagy 
upon inhibition of PKA and Sch9p, although they are dispensable in the induction 
of autophagy by rapamycin (Yorimitsu et al., 2007). It was also shown that the 
upregulation of Rim15p is required to improve oxidative stress response and 
mitochondrial function and to extend yeast lifespan in CR conditions downstream 
of Ras/PKA, TORC1 and Sch9p pathways (Wei et al., 2008). More recently, it was 
shown that aminoacids threonine and valine promote increased sensitivity to 
general stress and aging primarily by activating the TORC1-Sch9p pathway 
whereas serine stimulates Sch9p through Pkh1/2p, which in turn inhibits Rim15p 
activity (Mirisola et al., 2014). 
 
1.3.3.2. Mitochondrial quality control mechanisms 
 
Mitochondrial dynamics, which is dictated by a series of fusion and fission 
events in the mitochondrial network, is involved in the regulation of important 
cellular processes, namely mitochondrial metabolism, redox dynamics, apoptosis 
and cell death. Together with macroautophagy and the selective mitochondrial 
turnover (mitophagy), mitochondrial dynamics forms an interconnected quality 
control system that contributes to homeostatic turnover of mitochondria and 
sustained ATP production and removal of damaged mitochondria and oxidized 
biomolecules (proteins, DNA and lipids), processes that are tightly regulated to 
preclude aging. It is therefore conceivable that dysfunctional quality control 
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mechanisms may constitute a major cause of mitochondrial dysfunction, leading to 
oxidative stress and cell death during aging.  
 
 
1.3.3.2.1. Mitochondrial dynamics  
 
 Mitochondria are dynamic structures that migrate throughout the cell, fuse 
and divide, and undergo regulated turnover. These highly coordinated processes 
are important on the regulation of mitochondrial function and cell physiology by 
allowing mitochondrial compartmentalization within the cell, mitochondrial 
communication, regulation of the mitochondrial shape and to general quality 
control (Westermann, 2010).  
  Mitochondrial morphology relies on a fine balance between fusion and 
fission activities. The induction of mitochondrial fusion allows the formation of 
extended and interconnected mitochondrial networks, whereas a shift toward 
fission generates numerous morphologically and functionally distinct organelles, 
suggesting that this morphological adaptation is important for mitochondrial 
adaptation and compartmentalization according to cellular demands (Detmer & 
Chan, 2007, Berman et al., 2008, Chen & Chan, 2009, Westermann, 2012, 
Mirisola et al., 2014) (Figure 1.4). Furthermore, the connectivity of the 
mitochondrial network is an important factor that determines the cell’s response to 
calcium signals, which is an important pro-apoptotic factor (Westermann, 2010). 
 The fusion of mitochondria is an essential step in certain developmental 
processes, such as embryonic development and spermatogenesis (Zhang et al., 
2007). In addition to mitochondrial network formation, fusion serves to mix and 
unify the mitochondrial compartment, which is thought to constitute an adaptive 
mechanism against gradual accumulation of damage and mtDNA deterioration 
with aging (Zhang et al., 2007, Westermann, 2010). Apparently, fusion of 
mitochondria may counteract deleterious biological repercussions for the cell by 
allowing complementation of mtDNA gene products in heteroplasmic cells that 
have accumulated different somatic mutations, thus diluting the effect of 
deleterious mtDNA mutations and depolarized mitochondria during aging (Zhang 
et al., 2007, Seo et al., 2010, Westermann, 2010).  
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 The major components of the mitochondrial fusion machinery have been 
evolutionarily conserved from yeast to mammals. The protein machinery has been 
primarily identified in the yeast S. cerevisiae, which has emerged as the prime 
model organism to study the molecular mechanisms of mitochondrial membrane 
fusion (Westermann, 2008). The fusion core machinery in yeast consists of three 
proteins, namely Fzo1p (the yeast homologue of mammalian mitofusins MFN1 and 
MFN2) and Ugo1p (orthologs in higher organisms were not identified), which are 
located in the outer membrane. Mgm1p, the yeast homologue of OPA1 in 
mammals, is an intermembrane space protein anchored to the inner membrane 
(Westermann, 2008, Seo et al., 2010) (Figure 1.4). Mutant yeast cells on these 
proteins are characterized by a fragmented mitochondria phenotype and defective 
mtDNA inheritance, presumably due to unopposed fusion (Seo et al., 2010, 
Westermann, 2012). Exchange of mitochondrial matrix content is blocked both in 
vivo and in vitro, suggesting that these proteins are required for mitochondrial 
fusion. In this process, Fzo1p mediate outer membrane fusion whereas Mgm1p 
has the ability to form trans-complexes that tether apposing inner membranes 
(Figure 1.4) (Westermann, 2010). Studies in mammals have demonstrated that 
OPA1 is the main mediator of inner membrane fusion and maintenance of mtDNA 
integrity (Song et al., 2009).   
 The relevance of mitochondrial fusion to underlying mechanisms of aging 
has recently been highlighted. Mutations in MFN2 impair oxidative metabolism, 
cell-cycle progression and cell survival, and contribute to Charcot-Marie-Tooth 
neuropathy type 2A (Chen & Chan, 2009). Absence of MFN1 and MFN2 promotes 
mitochondrial fragmentation and enhanced sensitivity to apoptotic stimuli (Sugioka 
et al., 2004). In contrast, overexpression of MFN1/2, apart from increasing 
mitochondrial connectivity, delays Bax activation, cytochrome c release, and 
apoptotic death, implicating mitofusins in cell death (Suen et al., 2008, 
Westermann, 2010) (Figure 1.4).  
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Figure 1.4. Biological functions of mitochondrial dynamics.	  Mitochondrial fission and 
fusion are crucial to maintain functional mitochondria upon metabolic or environmental 
stresses. Fusion attenuates mitochondrial stress by mixing the contents of partially 
damaged or depolarized mitochondria by complementation. Fission allows the constitution 
of new mitochondria and contributes to quality control and turnover (together with 
mitophagy) by enabling the clearance of damaged mitochondria that may induce 
apoptosis during high cellular stress. The disruption in the homeostasis of these 
processes affect normal development, and they have been implicated in human diseases. 
The Figure was adapted from Westermann B, 2010. 
Chapter I 
	   	   61	  
 Similar to fusion, mitochondrial fission also plays a key role in cell death 
and aging (Westermann, 2010). As mitochondria propagate by expansion and 
division of pre-existing organelles, mitochondrial inheritance depends on 
mitochondrial fission (Figure 1.4). Furthermore, mitochondrial division is important 
for several developmental and cell differentiation processes, including embryonic 
development in C. elegans and formation of synapses and dendritic spines (Seo et 
al., 2010).  
 Additionally, the mitochondrial fission machinery actively participates in 
apoptosis by inducing fragmentation of the mitochondrial network prior to 
cytochrome c release and caspase activation (Westermann, 2010, Westermann, 
2012) (Figure 1.4). In fact, excessive mitochondrial fission appears to be a 
requisite step in apoptotic pathways, at least for the normal rate of cytochrome c 
release and caspase activation, as several components of the mitochondrial 
fission machinery (DRP1 and FIS1) have been implicated in programmed cell 
death progression (Frank et al., 2001, Seo et al., 2010, Westermann, 2010). 
Dnm1p, the yeast orthologue of DRP1, has been shown to promote mitochondrial 
fission and cell death following exposure to environmental stress. Increased fission 
events are also associated with decreased complementation and mitochondrial 
function, loss of mtDNA integrity and increased oxidative damage, eventually 
leading to cell death (Seo et al., 2010, Westermann, 2010). 
 In yeast, mitochondrial fission is mainly dictated by the activity of four 
proteins, including Fis1p in the outer membrane and three cytosolic proteins 
(Dnm1p, Mdv1p, and Caf4p) that assemble at the organellar surface near the 
assembly site (Westermann, 2008, Westermann, 2010) (Figure 1.4). Yeast cells 
defective in outer membrane fission contain complex, extensively interconnected 
mitochondrial nets due to ongoing fusion unrestrained by fission. Mostly from 
yeast studies, the mitochondrial fission process has been characterized to some 
detail. Dnm1p is a dynamin-related GTPase that assembles into an oligomeric 
spiral-like structure on the mitochondrial outer membrane (Ingerman et al., 2005). 
Assembly of this OM complex is mediated by Fis1p and Mdv1p, the latter acting as 
an adaptor between Fis1p and Dnm1p-GTP domain (Westermann, 2010). 
Ultimately, these oligomeric structures collapse and separate into two newly 
separated mitochondria (Ingerman et al., 2005). 
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1.3.3.2.2. Autophagy and mitophagy in cellular damage control 
 
 I. Autophagy 
  
 Autophagy is an evolutionarily conserved process in eukaryotic cells that 
involves the sequestration of cytoplasmic cargo into double-membrane vesicles 
called autophagosomes. After their formation, autophagosomes fuse to the 
vacuole (lysosome in mammals), within which the inner membrane and the cargo 
are degraded (Loewith & Hall, 2011, Ryter et al., 2013, Russell et al., 2014) 
(Figure 1.5). The importance of autophagy and autophagic-like processes comes 
from their recognition as key regulators in normal development and cellular 
homeostasis whose dysfunction with aging is associated with the onset of 
diseases including cancer, diabetes, neurodegeneration, cardiovascular and 
hepatic ailments (Boya et al., 2013). 
 A basal level of autophagy is crucial for routine clearance of cytoplasmic 
components under normal conditions. It is also critical for protein and organelle 
homeostasis and turnover and cellular quality control in post-mitotic differentiated 
cells, such as neurons (Mizushima & Levine, 2010). In addition, autophagy 
becomes activated in response to starvation, therefore providing a source of 
nutrients and energy to sustain overall cellular energetics and metabolism 
(Mizushima & Levine, 2010, Loewith & Hall, 2011, Laplante & Sabatini, 2012). 
Autophagy is also triggered as an adaptive response to a broad range of other 
extracellular or intracellular stimuli, namely hypoxia, heat stress, ROS and 
accumulation of damaged cytoplasmic components (Levine & Klionsky, 2004). 
Three major subtypes of the autophagy have been described: the non-selective 
macroautophagy, microautophagy, and chaperone-mediated autophagy (CMA) 
(Ravikumar et al., 2010, Yang & Klionsky, 2010).  
 Macroautophagy is the most prevalent form of autophagy and will be herein 
referred to as autophagy. It is the process by which biomolecules or entire 
organelles are engulfed in autophagosomes and subsequently degraded by 
vacuolar/lysosomal hydrolases in a non-selective manner (Russell et al., 2014). 
Autophagy plays many roles in the cell, namely in starvation adaptation and 
general metabolism as well as development and differentiation (Ravikumar et al., 
2010, Yang & Klionsky, 2010, Ryter et al., 2013). Microautophagy is a process in 
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which the cytoplasm is directly engulfed at the surface of the degradative organelle 
(the vacuole or lysosome) without the production of autophagosomes. The 
membrane invaginates and pinches off to form an internal autophagic vesicle 
containing cytoplasmic material (Wang & Klionsky, 2003). Both macroautophagy 
and microautophagy are essentially non-selective, in the way that 
autophagosomes and vacuole invaginations do not appear to discriminate the 
sequestered material. The selective autophagy of particular organelles has been 
described, namely mitophagy, pexophagy and ribophagy, which are involved in the 
selective turnover of mitochondria, peroxisomes and ribosomes, respectively. 
Although non-selective autophagy plays an essential role in survival by nitrogen 
starvation, by providing amino acids to the cell, selective autophagy is more likely 
to have a function in the maintenance of cellular structures, both under normal 
conditions as a “housecleaning” process, and under stress conditions by 
eliminating altered organelles and macromolecular structures. 
  The chaperone-mediated autophagy (CMA) is a selective form of 
autophagy, so far only detected in mammalian cells, that is activated during long-
term nutrient deprivation and proteostasis (Cuervo & Wong, 2014). CMA does not 
involve the formation of a double membrane vesicle and targets chaperones to 
proteins that contain a motif biochemically related to the pentapeptide KFERQ. 
The chaperone-KFERQ-containing protein complex then binds LAMP-2A 
(lysosome-associated membrane protein) receptors on the lysosome membrane 
and translocates the target protein into the lysosomes for degradation (Cuervo & 
Wong, 2014).  
 Autophagy can also be involved in biosynthetic-related processes. The 
cytoplasm to vacuole (Cvt) targeting pathway is a yeast-specific autophagy-like 
pathway in which vacuolar hydrolases, such as aminopeptidase I (ApeI) and α-
mannosidase, are selectively delivered to the vacuole and converted into 
enzymatically active forms at the vacuolar lumen. This pathway employs most of 
the autophagic machinery (Scott et al., 1996, Reggiori & Klionsky, 2013). 
 Thirty-five autophagy-related genes (ATG) in yeast have been so far 
identified, and, many of them were essential to identify homologues in higher 
eukaryotes. ATG proteins are organized in functional complexes that mediate the 
diverse steps of macroautophagy and other selective forms of autophagy: 
induction/initiation, vesicle nucleation, cargo recognition and packaging, vesicle 
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expansion and sealing, fusion with the lysosome (vacuole in yeast), vesicle 
breakdown and recycling of the resulting macromolecules (Maiuri et al., 2007) 
(Figure 1.5).  
 
Figure 1.5. Schematic diagram of the various stages of autophagy. Autophagy 
induction upon mTOR inhibition, a sensor of nutrients (aminoacids), allows the activation 
of the ULK1 kinase complex. In nucleation, the Class III PI(3)K complex forms PI(3)P, 
which is necessary for formation of the isolation membrane. The membrane expands to 
engulf cytosolic contents in vesicle elongation, a process that requires the two ubiquitin-
like conjugation steps of ATG5–ATG12 and LC3/At8p–PE. In vesicle retrieval, the 
transport of ATG9 between the PAS and non-PAS sites is necessary for autophagosome 
formation and requires ATG18. During vesicle maturation, trafficking and fusion of the fully 
enclosed double-membrane autophagosome to various endosomal compartments occurs, 
eventually fusing to the lysosome (vacuole in yeast) to form the autolysosome. In the final 
stage, degradation of the contents of the autolysosome occurs by the resident lysosomal 
enzymes. Although the process is described for mammalian cells, similar features are also 
observed for yeast cells. The Figure was obtained from Maiuri et al., 2007. 
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II. Autophagy regulation and cell signalling pathways 
 
 In yeast, some signalling pathways have been characterized as playing an 
important role in the regulation of autophagy. The regulatory proteins of these 
pathways are TORC1, Sch9p, PKA, and Pho85p protein kinases (Reggiori & 
Klionsky, 2013).  
 Under nutrient-rich conditions, autophagy is inhibited because TORC1 is 
active and hyperphosphorylates Atg13p (Kamada et al., 2010, Reggiori & 
Klionsky, 2013), resulting in a lower affinity for the serine-threonine protein kinase 
Atg1p and Atg17p to induce the process (Figure 1.5). PKA and Sch9p are also 
involved in the regulation of Atg13p phosphorylation and localization to the 
phagophore assembly site (PAS) (Stephan et al., 2009), although the mechanisms 
involved are yet fully understood. 
 When TORC1 activity is inhibited, either by rapamycin or starvation, Atg13p 
is rapidly dephosphorylated by unknown mechanisms (to yield a hypo-
phosphorylated form of Atg13p) and interacts with Atg1p (Kamada et al., 2010, 
Reggiori & Klionsky, 2013). The Atg1p-Atg13p protein complex then associates 
with Atg17p, which is part of a ternary complex with Atg29p and Atg31p. The 
Atg1p-Atg13p protein complex then recruits other Atg proteins to the phagophore 
assembly site and controls their assembly and dynamics (Reggiori & Klionsky, 
2013). Autophagosome nucleation requires a complex containing Atg9p and the 
class III phosphatidylinositol 3-kinase Vps34p, the latter generating 
phosphatidylinositol 3-phosphate (Maiuri et al., 2007, Reggiori & Klionsky, 2013) 
(Figure 1.5).  
 The expansion of autophagosomal membranes involves two ubiquitin-like 
proteins, Atg12p and Atg8p, an E1 ubiquitin activating enzyme (Atg7p), two 
analogues of ubiquitin-conjugated enzymes (Atg10p and Atg3p), an Atg8p 
modifying protease (Atg4p), the protein target of Atg12p attachment (Atg5p) and 
Atg16p (Figure 1.5). In the first ubiquitination reaction, the E1-like Atg7p and the 
E2-like Atg10p promote the association of Atg12p with Atg5p (Suzuki et al., 2001, 
Suzuki et al., 2007). This conjugate subsequently interacts with Atg16p to 
generate pre-autophagosomal structures (Mizushima et al., 1999). In the second 
ubiquitin reaction, Atg8p is cleaved by the protease Atg4p and conjugated to 
phosphatidylethanolamine (PE) by Atg7p (E1-like) and Atg3p (Kim et al., 1999, 
Chapter I 
	   	   66	  
Kirisako et al., 1999). This lipidated form of Atg8p is essential to drive proper 
autophagosome biogenesis (Figure 1.5). Upon completion of autophagosome 
formation, the Atg12p–Atg5p–Atg16p protein complex is released into the cytosol, 
whereas Atg8p-PE remains stably associated with the autophagosomal 
membranes (Kirisako et al., 2000). At this point, the outer autophagosomal 
membrane fuses with the vacuolar membrane to produce an autophagic body 
(autolysosome in mammalian cells) (Reggiori & Klionsky, 2013) (Figure 1.5). 
Several proteins are known to regulate the autophagosome-to-vacuole fusion step, 
namely the Rab protein Ypt7p (Kim et al., 1999), its GDP-exchange factor Ccz1p-
Mon1p (Wang et al., 2003), and several SNARE proteins such as Vam3p, Vam7p, 
Vti1p and Ykt6p along with the class C Vps/HOPS complex, which are essential 
for proper tethering and fusion (Reggiori & Klionsky, 2013). The remaining single-
membrane that envelops the cargo is lysed and the population of Atg8-PE 
together with the enclosed cargo are released into the vacuolar lumen and 
degraded by resident vacuolar hydrolases (proteases, lipases, nucleases and 
glucosidases). The resulting degradation products are released back into the 
cytosol through the activity of specific membrane permeases for recycling 
(Reggiori & Klionsky, 2013).  
 
 III. Autophagy and lifespan  
 
 The relationship between CLS and autophagy is extremely complex and not 
fully understood. Autophagy appears to be a common downstream process of 
multiple cellular pathways with well-known roles in longevity regulation and 
disease (Madeo et al., 2010). The upregulation of autophagy extends 
chronological lifespan in mice, C. elegans, yeast and other organisms. Importantly, 
the TORC1-Sch9p and the Ras/cAMP-dependent protein kinase proteins, which 
integrate the network of nutrient- and energy-sensing pathways that regulate 
autophagy, are known to be involved in proper regulation of longevity pathways 
(Wei et al., 2008, Galdieri et al., 2010, Evans et al., 2011, Swinnen et al., 2013). 
Recently, Hansen et al. found that dietary restriction and TOR inhibition in C. 
elegans produce an "autophagy" phenotype and that inhibiting genes required for 
autophagy prevents dietary restriction and TOR inhibition from extending lifespan, 
corroborating with this conception (Hansen et al., 2008). 
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 Screenings performed in yeast have demonstrated that mutants for genes 
encoding proteins of the autophagic machinery (ATG5, ATG7, ATG8, ATG12 and 
ATG18) are short-lived (Matecic et al., 2010) and some genes are required to 
extend CLS upon rapamycin treatment (ATG1 and ATG7) (Alvers et al., 2009). 
Suppression of autophagy by knockdown of essential autophagy genes triggers 
apoptosis or necrosis in cells that would otherwise survive under stress conditions 
(Kourtis & Tavernarakis, 2009, Suzuki et al., 2011). Autophagy appears to serve 
primarily a cytoprotective function by maintaining nutrient and energy homeostasis 
during starvation or by degrading damaged cellular components and invasive 
pathogens (Reggiori & Klionsky, 2013). Although autophagy is a predominantly 
pro-survival mechanism, it can also play a role in cell death, which is not restricted 
to developmental programmed cell death, but extends to cell death that occurs in 
many pathological conditions (Codogno & Meijer, 2005, Tsujimoto & Shimizu, 
2005). Excessive autophagy induced by extreme conditions such as toxins and 
necrosis-triggering insults might cause uncontrollable degradation or sequestration 
of cells contents resulting in undesirable cell death if not properly regulated 
(Codogno & Meijer, 2005).   
 
 IV. Mitophagy 
 
 The mitochondrial theory of aging predicts that an accumulation of oxidative 
damage and mtDNA mutations is associated with the onset of age-associated 
pathologies and cell death (Shokolenko et al., 2014). Mitophagy promotes the 
removal of damaged/dysfunctional or oxidized mitochondria and contributes to the 
homeostatic maintenance of sustainable mitochondrial function and thereby allows 
an efficient process for ATP production and maintenance of proper cellular 
energetics (Seo et al., 2010).  
 There is some evidence in yeast studies suggesting that damaged 
mitochondria are eliminated by mitophagy. For example, interference with F1Fo-
ATPase biogenesis in a temperature sensitive fmc1ts mutant (Priault et al., 2005) 
or osmotic swelling of mitochondria caused by depletion of the mitochondrial K+/H+ 
exchanger Mdm38p induce mitophagy (Nowikovsky et al., 2007). It is conceivable 
to assume that mitophagy also mitigates the deleterious effect of mtDNA 
mutations in heteroplasmic cells, together with mitochondrial dynamics (Figure 
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1.4). Supporting this view, Mao et al. have recently reinforced the important link 
between mitophagy and mitochondrial dynamics (Mao et al., 2013). On this basis, 
both processes seem to act in a coordinate manner to assure the proper 
connectivity of the mitochondrial network, which is an important factor that 
determines cell’s fate (Figure 1.4).  
 The core autophagic machinery used is common with other types of 
autophagy. The requirement of several ATG genes for mitophagy has been 
reported by several groups and the screening of ATG mutants in S. cerevisiae 
allowed the identification of some ATG proteins selectively involved in mitophagy, 
namely Atg32p and Atg33p (Kanki et al., 2009a, Kanki & Klionsky, 2010a). 
Recently, the Slt2p and Hog1p mitogen activated protein kinases (MAPK) were 
identified as key mediators of mitophagy by regulating the phosphorylation of 
Ser114 and Ser119 on Atg32p (Aoki et al., 2011, Mao et al., 2011) (Figure 1.6).  
 Importantly, Slt2p is required for proper recruitment of mitochondria to PAS 
(Mao et al., 2011). Whi2p, Uth1p, and Aup1p are also required for mitophagy, 
although the function of these proteins in mitophagy remains to be established 
(Bhatia-Kiššová & Camougrand, 2010, Hirota et al., 2012) (Figure 1.6). Casein 
kinase 2 (CK2) phosphorylates Atg32p and activates mitophagy in yeast, but the 
relevance for the process is not yet understood (Kanki et al., 2013). In an elegant 
work, Bockler and Westermann identified a complex connecting mitochondria and 
the ER structure termed ERMES (ER mitochondria encounter structure), which 
mediated the mitochondrial-ER tethering (mitochondrial-ER contacts) and is 
essential for the formation of the isolation membrane destined to the formation of 
mitophagosomes (Bockler & Westermann, 2014). 
 In yeast studies, there are several ways to induced mitophagy. The most 
common is the incubation in non-fermentable medium to induce the proliferation of 
mitochondria (Kissova et al., 2004, Kanki et al., 2009b) (lactate or glycerol as sole 
carbon sources). Cells can then be grown upon nitrogen starvation conditions to 
induce mitophagy (Mao et al., 2011). Rapamycin has also been reported to induce 
the process (Mendl et al., 2011). The importance of mitophagy is demonstrated by 
its association with the onset of age-associated ailments, such as 
neurodegenerative diseases (Mijaljica et al., 2010). 
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Figure 1.6. Mitophagy associated signalling in yeast. The MAPK Slt2p and Hog1p 
regulate the phosphorylation of Atg32p at s Ser114 and Ser119 residues. This 
phosphorylation is important for the Atg11p-Atg32p interaction. Atg11p recruits 
mitochondria to the PAS to be enclosed in mitophagosomes. Proteins Atg33p, Whi2p, 
Uth1p, and Aup1p have been reported to be important for the induction of mitophagy. 
However, their regulatory role remains to be established. The Figure was modified from 
Hirota et al., 2012.  
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1.4. Sphingolipids 
  
1.4.1. Structure  
 
 Sphingolipids are important structural components of cell membranes found 
in essentially all animals, plants and fungi, as well as some prokaryotic organisms 
(Hannun & Obeid, 2008). They are mostly found on the outer leaflet of the plasma 
membrane, although they are also present at membranes of different organelles at 
variable ratio (Hannun & Obeid, 2008). Furthermore, they are major constituents of 
lipoproteins. Sphingolipids, including sphingosine, ceramide and sphingosine-1-
phosphate (S1P), have emerged as core metabolites in this metabolism as they 
regulate a vast number of cellular processes including cell growth, adhesion, 
migration, senescence, apoptosis, endocytosis, and most recently, autophagy in 
yeast and higher eukaryotes (Dickson, 2008, Hannun & Obeid, 2008, Young et al., 
2013). Since they have the ability to modulate the activity of some proteins and the 
activation of some signalling pathways, variations in the relative levels of different 
sphingolipid species result in important changes in overall cellular functions and 
fate (Hannun & Obeid, 2008).  
 From a structural point of view, sphingolipids have an amphipathic nature 
and are composed by a long chain sphingoid base (LCB) (sphingosine (SPH) in 
mammals, and phytosphingosine (PHS) and dihydrosphingosine (DHS) in yeast), 
with the 2-amino group amide-linked to a fatty acid, thereby forming the core unit, 
to which polar groups are added at C1-hydroxyl group to give rise to different 
types of sphingolipids (Hannun & Obeid, 2008, Rego et al., 2014) (Figure 1.7). The 
nature of the fatty acid (carbon length, degree of unsaturation and hydroxylation) 
along with other modifications of the long-chain bases and the polar head group 
define the vast family of sphingolipids. 
 
1.4.2. Bioactive sphingolipids and aging 
 
Sphingolipid metabolism is highly complex and interconnected, which 
enable cells to orchestrate different cellular responses by regulating sphingolipid 
interconversions (Hannun & Obeid, 2008, Rao et al., 2013).  
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Figure 1.7. The general structure of sphingolipids. Sphingolipid are composed of 
LCBs, which can be linked to a fatty acid via an amide bond and to a polar head of 
different chemistry. The nature of the fatty acid and the polar headgroup define the 
extended family of sphingolipids. The Figure was modified from Rego et al., 2014.  
 
 
In response to both extracellular stimuli (UV, hypoxia, toxins, heat stress, etc.) and 
alterations in cellular physiology, the enzymes involved in sphingolipid metabolism 
act in a coordinated manner to regulate not only the levels of individual bioactive 
lipids, but also their metabolic interconversion and the physiological response 
generated after proper integration of cellular signalling (Hannun & Obeid, 2008).  
The sphingolipids ceramide, sphingosine and sphingosine-1-phosphate are 
the main representatives of sphingolipid metabolism and play crucial roles in the 
regulation of many cellular processes (Hannun & Obeid, 2008, Rego et al., 2014). 
The first sphingolipid to be identified was sphingosine and it exerts pleiotropic 
effects on protein kinases and other targets (Hannun & Obeid, 2008). Sphingosine 
and its related sphingoid bases have roles in regulating the actin cytoskeleton, 
endocytosis, cell cycle and apoptosis. Ceramide mediates many cell-stress 
responses that include the promotion of pro-apoptotic events and cell senescence, 
by modulating the activity of ceramide-activated protein kinases (e.g. PKCζ) and 
phosphatases [ceramide-activated protein phosphatase (CAPP), phosphoprotein 1 
(PP1) and phosphoprotein 2A (PP2A)] (Hannun & Obeid, 2008, Rao et al., 2013) 
(Figure 1.8). On the other hand, S1P promotes cell proliferation and survival by 
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acting in an autocrine manner on S1P receptors (Hannun & Obeid, 2008, Rao et 
al., 2013) (Figure 1.8). Consequently, alterations in the relative amounts of 
sphingosine-1-phosphate and sphingosine/ceramide have significant effects on 
cell physiology and metabolism and ultimately on cell fate (Figure 1.8). This 
explains why sphongolipid metabolism is highly regulated (Hannun & Obeid, 2008, 
Rao et al., 2013). Other components of the family of sphingolipids include 
ceramide-1-phosphate (C1P), involved in inflammation and vesicular trafficking, 
glucosylceramide, mostly associated with post-Golgi trafficking and drug 
resistance, lyso-sphingomyelin and dihydroceramide (Hannun & Obeid, 2008, Rao 
et al., 2013). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8. Sphingolipid metabolism and signalling. In response to several stimuli, 
sphingolipid metabolism can be adaptively activated. Whereas ceramide and sphingosine 
are mostly associated with apoptosis and cellular senescence by activating protein 
kinases and phosphatases, sphingosine-1-phosphate (S1P), conversely, promotes cell 
proliferation and protection from apoptosis by acting on receptors, usually in an autocrine 
manner. Therefore, the regulation of ceramide/S1P is crucial to determine cell fate. The 
Figure was adapted from Hannun & Obeid, 2008. 
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The importance of sphingolipid signalling derives from the early recognition of their 
contribution in the pathobiology of human cancers and other human ailments such 
as diabetes and heart disease, microbial infections, neurological and immune 
dysfunctions (Kolter & Sandhoff, 2006, Ozbayraktar & Ulgen, 2009, Kolter, 2011, 
Hla & Dannenberg, 2012, Young et al., 2013). Additionally, sphingolipids have 
been implicated in the regulation of stress responses and longevity. In mammals, 
ceramide levels and SMase activity increase and induce a senescent phenotype 
morphologically and biochemically (inhibition of cell cycle progression, inhibition of 
the PKC/PLD pathway, induction of Rb dephosphorylation and inhibition of the 
pro-proliferative AP1 activity) (Obeid et al., 1993, Obeid & Venable, 1997, Hannun 
& Luberto, 2000). Senescence and growth inhibition were also correlated with the 
inhibition of telomerase transcription and activity by ceramide (Ogretmen et al., 
2001). Yeast mutants lacking Ydc1p (dihydroceramidase) are characterized by 
increased CLS whereas the overexpression of YDC1 triggers mitochondria and 
vacuolar fragmentation, apoptosis and accelerated aging in yeast (Aerts et al., 
2008). Genes involved in sphingolipid metabolism (LAG1, YPC1, YSR3, IPT1, and 
LCB5) show variable expression in senescent and apoptotic cells (Laun et al., 
2005). More recently, it was shown that the downregulation of sphingolipid 
biosynthesis increases yeast CLS in part due to a reduction in long-chain bases 
(LCBs) mediated activation of the Pkh1p-Sch9p pathway (Huang et al., 2012). 
Furthermore, ceramide synthase (Lag1p) and LCB kinase (Lcb4p) activities 
decrease upon entry into the stationary phase, leading to a large increase in the 
levels of LCBs (Lester et al., 2013).  
Over the past few decades, many studies attempted to unveil the role of 
sphingolipids in signal transduction pathways involved in the regulation of these 
biological processes. However, the mechanisms by which sphingolipids control 
many aspects of cell physiology and metabolism remains to be characterized in 
more detail. 
 
1.4.3. Yeast sphingolipid metabolism  
 
 The sphingolipid metabolism is highly conserved between yeast and 
mammals and shares a similar spatial organization (Figure 1.9). 
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It takes place in the ER and the subsequent processes occur in the Golgi 
apparatus, where the delivery of intermediate metabolites and synthesis of 
complex sphingolipids manifest (Hannun & Obeid, 2008, Rego et al., 2014). 
Sphingolipids metabolism involves the biosynthesis and recycling of a large of 
number of intermediate metabolites. Despite the diversity of structure and function 
of sphingolipids, this metabolism is governed by an integrated network of common 
synthetic and catabolic pathways in response to different stimuli (Hannun & Obeid, 
2008, Rego et al., 2014) (Figure 1.9). 
 
1.4.3.1. De novo biosynthesis in the ER 
 
 The first and rate-limiting step in yeast sphingolipid metabolism involves 
the condensation of serine and palmitoyl-CoA in the ER in a reaction catalyzed by 
serine palmitoyltransferase (SPT), yielding 3-keto-dihydrosphingosine (Dickson & 
Lester, 1999). This first step is the only known entry route in the biosynthetic 
sphingolipid metabolism and the subtract availability in this reaction regulates the 
flux through the pathway (Alvarez-Vasquez et al., 2005). SPT is encoded by two 
homologous subunits, LCB1 and LCB2, both of which are required for proper 
activity (Nagiec et al., 1994). In yeast, a third small subunit of SPT, Tsc3p 
(temperature-sensitive suppressor of calcium sensitivity) is required for the activity 
by forming a heterodimer with Lcb1p and Lcb2p (Gable et al., 2000). Tsc3p 
function is unknown but it influences Lcb2p activity in the Tsc3p-Lcb2p-Lcb1p 
complex (Monaghan et al., 2002). 
More recently, some important regulators of the sphingolipid biosynthetic 
pathway have been uncovered. An important regulator of SPT activity is the 
TORC2-Pkh1p-Ypk1p-Orm1/2p pathway (Berchtold et al., 2012, Niles & Powers, 
2012, Muir et al., 2014). In response to mechanical changes or depletion in the 
content of complex sphingolipids at the plasma membrane (e.g. upon treatment 
with myriocin and aureobasidin A), TORC2 becomes activated and stimulates the 
de novo biosynthesis of sphingolipids via phosphorylation and activation of Ypk1p 
at the hydrophobic motif (HM) site (Roelants et al., 2011, Berchtold et al., 2012, 
Niles & Powers, 2012) (Figure 1.10). Apart from TORC2, the Pkh1/2p protein 
kinases also phosphorylate Ypk1p at the activation loop (A-loop) in the plasma 
membrane, which is required for full activation of Ypk1p (Berchtold et al., 2012) 
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(Figure 1.10). After being activated, Ypk1p phosphorylates and inactivates 
Orm1/2p, two evolutionarily conserved integral membrane proteins of the ER 
(Breslow et al., 2010, Roelants et al., 2011) (Figure 1.10). Since Orm1/2p are 
inhibitors of SPT, (Breslow et al., 2010), which catalyzes the first step in 
sphingolipid biosynthesis, their inactivation by a Ypk1p-dependent phosphorylation 
alleviates SPT inhibition and boosts sphingolipid production (Breslow et al., 2010, 
Roelants et al., 2011, Berchtold et al., 2012) (Figure 1.10). In this regulatory 
network, the pleckstrin homology (PH) domain proteins Slm1p/Slm2p are recruited 
to the plasma membrane by TORC2-mediated phosphorylation and play an 
essential role in the activity of Ypk1/2p by increasing the efficiency of 
phosphorylation of Ypk1p by TORC2 and Pkh1/2p (Tabuchi et al., 2006, Berchtold 
et al., 2012, Niles & Powers, 2012) (Figure 1.10). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.10. TOR Complex 2-Pkh1/2p-Ypk1p-Orm signalling maintains sphingolipid 
homeostasis by targeting the de novo biosynthesis pathway. In response to 
sphingolipid depletion (e.g. myriocin treatment), TORC2 is activated and phosphorylates 
the downstream effector Ypk1p, which is also phosphorylated by Pkh1/2p for full 
activation. Once Ypk1p is activated, it phosphorylates and inhibits the Orm1/2p proteins, 
which act as inhibitors of SPT (Lcb1/2p protein complex). As a result, Orm1/2p-mediated 
inhibition of SPT activity is alleviated, therefore boosting sphingolipid biosynthesis. 
Chapter I 
	   	   77	  
It is noteworthy that TORC2 also stimulates ceramide synthase through 
Ypk2p (Aronova et al., 2008) (a paralog of Ypk1p) and also inhibits Isc1p, the 
homologue of mammalian neutral sphingolmyelinase 2 (nMase2), via modulation 
of Slm1/2p (Tabuchi et al., 2006). Thus, Slm1p and Slm2p regulate both ceramide 
biosynthesis, via the TORC2-Ypk1/2p-SPT-ceramide synthase cascade, and 
ceramide turnover by hydrolysis of complex sphingolipids mediated by Isc1p.  
After 3-keto-dihydrosphingosine generation, this intermediate is converted 
to the LCB dihydrosphingosine (DHS) in an NADPH-dependent manner by Tsc10p 
protein (Figure 1.9). Sur2p/Syr2p catalyzes the hydroxylation of DHS at C4 
position to produce phytosphingosine (PHS) (Haak et al., 1997) (Figure 1.9). 
Structurally, DHS and PHS also vary in the chain length: DHS contains 16, 18 or 
20 carbons while PHS presents 18 or 20 carbons (Dickson, 2008). Together, DHS 
and PHS constitute the LCBs in yeast, and both can undergo either 
phosphorylation at C1 or N-acylation. DHS and PHS can be phosphorylated by 
two LCB kinases, encoded by LCB4 and LCB5 genes, forming DHS-1-phosphate 
and PHS-1-phosphate, respectively (Nagiec et al., 1998) (Figure 1.9). Finally, 
these phosphorylated products can be either dephosphorylated back to DHS and 
PHS by the phosphatases Lcb3p/Ysr2p and Ysr3p or catabolized by 
dihydrosphingosine-1-phosphate lyase (Dpl1p) (Skrzypek et al., 1999) to generate 
palmitaldehyde and phosphoethanolamine (Figure 1.9). The production of these 
non-sphingoid molecules constitutes the only known exit route from the 
sphingolipid metabolism (Hannun & Obeid, 2008). 
 
 1.4.3.2. Ceramide generation and breakdown 
 
Apart from phosphorylation, DHS or PHS can be N-acylated to produce the 
correspondent dihydro- and phytoceramides (Figure 1.9). This reaction requires 
two ceramide synthases, encoded by LAG1 (longevity assurance gene 1) and 
LAC1 (longevity assurance gene 1 cognate) (Guillas et al., 2001) (Figure 1.9). 
LAG1 was firstly associated as a gene involved in the aging process since its 
expression is diminished in aged yeast cells (D'Mello N et al., 1994). LAC1 was 
then identified as a homologue of LAG1; both proteins are required for ceramide 
synthesis (Guillas et al., 2001). These enzymes are highly homologous and 
present redundant function and the double deletion of LAG1 and LAC1 is required 
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to prevent de novo biosynthesis of ceramide (Guillas et al., 2001, Schorling et al., 
2001). In addition, Lip1p forms a heteromeric complex with Lac1p and Lag1p and 
is essential for ceramide synthase activity in vivo and in vitro (Vallee & Riezman, 
2005). Dihydro- and phytoceramides can be deacylated to form DHS/PHS by 
ceramidases Ydc1p and Ypc1p (Mao et al., 2000a, Mao et al., 2000b), or can be 
used as substrates for the biosynthesis of complex sphingolipids (Figure 1.9). 
 
 1.4.3.3. Biosynthesis of complex sphingolipids 
 
After ceramide formation, it must be transported from the ER to the Golgi 
compartment either by a vesicular and non-vesicular transport mechanism 
involving direct membranous contact between the ER and Golgi compartment 
(Hannun & Obeid, 2008). Once ceramide reaches the Golgi apparatus, it becomes 
the substrate for the production of complex sphingolipids, namely inositol-
phosphoceramide (IPC), mannosyl-inositol phosphoceramide (MIPC) and 
mannosyl-di-inositol-phosphoceramide [M(IP)2C] (Figure 1.9).  
The first complex sphingolipid, inositol-phosphoceramide (IPC), is formed 
by transferring a myo-inositol phosphate group from phosphatidylinositol (PI) to 
ceramide with the concomitant release of diacylglycerol (DAG). This step is 
catalyzed by the IPC synthase encoded by AUR1, an essential gene whose 
deletion is lethal (Nagiec et al., 1997) (Figure 1.9). The second complex 
sphingolipid, MIPC, is generated by transferring the mannose group from GDP-
mannose onto the inositol 2-OH moiety of IPC (Uemura et al., 2003, Uemura et al., 
2007). The enzyme inositol phosphorylceramide mannosyl transferase catalyzes 
this reaction and can be present in two forms. One contains the Csg1p and Csg2p 
proteins, and the other contains the Csh1p and Csg2p. The Csg1p and Csh1p 
appear to be the catalytic subunits, whereas Csg2p performs a regulatory function 
(Uemura et al., 2007).  
 The terminal yeast complex sphingolipid made in the Golgi apparatus is 
M(IP)2C. It is the most abundant complex sphingolipid in yeast and it is 
synthesized by the addition of another inositol phosphate group to MIPC by a 
process catalyzed by inositol-phosphotransferase (Ipt1p) (Dickson et al., 1997) 
(Figure 1.9). Hechtberger et al. have reported that complex sphingolipids in S. 
cerevisiae are mostly present in the Golgi compartment, vacuole and plasma 
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membrane (where they are thought to coexist with ergosterol to form lipid rafts), 
and also observed in the mitochondria at lower levels, but not in the ER 
(Hechtberger et al., 1994). 
 
1.4.3.4. Sphingolipid catabolism  
 I. The Inositol phosphosphingolipid phospholipase C 
 
Complex sphingolipids turnover to regenerate ceramide is performed by 
inositol phosphosphingolipid phospholipase C (Isc1p), which has phospholipase-C 
type activity and catalyzes the removal of the polar head groups from complex 
sphingolipids, releasing dihydroceramide and phytoceramide (Sawai et al., 2000, 
Rego et al., 2014) (Figure 1.9). Ella et al. have firstly demonstrated that yeast 
presents an enzyme with the ability to hydrolyze mammalian sphingomyelin at 
neutral pH, despite the absence of this sphingolipid in yeast (Ella et al., 1997). 
Then, the detection of Isc1p as a membrane-associated phospholipase C-type 
activity that produced ceramide from IPC, MIPC, and M(IP)2C was identified with 
significant homology to bacterial sphingomyelinases (Ella et al., 1997). 
Consistently, Isc1p overexpression results in an increase of ceramide levels, 
whereas ISC1 deletion results in an accumulation of complex sphingolipids (Sawai 
et al., 2000).  
  Isc1p belongs to the sphingomyelinase family since it shares very 
significant homology to bacterial sphingomyelinases of Bacillus cereus and 
Staphylococcus aureus (Clarke et al., 2006). In particular, Isc1p is the yeast 
homolog of mammalian neutral sphingomyelinase type 2 (nSMase2) and shares 
30% identity in sequence to its counterpart. From a structural point of view, Isc1p 
is activated by phosphatidylserine (PS), phosphatidylglycerol (PG), and cardiolipin 
(CL) at the C-terminus and is dependent on the presence of Mg2+ as a cofactor for 
optimal activity (Sawai et al., 2000, Vaena de Avalos et al., 2004). According to the 
proposed “tether-and-pull” model, the C-terminus of Isc1p associates with PS, CL, 
and PG lipids and consequently, the N-terminal catalytic domain is “pulled” to the 
membrane to interact with the substrates (Okamoto et al., 2003). The activity of 
Isc1p relies on the highly conserved residues E100, D234, and H334, located at 
the P-loop-like catalytic domain, which may be involved in Mg2+ metal binding, 
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interaction with the phosphate group, and as a general base in the catalytic 
reaction, respectively (Okamoto et al., 2003). Ideally, Isc1p presents optimal 
activity around pH 7.5 and very low activity in acidic and very alkaline conditions 
(Okamoto et al., 2003). 
Interestingly, Isc1p is post-translationally regulated by translocation from 
the ER into mitochondria upon the transition from fermentative to the respiratory 
metabolism during the so-called post-diauxic shift (PDS) (Vaena de Avalos et al., 
2004). This appears to be associated with the regulation of mitochondrial 
sphingolipid metabolism and function, namely the generation of α-hydroxylated-
phytoceramides, which are necessary for proper function of this organelle 
(Kitagaki et al., 2007, Kitagaki et al., 2009). The regulatory role of Isc1p on 
mitochondrial function is reinforced by the fact that Isc1p-deficient cells exhibit a 
growth defect upon the transition to the PDS phase associated with the inability to 
upregulate genes required for respiratory metabolism, despite presenting intact 
mitochondrial DNA (Kitagaki et al., 2007, Kitagaki et al., 2009). In fact, these 
mutants display defective growth on non-fermentable carbon sources and 
enhanced frequency of petite formation. The mutant strain also displays 
decreased levels of the mitochondrial ETC complex IV (cytochrome c oxidase, 
COX) subunits Cox3p and Cox4p and this is correlated with decreased COX 
activity and oxygen consumption in isc1Δ cells (Almeida et al., 2008, Kitagaki et 
al., 2009, Barbosa et al., 2011).   
 
 II. Isc1p-driven signalling in mitochondrial function and aging  
 
Initial studies have demonstrated that Isc1p is implicated in the regulation of 
important cellular processes, namely responses to osmostress, heat stress and 
genotoxic agents. Almeida et al. have firstly reported that Isc1p is involved in the 
regulation of oxidative stress resistance, mitochondrial function and chronological 
lifespan (Almeida et al., 2008). In fact, isc1Δ cells display shortened CLS, 
increased hydrogen peroxide sensitivity, which appear to be associated with 
mitochondrial dysfunction and increased iron uptake (Almeida et al., 2008). 
Together with mitochondrial dysfunction, it promotes a vicious cycle of oxidative 
damage to biomolecules and contributes to cell death by apoptosis (Almeida et al., 
2008, Kitagaki et al., 2009, Barbosa et al., 2011).  
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 In an attempt to dissect possible signalling pathways governing isc1Δ 
phenotypes, important downstream targets of Isc1p were identified and implicated 
in the regulation of mitochondrial function and CLS (Figure 1.11). Lipidomic 
analysis showed specific changes in sphingolipids in Isc1p-deficient cells during 
aging, including decreased dihydrosphingosine levels and an increase of very long 
chain base species, namely dihydro-C26-ceramide and phyto-C26-ceramide, the 
latter raising the possibility of activation of ceramide-dependent protein 
phosphatases. On this basis, it was shown that the deletion of SIT4 gene, which 
encodes for the catalytic subunit of type 2A ceramide-activated protein 
phosphatases and presents considerable homology to human protein 
phosphatase 6 (PP6) (Bastians & Ponstingl, 1996), supresses mitochondrial 
dysfunctions, oxidative stress sensitivity and shortened CLS of Isc1p-deficient 
cells (Barbosa et al., 2011) (Figure 1.11).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.11. The sphingomyelinase Isc1p modulates ceramide signalling to regulate 
mitochondrial function and CLS in yeast. Isc1p-mediated signalling controls the activity 
of the ceramide-activated PP2A-like phosphatase Sit4p and the MAPK Hog1p, by 
regulating ceramide content in yeast. 
 
Among other signalling pathways, the yeast high osmolarity-responsive 
(HOG) MAPK pathway, the HOG pathway, was also studied. It is activated in 
response to hyperosmotic stress via two independent osmosensing branches, the 
Sln1p and the Sho1p branches, which in turn control the phosphorylation of the 
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main effector, the MAPK Hog1p (Rep et al., 2000, Alepuz et al., 2001, Proft et al., 
2001, de Nadal et al., 2003, de Nadal et al., 2004, O'Rourke & Herskowitz, 2004, 
Proft et al., 2006). It was demonstrated that sphingolipids are also able to 
modulate the HOG pathway in response to the inibition of the de novo biosynthetic 
pathway or depletion of ergosterol (Tanigawa et al., 2012). Hog1p activation is 
deleterious for cells devoid of Isc1p since ceramide signalling increases Hog1p 
phosphorylation and the deletion of HOG1 attenuates isc1Δ phenotypes (Barbosa 
et al., 2012). 
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Scope of the thesis 
 Sphingolipids are important components of membranes in eukaryotes. More 
recently, they are recognized as important bioactive biomolecules implicated in the 
regulation of signalling transduction and important biological processes.   
 Several lines of evidence suggest an intricate interplay between 
sphingolipid metabolism and TOR signalling. In particular, TOR signalling is 
involved in the regulation of mitochondrial function, oxidative stress response and 
chronological lifespan (CLS) in yeast. Since isc1Δ cells exhibit mitochondrial 
dysfunction, hydrogen peroxide sensitivity and premature aging, we aimed to 
uncover the role of the nutrient-sensing Target Of Rapamycin Complex 1 (TORC1) 
and its downstream effector, the AGC protein kinase Sch9p, in these phenotypes. 
  
 The involvement of ceramide signalling in the regulation of important 
biological functions, such as autophagy and related processes, and mitochondrial 
quality control mechanisms, has been recently addressed in mammals. On this 
basis, we also aimed to determine how the Isc1p sphingomyelinase-driven 
ceramide signalling regulates macroautophagy, mitophagy and mitochondrial 
dynamics and evaluate its impact on longevity in yeast.  
 The deletion of SIT4 extends lifespan in yeast by boosting mitochondrial 
function (mitochondrial catabolic derepression) and stress response. Although the 
PP2A-like protein phosphatase Sit4p functions downstream of Isc1p, the 
phosphatase is downregulated by TORC1 and was recently shown to control the 
turnover of complex sphingolipids in a Npr1p-dependent manner. However, how 
Sit4p integrates nutrient and sphingolipid signalling to regulate lifespan is not yet 
established. On this basis, we aimed to establish a functional association between 
Sit4p and sphingolipid metabolism and evaluate the impact on cell survival.  
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 Science goes from question to question; big questions, and little, tentative 
answers. The questions as they age grow ever broader, the answers are seen to 
be more limited.  
 
                      George Wald 
CHAPTER II 
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Reduced TORC1 signalling abolishes mitochondrial dysfunctions 
and shortened chronological lifespan of Isc1p-deficient cells 
 
Vitor Teixeira, Tânia C. Medeiros, Rita Vilaça, Pedro Moradas-Ferreira 
and Vítor Costa 
 
Keywords: Isc1p; Tor1p; Sch9p; oxidative stress; chronological aging, 
mitochondrial function, ROS, ceramide. 
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Abstract 
 
 The target of rapamycin (TOR) is an important signalling pathway on a 
hierarchical network of interacting pathways regulating central biological 
processes, such as cell growth, stress response and aging. Several lines of 
evidence suggest a functional link between TOR signalling and sphingolipid 
metabolism. Here, we report that the TORC1-Sch9p pathway is activated in cells 
lacking Isc1p, the yeast orthologue of mammalian neutral sphingomyelinase 2. 
The deletion of TOR1 or SCH9 abolishes the premature aging, oxidative stress 
sensitivity and mitochondrial dysfunctions displayed by isc1Δ cells and this is 
correlated with the suppression of the autophagic flux defect exhibited by the 
mutant strain. The protective effect of TOR1 deletion, as opposed to that of SCH9 
deletion, is not associated with the attenuation of Hog1p hyperphosphorylation, 
which was previously implicated in isc1Δ phenotypes. Our data support a model in 
which Isc1p regulates mitochondrial function and chronological lifespan in yeast 
through the TORC1-Sch9p pathway although Isc1p and TORC1 also seem to act 
through independent pathways, as isc1Δtor1Δ phenotypes are intermediate to 
those displayed by isc1Δ and tor1Δ cells. We also provide evidence that TORC1 
downstream effectors, the type 2A protein phosphatase Sit4p and the AGC protein 
kinase Sch9p, integrate nutrient and stress signals from TORC1 with ceramide 
signalling derived from Isc1p to regulate mitochondrial function and lifespan in 
yeast. Overall, our results show that TORC1-Sch9p axis is deregulated in Isc1p-
deficient cells, contributing to mitochondrial dysfunction, enhanced oxidative stress 
sensitivity and premature aging of isc1Δ cells. 
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2.1. Introduction 
 
 Sphingolipids are ubiquitous structural components of eukaryotic cell 
membranes, and their bioactive metabolites (sphingosine, sphingosine-1-
phosphate, ceramide, ceramide-1-phosphate and lyso-sphingomyelin) are known 
to act as second messengers in the transduction and regulation of signalling 
pathways (Dickson & Lester, 1999, Jenkins & Hannun, 2001, Spiegel & Milstien, 
2003, Dickson, 2008, Hannun & Obeid, 2008, van Meer et al., 2008). Sphingosine 
(and related sphingoid bases) and ceramide are involved in the regulation of actin 
cytoskeleton organization, endocytosis, degradation of nutrient permeases, 
apoptosis, cell senescence and cell cycle arrest whereas sphingosine-1-
phosphate plays a key role in proliferation, mitogenesis, cell migration, cell survival 
and inflammation (in higher eukaryotes) (Hannun & Obeid, 2008). Thus, subtle 
variations on the relative amounts of sphingosine-1-phosphate and 
sphingosine/ceramide are expected to determine cell fate in response to 
environmental or metabolic stresses. The importance of sphingolipids is 
recognized by the fact that sphingolipid signalling is implicated in the pathobiology 
of human cancers and other human diseases such as diabetes and heart disease, 
microbial infections, neurological and immune dysfunctions (Kolter & Sandhoff, 
2006, Ozbayraktar & Ulgen, 2009, Kolter, 2011, Hla & Dannenberg, 2012, Young 
et al., 2013). 
 Sphingolipids metabolism and their route of synthesis are highly conserved 
from yeast to mammalian cells. Studies using the budding yeast Saccharomyces 
cerevisiae have served in many ways to foster our understanding of sphingolipid 
dynamics and their role in the regulation of cell cycle, cell integrity, endocytosis, 
cytoskeleton dynamics and protein turnover (Dickson, 2008, Hannun & Obeid, 
2008). Additionally, sphingolipids have been implicated in the regulation of stress 
responses and longevity. For instance, yeast mutants lacking Ydc1p 
(dihydroceramidase) are characterized by increased chronological lifespan (CLS) 
whereas the overexpression of YDC1 triggers mitochondria and vacuolar 
fragmentation, apoptosis and accelerated aging in yeast (Aerts et al., 2008). 
Genes involved in sphingolipid metabolism (LAG1, YPC1, YSR3, IPT1, and LCB5) 
show variable expression in senescent and apoptotic cells (Laun et al., 2005). 
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More recently, it was demonstrated that the downregulation of sphingolipid 
synthesis increases yeast CLS in part due to a reduction in long-chain bases 
(LCBs) mediated activation of Sch9p, the yeast homologue of mammalian 
ribosomal S6K protein kinase (Huang et al., 2012). Furthermore, ceramide 
synthase (Lag1p) and LCB kinase (Lcb4p) activities decrease upon entry into the 
stationary phase, leading to a large increase in the levels of LCBs (Lester et al., 
2013).  
 We have previously demonstrated that Isc1p, the yeast orthologue of 
mammalian neutral sphingomyelinase-2 (nSMase2) responsible for the hydrolysis 
of complex inositol phosphosphingolipids to produce ceramide, is implicated in 
oxidative stress resistance and chronological lifespan in yeast. Isc1p-deficient cells 
display shortened CLS, oxidative stress sensitivity and impaired redox and iron 
homeostasis (Almeida et al., 2008). Analogous to the role of ceramide and 
ceramide-activated protein phosphatases in regulating mammalian cell apoptosis, 
Isc1p acts upstream of Sit4p, the catalytic subunit of protein phosphatase related 
to type 2A protein phosphatases (PP2A) in yeast. Indeed, SIT4 deletion restores 
mitochondrial function of isc1Δ cells, increasing oxidative stress resistance and 
extending CLS (Barbosa et al., 2011). The activation of the HOG (High Osmolarity 
Glycerol) pathway is also deleterious for isc1Δ cells since ceramide signalling 
increases the phosphorylation of the Hog1p mitogen activated protein kinase 
(MAPK) and the deletion of HOG1 attenuates the phenotypes of Isc1p-deficient 
cells (Barbosa et al., 2012).  
 Recent studies also link ceramide to other important signalling pathways 
involved in the regulation of cell growth and survival, namely the TOR (Target of 
Rapamycin) pathway. This pathway is highly conserved among organisms, 
ranging from flies, nematodes, protozoa alongside with mammals (Raught et al., 
2001, Dann & Thomas, 2006, de Virgilio & Loewith, 2006, Laplante & Sabatini, 
2012, Johnson et al., 2013, Markaki & Tavernarakis, 2013). In S. cerevisiae, the 
TOR pathway is controlled by two Ser/Thr protein kinases, Tor1p and Tor2p, 
which assemble into two protein complexes with distinct subunit composition and 
regulatory roles (Loewith et al., 2002, Kim & Guan, 2011, Loewith & Hall, 2011). 
The rapamycin-sensitive TOR complex 1 (TORC1) contains either Tor1p or Tor2p 
and is mostly associated with the regulation of cell growth (nutrient sensing), 
autophagy, ribosomal and protein turnover and cell proliferation (Evans et al., 
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2011, Kim & Guan, 2011). The TOR complex 2 (TORC2) contains Tor2p, but not 
Tor1p, and mediates the proper maintenance of the cell cytoskeleton (Cybulski & 
Hall, 2009) and was recently implicated in the regulation of ceramide biosynthesis 
by a Ypk2p-dependent mechanism (Aronova et al., 2008). Furthermore, TORC2 
indirectly modulates Isc1p turnover through the phosphorylation and activation of 
Slm1p and Slm2p (Tabuchi et al., 2006). 
 The TORC1 pathway has also been linked to mitochondrial function and 
yeast CLS (Bonawitz et al., 2007, Pan et al., 2011). In fact, the deletion of TOR1 
or pharmacological inhibition of TORC1 with rapamycin extends CLS in yeast and 
other organisms (Powers et al., 2006, Bonawitz et al., 2007, Kaeberlein & 
Kennedy, 2011). In yeast, TORC1 is active during early stages of growth and 
represses the induction of stress responses and entry into the stationary phase, in 
part by inhibiting the Rim15p protein kinase and consequently the translocation of 
Msn2p/4p and Gis1p transcription factors into the nucleus to induce adaptive 
response required for CLS extension (Wanke et al., 2005, Wei et al., 2008). 
Reducing TORC1 signalling at early stages of growth extends CLS by an intrinsic 
mechanism involving enhanced mitochondrial membrane potential and superoxide 
production. This in turn induces an adaptive response that contributes to decrease 
ROS production in the stationary phase and promote longevity in yeast (Pan et al., 
2011). Moreover, reduced TORC1 signalling derepresses Rim15p and triggers the 
expression of genes regulated by the mitochondrial signalling pathway known as 
the retrograde response (Komeili et al., 2000, Dilova et al., 2004, Liu & Butow, 
2006) as well as stress-related genes under the control of Msn2p/Msn4p (Beck & 
Hall, 1999, Wei et al., 2008). 
 Some authors have identified downstream targets of TORC1 involved in the 
regulation of stress response and aging, namely the AGC protein kinase Sch9p 
and the Sit4p protein phosphatase. Apart from sensing nutrient and stress signals 
from TORC1, both proteins also regulate CLS by integrating sphingolipid 
signalling. In addition to phosphorylation in the C-terminus mediated by TORC1, 
Sch9p is phosphorylated in a Thr570 residue in the activation loop by Pkh1/2p 
protein kinases, homologues of mammalian phosphoinositide-dependent protein 
kinase 1 (PDK1), in response to LCBs (Voordeckers et al., 2011, Huang et al., 
2012). On the other hand, Sit4p is downregulated by TORC1 in a Tip41p/Tap42p 
manner (Di Como & Arndt, 1996, Jacinto et al., 2001) but is also activated by 
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ceramide and functions downstream of Isc1p (Barbosa et al., 2011). How this 
complex network of interacting pathways regulates CLS remains poorly 
characterized.  
 Thus, we postulated that TORC1 may be deregulated in isc1Δ cells. In this 
study, we show that TORC1 activation impairs oxidative stress resistance, 
mitochondrial function and chronological lifespan in isc1Δ cells, suggesting that 
Isc1p regulates mitochondrial function and yeast chronological lifespan, either 
through the TORC1 pathway or in a functionally related pathway parallel to 
TORC1. The suppression of isc1Δ phenotypes by reduced TORC1 signalling is not 
associated with the attenuation of Hog1p hyperphosphorylation. Our data also 
support a model in which TORC1 downstream effectors Sit4p and Sch9p act as 
physiological hubs integrating nutrient and ceramide signalling driven by Isc1p. 
  
2.2. Results 
 
2.2.1. The deletion of TOR1 and SCH9 extends chronological lifespan and 
increases oxidative stress resistance of isc1Δ cells 
 
 To assess changes in TORC1 signalling associated with Isc1p deficiency, 
we have monitored TORC1 activity in vivo by assessing TORC1-dependent Sch9p 
phosphorylation at the C-terminus (Urban et al., 2007). The results show that 
Sch9p is hyperphosphorylated in isc1Δ mutants when compared to parental cells, 
indicative of increased TORC1 activity (Figure 2.1.A-B). Apart from TORC1, Sch9p 
is also phosphorylated by Pkh1/2p in response to LCBs. Since basal levels of 
phytosphingosine (PHS) are increased in isc1Δ cells during aging (Barbosa et al., 
2011), we also assessed the Pkh1/2p-dependent phosphorylation of Sch9p on the 
Thr570 residue. The results show that the levels of Sch9p-phospho-Thr570 were 
similar in parental and isc1Δ cells (Figure 2.S1). 
 This led us to postulate that TORC1 activation may contribute to isc1Δ 
phenotypes. To test this hypothesis, we then evaluated if the deletion of TOR1 or 
SCH9 could abolish the premature aging and hydrogen peroxide sensitivity of 
isc1Δ cells. In agreement with previous reports, isc1Δ cells presented a shortened 
CLS compared to parental cells (Figure 2.2.A). Although the acidification of the 
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growth medium due to acetic acid production decreases yeast lifespan (Burtner et 
al., 2009), it is unlikely that it contributes to the shortened CLS of isc1Δ cells since 
ISC1 deletion increases acetic acid resistance (Rego et al., 2012). As expected, 
tor1Δ and sch9Δ cells exhibited an increased lifespan (Figure 2.2.A).  
Figure 2.1. Isc1p-deficient cells exhibit enhanced TORC1 activity in vivo. The 
TORC1-dependent C-terminal phosphorylation of Sch9p was used to assess TORC1 
activity in vivo. S. cerevisiae BY4741 and isc1Δ cells transformed with pJU676 
(expressing SCH9-5HA) were grown in SC-medium to the exponential phase and NTCB-
treated protein extracts were analyzed by immunoblotting using anti-HA antibody, as 
described in Experimental Procedures. A representative blot out of three is shown. 
Quantification of band intensities was performed by densitometry. The ratio between 
phosphorylated and unphosphorylated Sch9p (Pi+/Pi-) is shown. Values are mean ± SD of 
at least three independent experiments. ****p<0.0001. 
 
 The effect of SCH9 deletion was significantly lower to that reported by other 
groups (Fabrizio et al., 2001). This probably arises from differences in the growth 
medium composition, in particular amino acid concentration. Indeed, sch9Δ 
mutants display increased lifespan when cells are grown in media supplemented 
with a 3.5-fold excess of amino acids but present shortened lifespan than parental 
cells when grown in media with 0.5-fold aminoacid content (Wu et al., 2013). 
Importantly, the deletion of TOR1 or SCH9 in isc1Δ cells significantly extended the 
CLS of this mutant but the isc1Δtor1Δ and isc1Δsch9Δ double mutants exhibited a 
shorter CLS compared to that of tor1Δ and sch9Δ cells, respectively (Figure 
2.2.A).  
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Figure 2.2. The deletion of TOR1 and SCH9 abolishes the shortened CLS, oxidative 
stress sensitivity and mitochondrial dysfunctions displayed by isc1Δ cells. 
A. S. cerevisiae BY4741, isc1Δ, tor1Δ and isc1Δtor1Δ, sch9Δ and isc1Δsch9Δ cells were 
grown in SC-medium and kept in the medium at 26°C. The viability was determined by 
standard dilution plate counts and expressed as the percentage of the colony-forming 
units at time T in relation to T0. Values are mean ± SD of at least three independent 
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experiments. (B, C). Yeast cells were grown in SC-medium to the exponential phase (B) 
or stationary phase (48 hours after exponential phase) (C) and exposed to 1.5 mM H2O2 
for 60 min (B) or 300 mM H2O2 for 30 min (C). Cell viability was determined by standard 
dilution plate counts and expressed as the percentage of the colony-forming units (treated 
cells versus untreated cells). Values are mean ± SD of at least three independent 
experiments. ****p<0.0001. ***p<0.001. D. S. cerevisiae BY4741, isc1Δ, tor1Δ and 
isc1Δtor1Δ, sch9Δ and isc1Δsch9Δ cells were grown in SC-medium to the exponential 
phase and then diluted to OD600=0.1. Fivefold dilution series were spotted on YPD 
(glucose) or YPG (glycerol) medium and cells were grown at 26°C for 4 days. E. Oxygen 
consumption rate was measured in cells grown to PDS phase, as described in 
Experimental Procedures. Values are mean ± SD of at least three independent 
experiments. ****p<0.0001; *p<0.05. F. Cytochrome c oxidase (COX) activity was 
determined in cells grown to the PDS phase. Cells were lysed and enzymatic activity was 
measured as described in Experimental Procedures. Values are mean ± SD of at least 
three independent experiments. ****p<0.0001; ***p<0.001 
 
 To assess oxidative stress resistance, cells were grown to the exponential 
or early stationary phase and treated with H2O2. Consistent with published data 
(Wei et al., 2009), tor1Δ and sch9Δ cells were more resistant to oxidative stress 
than parental cells (Figure 2.2.B-C). The deletion of TOR1 or SCH9 suppressed 
the hydrogen peroxide sensitivity of isc1Δ cells (Figure 2.2.B-C). Similar results 
were obtained by the pharmacological inhibition of TORC1 using rapamycin 
(Figure 2.S2). These results implicate TORC1-Sch9p activation in the premature 
aging and oxidative stress sensitivity of Isc1p-deficient cells. 
 
2.2.2. Reduced TORC1 signalling enhances mitochondrial coupled 
respiration in isc1Δ cells 
 
 It was previously shown that tor1Δ cells have an extended CLS in part 
associated with improved and better coupled mitochondrial respiration at early 
stages of growth, which ultimately preconditions yeast to better survive on the 
stationary phase (Pan et al., 2011). Therefore, we evaluated if the deletion of 
TOR1 and SCH9 could improve mitochondrial fitness of isc1Δ cells, eventually 
contributing to CLS extension observed in isc1Δtor1Δ and isc1Δsch9Δ double 
mutants. To address this hypothesis, we analyzed cell growth in medium 
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containing glycerol, a non-fermentable carbon source, as well as oxygen 
consumption and cytochrome c oxidase (COX) activity. It was observed that the 
growth defect of isc1Δ cells on glycerol medium was suppressed upon the deletion 
of TOR1 or SCH9 (Figure 2.2.D). As expected, the deletion of ISC1 almost 
completely abolished oxygen consumption and COX activity at the post-diauxic 
shift (PDS; respiratory) phase (Figure 2.2.E-F). In tor1Δ and sch9Δ cells, both 
oxygen consumption and COX activity were increased when compared to parental 
cells. Notably, TOR1 and SCH9 disruption suppressed the defects observed in 
isc1Δ cells: both oxygen consumption and COX activity increased in isc1Δtor1Δ 
and isc1Δsch9Δ cells, although to levels lower than those observed in tor1Δ and 
sch9Δ cells, respectively (Figure 2.2.E-F).  
 To assess if enhanced mitochondrial respiration coupling contributes to the 
lifespan extension of isc1Δ cells imposed by reduced TORC1 signalling, CLS was 
analyzed in cells treated with 2,4-dinitrophenol (DNP), which decreases 
mitochondrial membrane potential and uncouples electron transport from ATP 
synthesis. Untreated Isc1p-deficient cells exhibited a shortened CLS that was not 
affected by exposure to DNP (Figure 2.3), providing strong evidence that 
mitochondrial dysfunction largely contributes to isc1Δ phenotypes. In tor1Δ 
mutants, DNP significantly affected cell viability (e.g., it decreased 40% in DNP-
treated vs control cells aged for 2 days). However, the detrimental effect of DNP in 
tor1Δ mutants was lower to the observed in parental cells (in this strain, the 
viability of cells treated with DNP and aged for 2 days decreased 68%). This is 
consistent with published data showing that tor1Δ cells present better coupled 
respiration when compared to parental cells (Pan et al., 2011), and therefore are 
able to mount a more effective adaptive response to counteract DNP effects. The 
deletion of TOR1 in isc1Δ cells extended CLS (in cells untreated with DNP) and 
this effect appears to be correlated with an increased coupled respiration imparted 
by reduced TORC1 signalling since DNP treatment decreased cell viability in such 
conditions. The isc1Δtor1Δ double mutant presented an intermediate phenotype 
between parental and tor1Δ cells since, at day 2 of aging, parental, tor1Δ and 
isc1Δtor1Δ cells presented 32%, 60% and 40% cell viability, respectively. Taking 
together, we claim that improved mitochondrial fitness (increased coupled 
respiration) promoted by the deletion of TOR1 per se extends CLS in isc1Δ cells, 
in similar fashion as observed for the effect of TOR1 deletion in parental cells.  
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Figure 2.3. Increased mitochondrial coupled respiration imparted by reduced 
TORC1 signalling extends lifespan in isc1Δ cells. S. cerevisiae BY4741, isc1Δ, tor1Δ 
and isc1Δtor1Δ cells were grown in SC-medium to the PDS phase, treated with 10 µM 
2,4-dinitrophenol (DNP; square) or vehicle (DMSO; circle) and kept in the medium at 
26°C. The viability was determined by standard dilution plate counts and expressed as the 
percentage of the colony-forming units at time T in relation to T0. Values are mean ± SD of 
at least three independent experiments. The linear plot was used for better visual 
assessment.  
 
2.2.3. Hyperpolarization and fragmentation of the mitochondrial network in 
isc1Δ cells are suppressed by TOR1 or SCH9 deletion 
 
 To get further insights into alterations in mitochondrial function operating on 
isc1Δ cells, we assessed the mitochondrial membrane potential (Δψm), a 
parameter that has been used to monitor changes on bioenergetics as a key 
indicator of cell health or injury (Nicholls, 2004).  
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 For this purpose, yeast cells were labeled with a mitochondria-specific 
voltage-dependent dye, 3,3-dihexyloxacarbocyanine iodide [DiOC6(3)], which 
aggregates and preferentially accumulates into functional mitochondria, and 
analyzed by flow cytometry (Figure  2.4.A). 
 At PDS phase, cells lacking Isc1p displayed enhanced Δψm when 
compared to parental cells, which is consistent with mitochondrial 
hyperpolarization. In contrast, tor1Δ and sch9Δ cells had a slightly lower Δψm, 
which has been associated with mild mitochondrial uncoupling (Pan et al., 2011). 
Both TOR1 and SCH9 disruption in isc1Δ cells reversed the mitochondrial 
hyperpolarization and decreased the Δψm to values similar to those observed in 
the respective single mutants. This probably increases cell survival in isc1Δtor1Δ 
and isc1Δsch9Δ cells, since isc1Δ cells die by caspase-dependent apoptosis upon 
oxidative stress and during cell aging (Almeida et al., 2008) and mitochondrial 
hyperpolarization has been associated with the activation of a mitochondrial 
dependent apoptotic pathway, which initially involves a transient hyperpolarization 
followed by depolarization of the mitochondrial membrane and release of 
cytochrome c from the mitochondria into the cytosol (Kroemer et al., 2007).  
 The mitochondrial membrane potential plays a key role in the regulation of 
mitochondrial morphology and alterations on this parameter were demonstrated to 
impact on mitochondrial dynamics (Legros et al., 2002, Detmer & Chan, 2007, 
Berman et al., 2008, Oliveira, 2012). To assess changes in mitochondrial network 
dynamics, yeast cells expressing a mitochondrial-targeted DsRed protein were 
analyzed by fluorescence microscopy. At the exponential phase, the mitochondrial 
network was not yet fully developed and no significant differences were observed 
between the parental and isc1Δ cells (Figure 2.4.B). This was expected since cells 
are undergoing fermentative growth at this phase. However, in the PDS phase, 
loss of Isc1p led to the formation of a typical punctuate pattern contrasting with the 
tubular and well-organized network observed in healthy parental cells (Figure 
2.4.B). This structural alteration has been associated with mitochondrial 
fragmentation and observed in cells undergoing apoptotic cell death. The normal 
tubular mitochondrial network was restored upon disruption of TOR1 or SCH9 in 
isc1Δ cells (Figure 2.4.B), suggesting that TORC1 and its downstream target 
Sch9p are also implicated in the regulation of mitochondrial dynamics by 
promoting network fragmentation.  
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Figure 2.4. The mitochondrial membrane hyperpolarization and decreased 
autophagic flux contribute to mitochondrial dysfunction and impairment of 
mitochondrial dynamics in isc1Δ cells.  
A. S. cerevisiae BY4741, isc1Δ, tor1Δ and isc1Δtor1Δ, sch9Δ and isc1Δsch9Δ cells were 
grown in SC-medium to the PDS phase, stained with the potential-sensitive dye 3,3-
dihexyloxacarbocyanine iodide [DiOC6(3)] for 30 min and analyzed by flow cytometry. 
Treatment of the parental strain (BY4741) with FCCP (carbonyl cyanide 4-
(trifluoromethoxy)phenylhydrazone) was used as a positive control (depolarizing event). 
Values are mean ± SD of at least three independent experiments. ****p<0.0001; 
***p<0.001; **p<0.01. B. Yeast cells transformed with pYX222-mtDsRed were grown to 
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the exponential and PDS phases and analyzed by fluorescence microscopy, as described 
in Experimental Procedures. Live cells were visualized by fluorescence microscopy. A 
representative experiment out of three is shown. Scale bar: 5 µm. C. S. cerevisiae 
BY4741, isc1Δ, tor1Δ and isc1Δtor1Δ, sch9Δ and isc1Δsch9Δ cells carrying pRS416 
GFP-ATG8 were grown to the exponential phase in SC-medium and treated with either 
rapamycin (200 ng/mL) or DMSO (vehicle) for 3 h. Proteins were analyzed by 
immunoblotting, using anti-GFP antibody. D. The autophagic flux was calculated by the 
ratio between the free GFP signal and the sum of free GFP and GFP-Atg8p signals. 
Values are mean ± SD of at least three independent experiments ****p<0.0001; 
***p<0.001; **p<0.01. E. S. cerevisiae BY4741 and isc1Δ cells carrying pRS416           
GFP-ATG8 were grown to PDS phase, washed twice with water and then maintained in 
water. Proteins were analyzed by immunoblotting, using anti-GFP antibody.  
 
 Previous studies have demonstrated that autophagy has an important role 
in maintaining proper mitochondrial function and dynamics since autophagy-
defective mutants present severe mitochondrial dysfunctions (Suzuki et al., 2011, 
Aung-Htut et al., 2013). In particular, the regulation of the mitochondrial membrane 
potential appears to be crucial to regulate autophagic flux. In addition, 
accumulating evidence show that defects in autophagy compromise mitochondrial 
dynamics (Lee et al., 2012). Since isc1Δ cells present similar phenotypic features 
and TORC1, a negative regulator of autophagy, is activated in this mutant strain, 
we evaluated if these cells present autophagy defects. For this purpose, we have 
monitored the processing of GFP-Atg8p. Once autophagy is induced, GFP-Atg8p 
is recruited to drive autophagosome biogenesis and then delivered to the vacuole 
inside the autophagic body. Whereas Atg8p is degraded by resident vacuolar 
hydrolases, the GFP moiety is relatively resistant to proteolysis. Therefore, the 
appearance of free GFP signal is indicative of autophagy induction. To induce 
autophagy, yeast cells were treated with rapamycin. Under these conditions, the 
autophagic flux was significantly lower in Isc1p-deficient cells (35%) when 
compared to the parental strain (60%) (Figure 2.4.C-D). Notably, a slower 
migrating band (above free GFP) was observed in isc1Δ cells, both under basal 
conditions and upon rapamycin treatment (Figure 2.S3). It probably results from an 
incomplete or aberrant processing of GFP-Atg8p, possibly due to vacuolar 
dysfunction (defective Pep4p-dependent proteolytic activity) or alterations in 
vacuolar morphology upon deletion of ISC1 (Seeley et al., 2002). In isc1Δtor1Δ 
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and isc1Δsch9Δ double mutants, the autophagic flux increased to values close to 
those observed for the respective tor1Δ and sch9Δ single mutants (Figure 2.4.C-
D). It should be noted that rapamycin is predicted to have still some effect on tor1Δ 
cells because there is yet some functional TORC1 signalling. In fact, TORC1 
complex is sensitive to rapamycin due to binding of FKBP-rapamycin complex to 
subunits of TORC1. Thus, TORC1 is functional (although with reduced activity) in 
tor1Δ cells since it still contains Tor2p (which may replace Tor1p) in its 
composition. These results implicate TORC1 and its downstream effector, Sch9p, 
in the deregulation of autophagy, possibly contributing to mitochondrial network 
fragmentation and impairment of oxidative stress resistance and CLS in isc1Δ 
cells. 
 To provide further evidence that autophagy is impaired in isc1Δ cells, we 
have also monitored the autophagic flux during chronological aging. The rate of 
viability loss during aging of this mutant is very high when cells are grown in SC-
medium (Figure 2.2.A). Thus, to avoid unspecific changes that may occur due to 
cell death, we assessed autophagy under conditions of calorie restriction (cells 
grown to PDS phase, washed and maintained in water overtime). We have 
previously shown that calorie restriction increases CLS in both isc1Δ and parental 
cells, but isc1Δ mutants still exhibit a premature aging phenotype (Barbosa et al., 
2011). The results show that the autophagic flux increased in parental cells aged 
for 3-5 days, but it was significantly reduced in isc1Δ cells (Figure 2.4.E). Overall, 
the data suggests that autophagy is impaired in this mutant strain. 
 
2.2.4. TOR1 and SCH9 deletion in isc1Δ cells decreases ROS levels, catalase 
A deficiency and apoptotic cell death  
 
 Apoptosis and aging has been extensively associated with enhanced ROS 
production (Raftopoulou, 2005, Simm & Brömme, 2005, Kregel & Zhang, 2007, 
Marchi et al., 2012). Thus, the improvement of mitochondrial function and/or 
antioxidant defenses may decrease mitochondrial ROS production or increase its 
detoxification, leading to CLS extension. To test this hypothesis, ROS levels were 
measured by flow cytometry using early stationary phase cells stained with 
dihydroethidium (DHE), a molecular probe sensitive to superoxide radicals. The 
results show that ROS levels were low in parental, tor1Δ and sch9Δ cells but 
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approximately 50% of isc1Δ cells were DHE-positive (Figure 2.5.A). In isc1Δtor1Δ 
and isc1Δsch9Δ mutants, ROS levels were higher than in parental cells but 
significantly lower when compared to Isc1p-deficient cells (by approximately one-
half), suggesting that TOR1 and SCH9 deletion increases survival in isc1Δ cells by 
decreasing ROS generation. 
Figure 2.5. The deletion of TOR1 or SCH9 decreases ROS production, attenuates 
catalase A deficiency and diminishes apoptotic cell death in isc1Δ cells.  
A. S. cerevisiae BY4741, isc1Δ, tor1Δ and isc1Δtor1Δ, sch9Δ and isc1Δsch9Δ cells were 
grown to early stationary phase (day 1 in the CLS assay), stained with the 
dihydroethidium (DHE) for 10 min and analyzed by flow cytometry. Values are mean ± SD 
of at least three independent experiments. ***p<0.001; **p<0.01. B. Yeast cells were 
grown to the PDS phase and catalase activity was detected in situ after non-denaturing 
polyacrylamide gel electrophoresis, using the H2O2/peroxidase system, as described in 
Experimental Procedures. A representative experiment out of three is shown. C. BY4741, 
isc1Δ, tor1Δ and isc1Δtor1Δ cells were double stained with DiOC6(3) and PI (propidium 
iodide) and analyzed by flow cytometry, as described in Experimental Procedures. 
Representative histograms are shown. 
 
 Increased ROS levels have been associated with homeostatic imbalance 
partially dictated by impaired cellular antioxidant defences. Hence, we 
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hypothesized that the improvement of the mitochondrial function and dynamics in 
isc1Δtor1Δ and isc1Δsch9Δ cells may contribute to upregulate antioxidant defence 
mechanisms and decrease ROS levels during the aging process. It was previously 
shown that isc1Δ cells fail to induce CTA1 gene expression in the PDS phase 
(Kitagaki et al., 2009) and display a low activity of Cta1p (Barbosa et al., 2011), 
the catalase A form present in mitochondria and peroxisomes. Moreover, CTA1 
overexpression partially suppresses isc1Δ phenotypes (Barbosa et al., 2011). Our 
results show that Cta1p activity was partially restored in isc1Δtor1Δ and 
isc1Δsch9Δ cells (Figure 2.5.B). In sch9Δ and isc1Δsch9Δ cells, Ctt1p (cytosolic 
catalase) activity was not detected, which is consistent with the fact that the Sch9p 
kinase is directly or indirectly involved in the transcriptional control of CTT1 
expression in yeast (Pascual-Ahuir & Proft, 2007). The analysis of superoxide 
dismutase activity did not reveal changes in Sod1p (cytosolic form) or Sod2p 
(mitochondrial form) activity upon the deletion of TOR1 or SCH9 in isc1Δ cells 
(data not shown). 
 To evaluate if the decrease in ROS production and enhancement of 
antioxidant defenses (Cta1p) contribute to decrease apoptotic cell death in 
isc1Δtor1Δ mutants, early stationary phase cells were labeled with 
DiOC6(3)/propidium iodide (PI). The analysis of yeast cells by flow cytometry 
allows the definition of four distinct populations: healthy cells (DiOC6(3)-
positive/PI-negative), early apoptosis (DiOC6(3)-negative/PI-negative), late 
apoptosis (DiOC6(3)-positive/PI-positive) and necrosis (DiOC6(3)-negative/PI-
positive). The results (Figure 2.5.C) clearly show that the large majority of parental 
and tor1Δ cells remained healthy whereas 61% of the isc1Δ cell population was 
already undergoing early (15%) or late (46%) apoptosis. In the isc1Δtor1Δ double 
mutant, however, a significant decrease of apoptotic markers was observed, 
particularly at late stages of apoptosis, where a reduction of approximately 50% 
(from 46% to 24%) was detected.  
 
2.2.5. SCH9 deletion but not reduced TORC1 signalling in isc1Δ cells 
attenuates Hog1p activation 
 
 The hyperactivation of the HOG signalling pathway was previously 
implicated in the premature aging and mitochondrial dysfunction exhibited by 
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Isc1p-deficient cells (Barbosa et al., 2012). Thus, we hypothesized that the 
suppression of isc1Δ phenotypes by TOR1 and SCH9 deletion could be 
associated with the modulation of the HOG pathway. To address this question, 
Hog1p phosphorylation was monitored by Western blotting using an anti-phospho-
p38 antibody that recognizes dually phosphorylated Hog1p, the active form of this 
kinase (Millar et al., 1995, Smith et al., 2004). As illustrated in Figure 2.6.A, Hog1p 
phosphorylation was increased in isc1Δ cells when compared to parental cells. In 
contrast, phosphorylated Hog1p could not be detected in tor1Δ cells. Notably, 
Hog1p phosphorylation levels in isc1Δtor1Δ cells were even higher to those 
detected in isc1Δ cells, suggesting a functional interplay between the HOG and 
TORC1 signalling pathways in isc1Δ cells.  
 
 
Figure 2.6. The deletion of TOR1 increases Hog1p phosphorylation without 
affecting its cytosolic localization whereas SCH9 disruption diminishes Hog1p 
phosphorylation in isc1Δ cells. 
A. Hog1p activation was monitored in BY4741, isc1Δ, tor1Δ and isc1Δtor1Δ cells by 
immunoblotting, using anti-phospho-p38 antibody (top panel) that detects the 
phosphorylated form of Hog1p, or anti-Pgk1p (loading control) as primary antibodies. A 
representative blot out of three is shown. B. S. cerevisiae BY4741, isc1Δ, tor1Δ and 
isc1Δtor1Δ cells expressing the consensus Rlm1p binding sequences fused to a LacZ 
reporter (2xRLM1-LacZ), were grown to the exponential phase and the β-galactosidase 
activity was measured as described in Experimental Procedures. Values are mean ± SD 
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of at least three independent experiments. ****p<0.0001; ***p<0.001; *p<0.05. C. Hog1p 
activation was monitored in BY4741, isc1Δ, sit4Δ and isc1Δsit4Δ cells by immunoblotting, 
as described in A. A representative blot out of three is shown. D. Hog1p activation was 
monitored in BY4741, isc1Δ, sch9Δ and isc1Δsch9Δ cells by immunoblotting, as 
described in A (left panel). BY4741 and sch9Δ cells were grown to the exponential phase 
and treated with either 10 µM C2-ceramide or DMSO (vehicle) for 1 h (right panel). A 
representative blot out of three is shown. 
 
 It was previously shown that Hog1p activation leads to its import into the 
nucleus where it phosphorylates the Msn2p/Msn4p, Hot1p, Sko1p and Smp1p 
transcription factors to promote adaptation to stress conditions (Marquez et al., 
1998, Reiser et al., 1999, Rep et al., 1999, Rep et al., 2000, Alepuz et al., 2001, 
Proft et al., 2001, de Nadal et al., 2003, de Nadal et al., 2004, O'Rourke & 
Herskowitz, 2004, Proft et al., 2006). Thus, we have also monitored Hog1p cell 
localization by fluorescence microscopy in cells expressing HOG1-GFP (Figure 
2.S4). Similarly to parental cells, Hog1p was present in the cytoplasm of isc1Δ, 
tor1Δ and isc1Δtor1Δ mutants, implying that TORC1 may not regulate Hog1p 
localization. We have also evaluated the activation of the Cell Wall Integrity (CWI) 
pathway, since we have previously reported a Hog1p-dependent activation of 
Slt2p, a MAPK of the CWI pathway in isc1Δ cells (Barbosa et al., 2012). For this 
purpose, we monitored the activation of Rlm1p, a transcription factor regulated by 
Slt2p, by measuring β-galactosidase activity in cells expressing a LacZ reporter 
under the control of Rlm1p promoter. Consistent with the hyperactivation of Hog1p 
and induction of the Rlm1p-driven LacZ reporter, β-galactosidase activity was 
increased by 1.7- and 4.3-fold in isc1Δ and isc1Δtor1Δ cells, respectively (Figure 
2.6.B). 
 It was previously shown that the protein phosphatase Sit4p is negatively 
regulated by TORC1 signalling (Jacinto et al., 2001) but activated by ceramide 
(Nickels & Broach, 1996). Moreover, the deletion of SIT4 suppresses isc1Δ 
phenotypes (Barbosa et al., 2011). Notably, Hog1p phosphorylation increased in 
sit4Δ cells and it was exacerbated in isc1Δsit4Δ cells (Figure 2.6.C), as observed 
in isc1Δtor1Δ cells (Figure 2.6.A). This suggests that the phosphorylation of Hog1p 
is also regulated by a Sit4p-dependent mechanism. Remarkably, the deletion of 
SCH9 decreased Hog1p phosphorylation in isc1Δ cells (Figure 2.6.D). It was 
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previously reported that ceramide signalling increases Hog1p phosphorylation 
(Barbosa et al., 2012). Thus, we tested if Sch9p regulates the HOG pathway in 
response to ceramide. As previously reported, C2-ceramide treatment increased 
Hog1p phosphorylation in parental cells (Figure 2.6.D). In contrast, the deletion of 
SCH9 completely abolished Hog1p phosphorylation upon treatment with ceramide 
(Figure 2.6.D). These results suggest that Sch9p is acting upstream of Hog1p in 
response to ceramide signalling.  
 Overall, the results show that the deletion of TOR1 or SIT4 does not 
suppress isc1Δ phenotypes through the attenuation of Hog1p hyperactivation and 
Sch9p appears to regulate the activation of the HOG pathway in response to 
ceramide in Isc1p-deficient cells. 
  
2.3. Discussion 
 
 The TORC1 pathway is a well-established nutrient response pathway that 
modulates aging and age-related diseases (Johnson et al., 2013). Here we 
provided evidence that TORC1 signalling is deregulated in cells lacking Isc1p, the 
yeast orthologue of mammalian neutral sphingomyelinase. Isc1p-deficient cells 
exhibit increased TORC1 activity, which is detrimental for this mutant. In fact, the 
deletion of TOR1 alleviates the premature aging, oxidative stress sensitivity and 
mitochondrial dysfunctions of isc1Δ cells. However, isc1Δtor1Δ cells exhibit lower 
resistance to oxidative stress, shortened CLS, slightly impaired mitochondrial 
function, and higher levels of ROS and apoptotic cell death markers compared to 
the tor1Δ mutant strain, suggesting that TORC1-independent mechanisms also 
contribute to isc1Δ phenotypes. In agreement, the overexpression of ISC1 does 
not suppress the rapamycin hypersensitivity of tor1Δ mutants, suggesting that 
Isc1p is not acting downstream of TORC1 (Figure 2.S5).  
 Several lines of evidence suggest an intricate interplay between 
sphingolipid metabolism and TOR signalling. Both TORC1 and TORC2 control the 
biosynthesis of sphingolipids through regulation of Orm1p and Orm2p, two 
evolutionarily conserved integral membrane proteins of the endoplasmic reticulum 
(Breslow et al., 2010, Liu et al., 2012, Shimobayashi et al., 2013). However, 
TORC1 and TORC2 signalling seems to function independently in the regulation of 
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sphingolipid metabolism. TORC1 negatively controls the synthesis of complex 
sphingolipids from ceramide via inhibition of Orm1/2p phosphorylation in a process 
mediated by Npr1p (Shimobayashi et al., 2013). TORC2 stimulates the de novo 
biosynthesis of sphingolipids via activation of Ypk1p, which then phosphorylates 
and inactivates Orm1/2p (Roelants et al., 2011). Since Orm1/2p bind to and inhibit 
serine palmitoyl-coenzyme A transferase (SPT) (Breslow et al., 2010), which 
catalyzes the first step in sphingolipid biosynthesis (Yard et al., 2007), its 
inactivation by a Ypk1p-dependent phosphorylation alleviates SPT inhibition and 
increases sphingolipid production. In addition, TORC2 stimulates ceramide 
biosynthesis by an Ypk2p-dependent mechanism (Aronova et al., 2008) and 
inhibits Isc1p activity via modulation of Slm1/2p (Tabuchi et al., 2006, Niles & 
Powers, 2012).  
 Our data suggests a genetic interaction between ISC1 and TOR1. A recent 
report suggests a link between ceramide generated by mammalian acid 
sphingomyelinase under amino acid deprivation conditions and mTOR inactivation 
by a PP1/PP2A-dependent mechanism (Taniguchi et al., 2012). Notably, yeast 
Isc1p appears to occupy a central position and may possibly act as a metabolic 
hub (together with ceramide synthase) in the TOR pathway to regulate ceramide 
dynamics, since Isc1p is functionally linked with both TORC1 and TORC2 
branches. In particular, the modulation of complex sphingolipids turnover by 
coupling TORC1-regulated biosynthesis with Isc1p-driven hydrolysis may be 
important to control ceramide flux in yeast. 
 The molecular mechanism by which TORC1 is activated in isc1Δ cells 
remains to be elucidated. Nevertheless, the activation of TORC1 in Isc1p-deficient 
cells may be part of a homeostatic response that aims to decrease the synthesis 
of complex sphingolipids, since isc1Δ cells accumulate inositolphosphorylceramide 
(IPC) and mannosyldiinositolphosphorylceramide (M(IP)2C) (Sawai et al., 2000, 
Tabuchi et al., 2006) and TORC1 negatively controls their biosynthesis 
(Shimobayashi et al., 2013). However, TORC1 activation impairs mitochondrial 
function and oxidative stress resistance in isc1Δ cells, and TOR1 deletion 
suppresses isc1Δ phenotypes. Such features are in agreement with previous 
studies showing that TOR1 deletion regulates yeast CLS by a cell-intrinsic 
mechanism (Bonawitz et al., 2007, Pan et al., 2011). Reduced TORC1 signalling 
increases mitochondrial coupling during active growth in yeast cells, eliciting an 
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adaptive response that preconditions yeast cells to better survive in the stationary 
phase and promotes longevity (Pan et al., 2011). Furthermore, TOR1 disruption 
leads to an increased translation of mtDNA-encoded subunits of the oxidative 
phosphorylation system (Bonawitz et al., 2007), which is consistent with the higher 
oxygen consumption and COX activity observed in this study. In addition, it 
improves oxidative stress resistance in stationary phase (Wei et al., 2009).  
 In the present study, we demonstrate that TORC1-driven Sch9p C-terminal 
phosphorylation is increased in isc1Δ cells and our results are consistent with 
TORC1 acting through Sch9p-associated mechanisms since the disruption of both 
TOR1 and SCH9 abolishes isc1Δ phenotypes. Importantly, Isc1p-deficient cells 
presented reduced autophagic flux, both upon treatment with rapamycin and 
during cell aging, which is consistent with the activation of the TORC1-Sch9p 
pathway. In agreement, TOR1 and SCH9 disruption reestablished the functional 
integrity of autophagy in isc1Δ cells and this is correlated with the restoration of 
mitochondrial function in the double mutants, ultimately abolishing the H2O2 
hypersensitivity and premature aging exhibited by this mutant strain. 
 It was previously demonstrated that the accumulation of very long chain 
ceramide species (dihydro-C26-ceramide and phyto-C26-ceramide species) and 
ceramide-activation of the protein phosphatase Sit4p are also implicated in isc1Δ 
phenotypes (Barbosa et al., 2011). Since TORC1 negatively regulates Sit4p by 
promoting its association with the inhibitor Tap42p (Jacinto et al., 2001) and both 
TOR1 and SIT4 deletions suppress isc1Δ phenotypes, we propose that Sit4p may 
act in parallel to TORC1 signalling, by directly sensing ceramide signals (Figure  
2.7).  
            Several pieces of evidence suggest a functional link between 
sphingolipids, TOR signalling and the HOG pathway. The constitutive activation of 
Hog1p is deleterious for isc1Δ cells since the deletion of HOG1 attenuates the 
shortened CLS, hydrogen peroxide sensitivity and mitochondrial dysfunctions of 
this mutant strain (Barbosa et al., 2012). The HOG pathway is activated upon 
treatment of yeast cells with myriocin, an inhibitor of the de novo sphingolipid 
biosynthesis, and in cells with impaired synthesis of IPC (Tanigawa et al., 2012). 
In addition, reduced TOR signalling lowers the basal activity of Hog1p in Candida 
albicans through the Hog1p tyrosine phosphatases Ptp2p and Ptp3p (Su et al., 
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2013) and our results show a decrease of Hog1p basal phosphorylation in the 
tor1Δ mutant.  
 
Figure 2.7. Sit4p and Sch9p integrate nutrient and stress signalling from TORC1 
with ceramide signals to regulate mitochondrial function and CLS in yeast. Cells 
lacking Isc1p present increased TORC1-Sch9p activity, ultimately leading to mitochondrial 
dysfunction, decreased oxidative stress resistance and shortened CLS. Apart from 
sensing signals from TORC1, the ceramide activated protein phosphatase Sit4p and the 
AGC protein kinase Sch9p also integrate ceramide signalling derived from Isc1p to 
regulate mitochondrial function, oxidative stress resistance and chronological lifespan in 
yeast. 
 
           In this study, we demonstrate that TOR1 deletion does not suppress Hog1p 
hyperactivation or alter Hog1p localization in isc1Δ cells. However, our results 
support a more intricate interplay between the two signalling pathways in isc1Δ 
cells. Indeed, Hog1p phosphorylation was even increased in isc1Δtor1Δ cells in 
comparison to isc1Δ cells and remarkably a similar feature was also observed for 
both sit4Δ and isc1Δsit4Δ cells, which present extended lifespan when compared 
to isc1Δ or even to parental cells (Barbosa et al., 2011). We propose that the 
deletion of TOR1 or SIT4 either suppresses putative deleterious effects of Hog1p 
hyperactivation on mitochondrial function and CLS or modulates the regulatory 
role of Hog1p to determine cell fate in Isc1p-deficient cells. In fact, the activation of 
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yeast Hog1p or its mammalian orthologue, p38 MAPK, has been implicated in both 
cell survival and cell death. For example, HOG1 deletion decreases osmotic and 
oxidative stress resistance and shortens CLS in yeast (Kaeberlein et al., 2002, 
Bilsland et al., 2004). However, the expression of constitutively active Hog1p 
mutant kinases or constitutive activation of the HOG pathway is lethal (Maeda et 
al., 1993, Maeda et al., 1994, Wurgler-Murphy et al., 1997), and hyperactivation of 
Hog1p is detrimental under heat stress conditions (Lee et al., 2002). In 
mammalian cells, p38 MAPK is activated during the onset of senescence (Wang et 
al., 2002, Deng et al., 2004), its inhibition moderately delays replicative 
senescence (Iwasa et al., 2003) and its activation promotes apoptosis (Xia et al., 
1995, Grethe et al., 2004).  
          Remarkably, we provide significant evidence that the activation of the HOG 
pathway is modulated by ceramide signalling by Sch9p-dependent mechanisms, 
ultimately contributing to isc1Δ phenotypes. Indeed, C2-ceramide-induced Hog1p 
phosphorylation (Barbosa et al., 2012) was suppressed by the deletion of SCH9. 
In addition, Hog1p phosphorylation is decreased upon deletion of SCH9 in Isc1p-
deficient cells and the results are consistent with both proteins acting in the same 
pathway since SCH9 (this study) and HOG1 (Barbosa et al., 2012) deletions 
suppress isc1Δ phenotypes. Therefore, our study points out to a model in which 
Sch9p integrates nutrient and stress signals from TORC1 with ceramide signalling, 
the latter contributing to the modulation of the Hog1p phosphorylation (Figure 2.7). 
Interestingly, this appears to be ceramide-specific since the addition of PHS had 
no effect on Hog1p phosphorylation (data not shown). It is known that Sch9p 
possesses a C2-domain, which is known to bind to several substrates, namely 
Ca2+, phospholipids, inositol polyphosphates, and intracellular proteins (Nalefski & 
Falke, 1996). Whether ceramide acts by binding directly to the C2-domain remains 
to be established.  
 Importantly, we also demonstrate that Isc1p-deficient cells presented 
reduced autophagic flux, which could further contribute to mitochondrial 
dysfunction. Remarkably, TOR1 and SCH9 disruption reestablishes the functional 
integrity of autophagy in isc1Δ cells, which is consistent with the restoration of 
mitochondrial function in the double mutants, possibly abolishing the H2O2 
hypersensitivity and premature aging exhibited by this mutant strain. 
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 In summary, our data implicate TORC1-Sch9p activation in the 
mitochondrial dysfunction, premature aging, oxidative stress sensitivity and 
impaired autophagy exhibited by isc1Δ cells. However, Isc1p and TORC1 also 
seem to act through independent pathways, as isc1Δtor1Δ phenotypes are 
intermediate to those displayed by isc1Δ and tor1Δ cells. The lifespan extension in 
isc1Δ cells imparted by reduced TORC1 signalling is not associated with the 
attenuation of Hog1p hyperphosphorylation. Our results suggest that complex 
signalling interconnections involving TORC1 and its downstream effectors Sch9p 
and Sit4p govern redox homeostasis and lifespan of isc1Δ cells and support a 
model in which both proteins act as physiological core centers integrating nutrient 
and stress signal from TORC1 and ceramide signalling derived from Isc1p to 
regulate mitochondrial function and CLS in yeast (Figure 2.7).  
 
 
2.4. Experimental procedures 
 
2.4.1. Yeast cells and growth conditions 
 
 S. cerevisiae BY4741 was the parental strain of all haploid derivatives used 
in this study (Table 2.5.1). Yeast cells were grown aerobically at 26°C in a gyratory 
shaker (at 140 r.p.m.), with a ratio of flask volume/ medium volume of 5:1. The 
growth media used were YPD [1% (w/v) yeast extract, 2% (w/v) bactopeptone, 2% 
(w/v) glucose], YPGlycerol [1% (w/v) yeast extract, 2% (w/v) bactopeptone, 4% 
(v/v) glycerol] or synthetic complete (SC) drop-out medium containing 2% (w/v) 
glucose, 0.67% yeast nitrogen base without amino acids and supplemented with 
appropriate amino acids (80 mg histidine L-1, 400 mg leucine L-1, 80 mg tryptophan 
L-1 and 80 mg uracil L-1). The tor1Δ cells were obtained by replacing TOR1 with a 
tor1::KanMX4 deletion cassette amplified by polymerase chain reaction (PCR) 
using the corresponding strain available from EUROSCARF (Germany) and the 
following primers: Fw (GAGAATCATTACCGGCGAAA) and Rv 
(ACGAACACGTTTTGGTGATG). For ISC1 disruption in tor1Δ and 
sch9Δ::KanMX4 cells, a deletion fragment containing LEU2 and the flanking 
regions of ISC1 was amplified by PCR using pRS315 and primers Fw 
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(ATTTGCGCTTTCCGTAAAAAGGGAAAAAAAGCAGATATTTAAGCAAGGATTTT
CT) and Rv (TCAGTAATTTTTTTACATATGCTAAAGAAAATCGATAATACCGCAT 
ATCGACCCTCGAGGAG). Cells were transformed by electroporation. The tor1Δ 
cells were selected in YPD medium containing geneticin (0.4 mg.mL-1) whereas 
isc1Δtor1Δ and isc1Δsch9Δ cells were selected in minimal medium lacking leucine 
[0.67% (w/v) yeast nitrogen base without amino acids, 2% (w/v) glucose 
supplemented with appropriate amino acids (40 mg histidine L-1, 40 mg uracil L-1 
and 40 mg methionine L-1)]. The correct insertion of all marker cassettes was 
confirmed by PCR. 
 To evaluate TORC1-dependent C-terminal phosphorylation of Sch9p, 
BY4741 and isc1∆ cells were transformed by electroporation with pJU676 (Urban 
et al., 2007) and selected in minimal medium lacking uracil. For the analysis of 
mitochondrial morphology, yeast cells were transformed with a plasmid expressing 
mitochondrial DsRed (pYX222-mtDsRed) and selected in minimal medium lacking 
histidine. To evaluate autophagic flux, cells were transformed by electroporation 
with pRS416-GFP-ATG8 (Yorimitsu et al., 2007) and selected in minimal medium 
lacking uracil. For Hog1p localization assays, yeast cells were transformed with 
pRS416-HOG1-GFP (Ferrigno et al., 1998) and selected in minimal medium 
lacking uracil. To assess the activation of the CWI pathway by Rlm1p reporter 
transcriptional activity, yeast cells were transformed with pLGΔ312-2xRLM1-LacZ 
(Jung et al., 2002) and selected in minimal medium lacking uracil. For epistatic 
analysis, BY4741 and tor1Δ strains were transformed with pYES2 and pYES2-
ISC1 (Almeida et al., 2008) and selected in minimal medium lacking uracil.  
 
2.4.2. Stress resistance and chronological lifespan 
 
 For H2O2 resistance assay, cells were grown to the exponential phase 
(OD600 = 0.6) or early stationary phase (48h after exponential phase) and exposed 
to 1.5 mM or 300 mM H2O2 (Merck) for 60 and 30 min, respectively. The CLS 
assay was performed as described (Fabrizio & Longo, 2003). For both assays, cell 
viability was determined by standard dilution plate counts on YPD medium 
containing 1.5 % (w/v) agar and expressed as the percentage of the colony-
forming units after growth at 26ºC for 3 days (time T vs. T0 (when viability was 
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considered 100%) for the CLS assay; treated vs. untreated cells for H2O2 
resistance). Values are mean ± SD of at least three independent experiments.  
 
2.4.3. Enzymatic activities and oxygen consumption 
 
 For enzyme activities, yeast cells were harvested by centrifugation for 5 min 
at 4,000 r.p.m. (4ºC). Cells were then ressuspended in 50 mM potassium 
phosphate buffer (pH 7.0) containing protease inhibitors (Complete, Mini, EDTA-
free Protease Cocktail Inhibitor Tablets; Boehringer Mannhein) and phosphatase 
inhibitors (50 mM sodium fluoride, 5 mM sodium pyrophosphate, 1 mM sodium 
orthovanadate). Total protein extracts were obtained by mechanical disruption 
through vigorous shaking of the cell suspension in the presence of glass beads for 
5 min. Short pulses of 1 min were applied followed by 1 min incubation on ice. Cell 
debris was removed by centrifugation at 13,000 r.p.m. for 15 min and protein 
content was determined by the method of Lowry, using bovine serum albumin as a 
standard. Catalase activity was analyzed in situ, in the presence of 3,3′-
diaminobenzidine tetrahydrochloride, using the H2O2/peroxidase system (Conyers 
& Kidwell, 1991). Cytochrome c oxidase (COX) activity was determined by 
measuring cytochrome c oxidation (Poyton et al., 1995). β-galactosidase activity 
determination was performed as previously reported (Barbosa et al., 2012). 
Oxygen consumption rate was measured for 3 x 108 cells in PBS buffer (pH 7.4), 
using an oxygen electrode (Oxygraph, Hansatech). Data was analyzed using the 
Oxyg32 V2.25 software.  
 
2.4.4. Mitochondrial membrane potential, ROS levels and cell death 
 
 The mitochondrial membrane potential was measured using the potential-
sensitive dye DiOC6(3). Briefly, 2x106 cells were ressuspended in sample buffer 
[10 mM 2-(N-morpholino) ethanesulfonic acid, 0.1 mM MgCl2 and 2% (w/v) 
glucose, pH 6.0]. DiOC6(3) (Molecular Probes) was added to a final concentration 
of 1 nM. The cell suspension was then incubated for 30 min at 26°C, collected by 
centrifugation and washed twice with PBS. Fluorescence was measured on the 
FL-1 channel of a Becton Dickinson FACS Calibur Analytic Flow cytometer with 
excitation and emission settings of 488 nm and 515–545 nm, respectively, without 
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compensation. For the quantification of ROS levels, 5x106 cells were 
ressuspended in PBS and the superoxide anion sensitive probe dihydroethidium 
(DHE, Molecular Probes) was added to a final concentration of 5 µM. Cells were 
incubated for 10 min at 26°C, pelleted by centrifugation, washed twice with PBS 
and analyzed by flow cytometry with excitation and emission settings of 488 nm 
and ≥670 nm (FL-3 channel), without compensation.  
 For the characterization of the cell death process, cells were dually stained 
with DiOC6(3) (1 nM) and propidium iodide (PI, 2 µg/mL, Molecular Probes) to 
evaluate mitochondrial membrane polarization and the plasma membrane 
integrity, respectively. Cells were incubated for 30 min at 26°C and harvested as 
previously described. After suitable compensation, fluorescence was measured by 
flow cytometry at different wavelengths: excitation/emission at 488/525 nm for 
DiOC6(3) (FL-1 channel), and at 536/600 nm for PI (FL-3 channel). Data treatment 
was performed using the FlowJo software (Tree Star). 
 
2.4.5. Western Blot analysis  
 
 To evaluate the TORC1-dependent C-terminal phosphorylation of Sch9p, 
cells transformed with pJU676 (expressing SCH9-5HA) were grown in SC-medium 
lacking uracil to the exponential phase. NTCB-chemical fragmentation analysis 
was done as described (Urban et al., 2007). Proteins were then analyzed by SDS-
PAGE using 10% polyacrylamide gels and blotted onto a nitrocellulose membrane 
(GE Healthcare, Buckinghamshire, United Kingdom). Immunodetection was 
performed using rabbit anti-HA (Sigma-Aldrich) at a 1:1,000 dilution as primary 
antibody, goat anti-rabbit IgG-peroxidase (Sigma-Aldrich) at a 1:5,000 dilution as 
secondary antibody, and the Lumigen HRP chemiluminescent substrate (GE 
Healthcare, RPN2109, Buckinghamshire, United Kingdom).  
 To monitor Hog1p phosphorylation, yeast cells were grown to the 
exponential phase and protein extracts (50 µg) were separated by SDS-PAGE and 
blotted onto a nitrocellulose membrane. The membrane was incubated with the 
primary antibodies rabbit anti-phospho-p38 MAPK (Cell Signalling Technology, 
Denver, USA) at a 1:500 dilution or mouse anti-Pgk1p (Invitrogen, Carlsbad, USA) 
at a 1:30,000 dilution. Subsequently, the membrane was incubated with the 
secondary antibodies, anti-rabbit IgG-peroxidase (Sigma-Aldrich) at a 1:5,000 
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dilution, or anti-mouse IgG-peroxidase (Molecular Probes) at a 1:3,000 dilution. 
Immunodetection was performed as described above.   
 The evaluation of LCBs mediated Phk1/2p-dependent phosphorylation of 
Sch9p was performed as described (Huang et al., 2012). To assess alterations in 
autophagic flux, cells were grown to the exponential phase in SC-medium and 
treated with either rapamycin (200 ng/mL, (Sigma-Aldrich) or DMSO (vehicle, 
Sigma-Aldrich) for 3 hours. For CLS assay in water, cells were grown to the PDS 
phase, washed twice with water and then maintained in water overtime. Total 
protein extracts (30 µg) were analyzed in similar conditions as previously 
described. The membrane was incubated with the primary antibodies mouse anti-
GFP (Roche, Basel, Switzerland) at a 1:3,000 dilution or mouse anti-Pgk1p 
(Invitrogen, Carlsbad, USA) at a 1:30,000 dilution. Subsequently, the membrane 
was incubated with the secondary antibody anti-mouse IgG-peroxidase (Molecular 
Probes) at a 1:3,000 dilution. Immunodetection was done as described.   
 
2.4.6. Fluorescence microscopy 
 
 For mitochondrial morphology analysis, cells transformed with pYX222-
mtDsRed were grown in SC-medium lacking histidine to the exponential or PDS 
phase. To assess Hog1p cell localization, cells expressing HOG1-GFP were 
grown in SC-medium lacking uracil to the exponential phase and stained with the 
fluorescent dye 4’,6’-diamidino-2-phenylindole, DAPI (Molecular Probes, 
Invitrogen, 2.5 µg/mL) to label the nucleus. Live cells were observed by 
fluorescence microscopy (AxioImager Z1, Carl Zeiss). Data image stacks were 
deconvolved by QMLE algorithm of Huygens Professional v3.0.2p1 (Scientific 
Volume Imaging B.V.). Maximum intensity projection was used to output final 
images using ImageJ 1.45v software. 
 
2.4.7. Statistical analysis 
 
 Data are expressed as mean values ± SD of at least three independent 
experiments. Values were compared by Student’s t-test. The 0.05 probability level 
was chosen as the point of statistical significance throughout. Statistical analyses 
were carried out using GraphPad Prism Software v5.01 (GraphPad Software). 
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2.5. Supplementary Information  
 
Table 2.5.1. Saccharomyces cerevisiae strains used in this study. 
Strain Genotype Source 
BY4741 Mata his3Δ1, leu2Δ0, met15Δ0, ura3Δ0 
[pJU676, pYX222-mtDsRed, pRS416-GFP-
ATG8, pRS416-HOG1-GFP, pLGΔ312-
2xRLM1-LacZ, pYES2, pYES2- ISC1] 
EUROSCARF 
isc1Δ BY4741 isc1Δ::KanMX4 [pJU676, pYX222-
mtDsRed, pRS416-GFP-ATG8, pRS416-
HOG1-GFP, pLGΔ312-2xRLM1-LacZ] 
EUROSCARF 
tor1Δ BY4741 tor1Δ::KanMX4 [pYX222-mtDsRed, 
pRS416-GFP-ATG8, pRS416-HOG1-GFP, 
pLGΔ312-2xRLM1-LacZ, pYES2,  pYES2-
ISC1] 
This study 
isc1Δtor1Δ BY4741 isc1Δ::LEU2 tor1Δ::KanMX4 
[pYX222-mtDsRed,  pRS416-GFP-ATG8, 
pRS416-HOG1-GFP, pLGΔ312-2xRLM1-
LacZ] 
This study 
sch9Δ BY4741 sch9Δ::KanMX4 [pYX222-mtDsRed,  
pRS416-GFP-ATG8] 
EUROSCARF 
isc1Δsch9Δ BY4741 isc1Δ::LEU2 sch9Δ::KanMX4 
[pYX222-mtDsRed, pRS416-GFP-ATG8] 
This study 
sit4Δ BY4741 sit4Δ::KanMX4 EUROSCARF 
isc1Δsit4Δ BY4741 isc1Δ::URA3 sit4Δ::KanMX4 Barbosa et al.  
(2011) 
Harboring plasmids are shown in square brackets 
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Figure 2.S1. The Pkh1/2p-dependent Sch9p phosphorylation does not contribute to 
isc1Δ phenotypes. The Pkh1/2p-mediated phosphorylation of Sch9p at Thr570 was 
monitored in BY4741 and isc1Δ cells by immunoblotting, using anti-phospho-Thr570-
Sch9p antibody (top panel) or anti-Pgk1p (loading control) as primary antibodies. A 
representative blot is shown. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.S2. Inhibition of TORC1 signalling with rapamycin suppresses oxidative 
stress sensitivity displayed by isc1Δ cells. Yeast cells were grown in SC-medium to 
the early exponential phase (OD600=0.3), pre-incubated with either 200 ng/mL rapamycin 
(Rap) or vehicle (DMSO) for 3h and then treated with 1.5 mM H2O2 for 60 min. Cell 
viability was determined as described in Experimental Procedures. ***p<0.001; *p<0.05. 
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Figure 2.S3. The autophagic flux is decreased in isc1Δ cells. S. cerevisiae BY4741 
and isc1Δ cells carrying pRS416 GFP-ATG8 were grown to the exponential phase in SC-
medium and treated with either 200 ng/mL rapamycin (Rap) or DMSO (vehicle) for 3 
hours. Proteins were analyzed by immunoblotting, using anti-GFP antibody. The Western 
blot shown here is a replicate of that shown in Figure 2.4.C (only for BY4741 and isc1Δ 
cells) with a longer exposure time. A slower migrating band (above free GFP) was 
observed in isc1Δ cells, both under basal conditions and upon rapamycin treatment. A 
similar upper band (marked with an arrow) was observed in parental cells upon treatment 
with rapamycin. Notably, this upper band was more abundant in isc1Δ cells when 
compared to the one observed in parental cells. It probably results from impaired or 
aberrant GFP-Atg8p processing, possibly due to vacuolar dysfunction (defective Pep4p-
dependent proteolytic activity) or alterations in vacuolar morphology upon deletion of 
ISC1, as mentioned in the main text. Thus, we have considered only the higher migrating 
band as free GFP (generated from processing of GFP-Atg8p) for autophagic flux 
quantification (Fig. 4D).  
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Figure 2.S4. The deletion of TOR1 does not alter Hog1p localization in isc1Δ cells. 
S. cerevisiae BY4741, isc1Δ, tor1Δ and isc1Δtor1Δ cells transformed with pRS416-HOG1-
GFP were grown to the exponential phase and live cells were visualized by fluorescence 
microscopy for GFP and DAPI, as described in Experimental Procedures. BY4741 cells 
treated with 0.7 M NaCl for 20 min were used as positive control to monitor Hog1p 
translocation to the nucleus. Scale bar: 5 µm. 
Chapter II 
	   	   120	  
 
 
Figure 2.S5. The rapamycin sensitivity of the tor1Δ mutant was not suppressed by 
ISC1 overexpression. S. cerevisiae BY4741 and tor1Δ cells carrying pYES2 or pYES2-
ISC1 were grown in SC-medium to the exponential phase and then diluted to OD600=0.1. 
Fivefold dilution series were spotted on glucose or galactose media containing either 
rapamycin (50 ng/mL, dissolved in DMSO) or DMSO (vehicle) and cells were grown at 
26°C for 5 days. 	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 One of the major challenges for (...) who wish to work in the domain of (...) 
biology is becoming conversant with the daunting intricacies of existing biological 
knowledge. Questions about the origin, function, and structure of living systems 
have been pursued by nearly all cultures throughout history, and the work of the 
last generations has been particularly fruitful. The knowledge of living systems 
resulting from this research is far too detailed and complex for any one human to 
comprehend. 
 
        Lawrence Hunter
CHAPTER III 
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Isc1p-driven ceramide signalling regulates vesicular trafficking, 
mitophagy and mitochondrial dynamics in yeast  
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Abstract  
 
Macroautophagy plays an important regulatory role in mitochondrial function, 
stress response and aging. It is deregulated in yeast cells lacking Isc1p, an 
orthologue of mammalian neutral sphingomyelinase type 2, but the impact of 
sphingolipid metabolism on autophagy still remains largely unknown. Here, we 
show that Isc1p deficient cells present reduced autophagic flux due to impaired 
vesicular trafficking and vacuolar function (protein sorting, proteolysis and 
acidification) and to vacuolar fragmentation. These phenotypes are suppressed by 
downregulation of TORC1 or its downstream effectors, the AGC protein kinase 
Sch9p and the PP2A-like phosphatase Sit4p, which integrate nutrient and stress 
signals from TORC1 with ceramide signalling from Isc1p. Notably, isc1Δ cells 
display hyperactivation of mitophagy and higher levels of Dnm1p associated with 
unbalanced mitochondrial fission, leading to mitochondrial fragmentation, oxidative 
stress sensitivity and shortened lifespan. Moreover, Isc1p and Dnm1p physically 
interacted in vitro, further supporting a regulatory role for Isc1p on mitochondrial 
dynamics. Overall, our work demonstrates that Isc1p-mediated ceramide signalling 
regulates macroautophagy, mitophagy and mitochondrial dynamics in yeast with 
impact on lifespan.  
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3.1. Introduction 
 
 Sphingolipids are important structural components of cell membranes found 
in all eukaryotes and some prokaryotic organisms (Dickson & Lester, 1999, 
Dickson, 2008, Hannun & Obeid, 2008, Pruett et al., 2008). Sphingosine, ceramide 
and sphingosine-1-phosphate (S1P) are core sphingolipids regulating fundamental 
cellular processes including cell growth, senescence, apoptosis and autophagy 
(Zheng et al., 2006, Dickson, 2008, Rego et al., 2012, Young et al., 2013). 
Sphingosine and ceramide exert pleiotropic effects on protein kinases and 
phosphatases and induce cell cycle arrest and apoptosis (Hannun & Obeid, 2008). 
In particular, ceramide regulates apoptosis (Obeid et al., 1993, Mullen & Obeid, 
2012) and cell senescence (Venable et al., 1995) by modulating the activity of 
ceramide-activated protein kinases (e.g. PRKCD/PKC) and phosphatases (CAPP, 
PP1 and PP2A) (Hannun & Obeid, 2008). In contrast, S1P promotes cell 
proliferation and survival by acting on receptors (Hla, 2004, Hannun & Obeid, 
2008). 
 The budding yeast Saccharomyces cerevisiae has been important to 
understand the mechanisms for sphingolipid homeostasis in mammals due to the 
high conservation of this metabolism (Dickson, 2008). Therefore, it is a useful 
model organism to study overall sphingolipid metabolism and functions (Rego et 
al., 2014). Initial studies have demonstrated that Isc1p, the yeast orthologue of 
mammalian neutral sphingomyelinase-2 (nSMase2) responsible for the hydrolysis 
of inositol phosphosphingolipids to produce ceramide, is implicated in oxidative 
stress resistance, mitochondrial function and chronological lifespan (CLS) 
(Almeida et al., 2008). Indeed, isc1Δ cells display premature aging, increased 
hydrogen peroxide sensitivity and several mitochondrial dysfunctions (Almeida et 
al., 2008). The ceramide-activated protein phosphatase Sit4p, related to the type 
2A family of protein phosphatases and with high homology to human protein 
phosphatase 6 (Bastians & Ponstingl, 1996), becomes activated in response to 
increased specific ceramide species during aging in isc1Δ cells and contributes to 
these phenotypes (Barbosa et al., 2011).  
 More recently, we showed that Isc1p deficiency leads to the activation of 
the TORC1-Sch9p and the HOG pathways, the latter in response to ceramide 
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signalling by Sch9p-dependent mechanisms, contributing to its phenotypes 
(Barbosa et al., 2012, Teixeira et al., 2014). 
 TORC1 is a major regulator of autophagy, a conserved process in 
eukaryotic cells involving the engulfment of cytoplasmic cargo into double-
membrane vesicles named autophagosomes. After fusing to the vacuole, the 
content is degraded by the resident hydrolases (Reggiori & Klionsky, 2013). 
Several Atg proteins are organized into functional complexes that mediate these 
steps (Huang & Klionsky, 2002, Nakatogawa et al., 2009, Boya et al., 2013). Upon 
starvation, autophagy becomes activated, providing a source of nutrients and 
energy (Ryter et al., 2013, Russell et al., 2014). In yeast, PKA and Sch9p 
negatively regulate autophagy, in parallel to the TORC1 pathway, by 
Msn2p/Msn4p and Rim15p dependent mechanisms (Yorimitsu et al., 2007). 
Pho85p also plays a regulatory role in this process (Budovskaya et al., 2004, Yang 
et al., 2010). Under nutrient-rich conditions, autophagy is inhibited because 
TORC1 is activated and hyperphosphorylates Atg13p, decreasing its affinity for 
Atg1p and Atg17p (Kamada et al., 2010). 
 The view of mitochondrial dynamics has expanded into an integral cell 
biological process influencing cell death and aging (Berman et al., 2008, Braun & 
Westermann, 2011). Mitochondria are dynamic structures that migrate throughout 
the cell, fuse and divide, and undergo regulated turnover (Westermann, 2010). 
The best-studied proteins involved in mitochondrial fusion are Fzo1p (the yeast 
homolog of mammalian mitofusins MFN1 and MFN2) and Ugo1p in the outer 
membrane, and Mgm1p, a dynamin-related GTPase located in the intermembrane 
space. The regulation of mitochondrial fission involves Fis1p, an adaptor protein in 
the mitochondrial outer membrane, and the cytosolic effector Dnm1p, which is 
recruited at sites of mitochondrial division on the surface (Westermann, 2008). 
 Mitochondrial dynamics and the selective degradation of mitochondria by 
mitophagy are important for proper mitochondrial function by allowing 
mitochondrial compartmentalization, mitochondrial communication and regulation 
of the mitochondrial shape (Detmer & Chan, 2007, Berman et al., 2008, Chen & 
Chan, 2009, Westermann, 2012). Importantly, mitophagy is associated with the 
removal of dysfunctional mitochondria, therefore contributing to sustainable 
mitochondrial function (ATP production) (Gomes & Scorrano, 2013). Several Atg 
proteins are required for mitophagy (Bhatia-Kiššová & Camougrand, 2010, Kanki 
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& Klionsky, 2010a, Kanki et al., 2010b), including Atg32p (Kanki et al., 2009a) and 
Atg33p (Kanki et al., 2010b), which are selectively involved in this process. 
Mitophagy and mitochondrial dynamics seem to act in a coordinated manner to 
assure the connectivity and maintenance of proper mitochondrial function, which 
are important factors determining cellular responses to the metabolic status and 
other factors, such as calcium and other pro-apoptotic signals (Seo et al., 2010, 
Mao et al., 2013). 
 In this study, we show that Isc1p is crucial for the regulation of 
macroautophagy, mitophagy and mitochondrial dynamics in yeast. We show that 
isc1Δ cells displayed reduced autophagic flux due to impaired vesicular trafficking 
and disturbed vacuolar proteolytic activity. In contrast, mitophagy is hyperactive 
and this was associated with mitochondrial fragmentation and decreased cell 
viability in isc1Δ cells. This was, at least in part, attributted to activation of the 
ceramide-activated Sit4p and the TORC1-Sch9p pathways, ultimately contributing 
to mitochondrial dysfunction, oxidative stress sensitivity and shortened CLS in 
isc1Δ cells. Notably, disrupted mitochondrial dynamics in the mutant strain is 
attributted to a slight impairment in mitochondrial fusion events and increased 
levels of fission protein Dnm1p but not Fis1p levels. We also demonstrated that 
Isc1p and Dnm1p interact in vitro, suggesting a regulatory role for Isc1p in 
mitochondrial dynamics.  
 
3.2. Results 
 
3.2.1. Isc1p regulates autophagy by targeting vesicular trafficking and 
vacuolar proteolysis 
 
 We have previously reported that isc1Δ cells exhibit defective autophagic 
flux suppressed by the deletion of TOR1 or SCH9 (Teixeira et al., 2014). To 
elucidate the role of Isc1p in this process, we have analyzed the autophagy 
reporter GFP-Atg8p dynamics by fluorescence microscopy in cells treated with 
rapamycin (Figure 3.1.A). The results show that GFP-Atg8p was properly 
delivered into the vacuole and processed to free GFP (inside the vacuoles). In 
isc1Δ mutants, a preferential accumulation of GFP-Atg8p was observed in the 
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cytosol (circa 90% of the analysed population). Although not apparent, we still 
observed GFP signal inside the vacuoles, which is consistent with the generation 
of free GFP derived from the processing of GFP-Atg8p (Teixeira et al., 2014). The 
localization of the phagophore assembly site (PAS) at the rim of the vacuole 
(visible as single green dots) was not altered in the mutant. Importantly, isc1Δ cells 
showed vacuolar fragmentation (Figure 3.1.A), suggesting that vacuolar 
dysfunction may contribute to the observed autophagic defects. 
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Figure 3.1. Isc1p-deficient cells exhibit vacuolar fragmentation and impaired 
autophagic flux.  
A. BY4741 and isc1Δ cells expressing GFP-Atg8p were grown in SC glucose-medium to 
exponential phase and exposed to rapamycin (200 ng/mL) for 3h. Vacuoles were 
visualized by FM 4-64 staining (red) and GFP-Atg8p dynamics was observed by 
fluorescence microscopy. Scale bar: 5 µm. B. BY4741 and isc1Δ cells expressing 
Pho8Δ60 were grown in YPD to exponential phase and treated as described in A. The 
Pho8Δ60 activity was normalized to the activity of WT cells treated with rapamycin, which 
was set to 100%. Values are mean ± SD of at least three independent experiments. 
****p<0.0001; ***p<0.001. C. The processing of the Cvt pathway marker protein prApeI to 
mApeI was analyzed by immunoblotting in BY4741, isc1Δ, vac8Δ and isc1Δvac8Δ cells 
grown to exponential phase and treated as described in A. 
 
 Next, we corroborated these results in a different strain background (W303) 
by measuring the activity of a truncated form of alkaline phosphatase (Pho8Δ60), 
which is converted to an enzimatically active form at the vacuoles upon induction 
of autophagy (Yorimitsu et al., 2007). ALP activity is routinelly used as a 
quantitative measure of autophagy induction (Yorimitsu et al., 2007). Rapamycin-
treated parental cells showed an increase in Pho8Δ60 activity, which was 
suppressed in atg1Δ cells where autophagy is blocked. Pho8Δ60 activity was 
lower in isc1Δ cells (Figure 3.1.B), supporting that the induction of autophagy is 
impaired in the mutant strain and that this phenotype is not strain specific.  
 The cytoplasm-to-vacuole targeting (Cvt) pathway is a vesicular transport 
mechanism that employs most of the macroautophagy machinery to deliver 
several hydrolases to the vacuole, including the percursor aminopeptidase I 
(prApeI) (Scott et al., 1996, Wang & Klionsky, 2003). We therefore sought to 
determine whether isc1Δ cells are also defective in this process by monitoring the 
processing of prApeI to the mature form (mApeI). We observed that prApeI 
accumulated in isc1Δ cells upon rapamycin treatment, a feature already observed 
at basal conditions when compared to parental cells (Figure 3.1.C). It was also 
analyzed the prApeI accumulation phenotype in a vac8Δ background. Vac8p is 
required for proper induction of the Cvt pathway but not for macroautophagy 
(Abeliovich et al., 2000). Therefore, in a vac8Δ background, prApeI can only be 
converted to its mature form when autophagy is induced. Non-treated vac8Δ cells 
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accumulated prApeI and the protein was rapidly processed to mApeI after 
incubation with rapamycin. In contrast, the accumulation of prApeI was still 
observed in rapamycin-treated isc1Δvac8Δ cells (Figure 3.1.C). Together, these 
results suggest that Isc1p is required for proper regulation of macroautophagy and 
the Cvt pathway in yeast. 
 To identify the steps at which autophagy is impaired in Isc1p-deficient cells, 
we have firstly examined vacuolar proteolysis. Pep4p constitutes the major 
vacuolar protease driving the maturation of vacuolar proteases. Accordingly, 
pep4Δ cells display defective GFP-Atg8p processing when autophagy is induced 
(Kirisako et al., 1999). To evaluate if Pep4p-dependent vacuolar proteolytic activity 
is impaired in isc1Δ cells, we monitored the maturation of carboxypeptidase Y 
(CPY), which occurs in a Pep4p-dependent manner (Figure 3.2.A). Most of the 
precursor CPY (prCPY) was converted to the mature form (mCPY) in parental 
cells, both under basal conditions and after incubation with rapamycin. In isc1Δ 
cells, prCPY maturation was significantly decreased, even after rapamycin 
treatment, suggesting that Pep4p activity is reduced in the mutant strain (Figure 
3.2.A). To provide further evidence that reduced Pep4p-mediated vacuolar 
hydrolysis contributes to reduced autophagic flux in isc1Δ cells, prApeI processing 
(which is Pep4p-dependent) was monitored in cells overexpressing PEP4. Indeed, 
the defective maturation of prApeI in isc1Δ cells was alleviated by PEP4 
overexpression (Figure 3.2.B).  
 To determine whether Isc1p is involved in autophagosome-to-vacuole 
fusion, we employed a protease protection assay to evaluate the sensitivity of the 
prApeI to an externally added protease in rapamycin-treated isc1Δ cells (Krick et 
al., 2010). After removing non-lysed cells by low speed centrifugation, we 
separated the total lysate (Figure 3.2.C, T, lane 1) in a 13,000 x g supernatant 
(S13, lane 2) and pellet fraction (P13, lane 3). With this method, we also used 
internal controls to determine the efficiency of spheroplast lysis (Pgk1p), and to 
verify the integrity of intracellular compartments including the vacuole (prCPY) 
and, by extension, autophagosomes. The resistance of the lumenal propeptide 
(prCPY) to trypsin in the absence of Triton X-100 (Figure 3.2.C, compare lanes 3 
and 4 versus lane 5) reflects the integrity of the vacuole (and autophagosomes). In 
this assay, the membrane fraction (P13) was untreated (lane 3) or treated with 
protease alone (lane 4) or with protease and detergent (lane 5).  
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Figure 3.2. Defective vacuolar proteolysis and acidification contributed to reduced 
autophagic flux in isc1Δ cells. 
A. The Pep4p-dependent processing of prCPY to mCPY was analyzed by immunoblotting 
in BY4741 and isc1Δ cells grown to exponential phase and treated with either DMSO 
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(vehicle) or rapamycin (200 ng/mL) for 3h. B. The Pep4p-dependent processing of prApeI 
to mApeI was analyzed by immunoblotting in BY4741 and isc1Δ overexpressing PEP4 
treated as described in 2A. Quantification of mApeI/(prApeI+mApeI) is shown. Values are 
mean ± SD of at least three independent experiments. **p<0.01. C. Cells devoid of Isc1p 
were grown to the exponential phase and treated with rapamycin (200 ng/mL) for 2h. After 
removing non-lysed cells, the total lysate (T, lane 1) was centirfuged to obtain a 13,000 x 
g supernatant (S13, lane 2) and pellet fraction (P13, lane 3). The P13 fraction was then 
ressupended in PS200 buffer (lane 3) and trypsin-digested with and without detergent 
(Triton X-100, lanes 4-5). The efficiency of spheroplast lysis (Pgk1p) and the integrity of 
intracellular compartments (vacuolar prCPY) were also monitored. *mApeI-protease-
protected intermediate form of prApeI. D. For the detection of secreted CPY, BY4741 and 
isc1∆ cells were grown on YPD plates and overlaid with a nitrocellulose filter. The vps4∆ 
mutant was used a positive control for CPY secretion. Secreted CPY was 
immunodetected with anti-CPY. E. Vacuolar acidification of BY4741 and isc1∆ cells grown 
to exponential phase was monitored using quinacrine staining and analyzed by flow 
cytometry. Unprobed and probed cells are depicted in red and blue, respectively. 
Representative histograms are shown. F. Concanamycin A-sensitive vacuolar ATPase (V-
ATPase) activity using acridine orange was analyzed in BY4741 and isc1∆ isolated 
vacuoles. Reactions were started in the presence of 15 µM acridine orange. When 
indicated, MgATP was added. Concanamycin A was added at the same time (dashed 
line). At the end of the assay, FCCP (15 mM) was added to dissipate the proton gradient.  
 
If prApeI is membrane-protected (inside Cvt vesicles or within the vacuole), then 
prApeI is only cleaved by the exogenously added protease in the presence of 
detergent. Our results suggest the presence of a membrane-enclosed 
intermediate form of ApeI (Figure 3.2.C, compare lane 1 versus lane 3) that was 
fully cleaved to the mature form by trypsin in the presence of detergent (Figure 
3.2.C, compare lanes 3 and 4 versus lane 5). This is consistent with our own 
observations that an intermediate form of ApeI accumulates in total extracts of 
isc1Δ cells, which may result from altered processing of ApeI, leading to its 
accumulation within the vacuoles (Figure 3.1.C). We also perfomed a similar 
assay using cells expressing GFP-Atg8p (Figure 3.S1). In parental cells, GFP-
Atg8p was fully degraded by trypsin, indicating it was readily accessible in the 
cytosol. This means GFP-Atg8p enclosed in autophagosomes is rapidly converted 
to free GFP in parental cells due to the rapid turnover of autophagosomes fusing 
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to the vacuoles. In isc1Δ cells, a small pool of GFP-Atg8p remained protease-
protected, probably enclosed by a membrane as it was degraded in the presence 
of the detergent (Figure 3.S1). Together, these results suggest that disturbed 
autophagic flux of isc1Δ cells is not attributed to alterations in the fusion of vesicles 
to the vacuole but rather to impaired Pep4p-mediated proteolysis. 
 Defective processing of ApeI through the Cvt pathway may also result from 
alterations in vacuolar protein sorting and trafficking, which is a crucial part of 
autophagy regulation. To assess if isc1Δ cells exhibit vesicular trafficking defects, 
we have evaluated whether CPY secretion is altered in isc1∆ cells. Several 
vacuolar protein sorting (vps) mutants that fail to deliver CPY to the vacuole 
display an aberrant secretion of CPY (Rothman & Stevens, 1986, Raymond et al., 
1992). Our results show that isc1∆ cells, in contrast to parental cells, exhibited 
CPY secretion, similarly to the vps4∆ mutant (Figure 3.2.D). Taken together, these 
data indicate that the accumulation of prCPY in isc1∆ cells may arise not only from 
defective Pep4p-mediated processing but also from impaired Golgi-to-vacuole 
trafficking. The mutual observation that the Cvt pathway and CPY trafficking are 
affected in isc1Δ cells, already under basal conditions, indicates that vesicular 
trafficking may contribute to reduced autophagic flux in this mutant strain. The 
overexpression of VAM3 (Darsow et al., 1997) and YKT6 (Kweon et al., 2003), 
which are involved in endocytic trafficking and vacuolar docking/fusion, had no 
effect on Cvt pathway and CPY secretion (Figure 3.S2.A and 3.S2.B), suggesting 
that the trafficking defect in isc1∆ cells does not occur at a step involving Vam3p 
and Ykt6p (t-SNARE/v-SNARE pairing).  
 Proper vacuolar acidification has been shown to be pivotal for autophagy as 
it is required for the activation of vacuolar proteases (Nakamura et al., 1997) and 
the autophagosome-vacuole fusion step (Abeliovich et al., 2000). This led us to 
assess whether vacuolar acidification is affected in isc1∆ cells by using the 
fluorescent weak base quinacrine, whose accumulation preferentially relies on 
acidic compartments. The results show that quinacine staining in isc1Δ cells was 
lower to that of parental cells (Figure 3.2.E). In agreement with these results, by 
measuring concanamycin A-sensitive ATPase activity in isolated vacuoles, we 
also show that isc1Δ vacuoles exhibited lower V-ATPase activity than wild-type 
vacuoles (Figure 3.2.F), indicating that isc1Δ cells display defective vacuolar 
acidification.  
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3.2.2. The Sit4p protein phosphatase and the TORC1-Sch9p pathway 
contribute to vesicular trafficking and vacuolar defects of isc1∆ cells 
 
 The ceramide-activated protein phosphatase Sit4p was previously 
implicated in isc1∆ phenotypes (Barbosa et al., 2011). Therefore, we analyzed 
whether Sit4p underlines the autophagic defects of this mutant. The deletion of 
SIT4 in isc1∆ cells increased GFP-Atg8p processing (Figure 3.3.A) and the 
maturation of prApeI (Figure 3.3.B) after rapamycin treatment. The deletion of 
TOR1 or SCH9, which suppresses the reduced autophagic flux of isc1∆ cells 
(Teixeira et al., 2014), also increased prApeI maturation in this mutant (Figure 
3.S3.A). 
 Next, we assessed if Sit4p and the TORC1-Sch9p pathway are also 
implicated in vesicular trafficking and vacuolar defects observed in isc1∆ cells. 
Lower Pep4p activity, the exacerbated CPY secretion and the defective vacuolar 
acidification exhibited by isc1∆ cells were abolished in isc1∆sit4∆ double mutants 
(Figure 3.3.C-E), as well as in isc1∆tor1∆ and isc1∆sch9∆ cells (Figure 3.S3.B-D).  
 Isc1p-deficient cells displayed trafficking defects and vacuolar 
fragmentation associated with impaired autophagy, similar to vam3∆ (Darsow et 
al., 1997) and ypt7∆ mutants (Kim et al., 1999). Notably, the restoration of the 
autophagic flux was also associated with the suppression of vacuolar 
fragmentation in isc1∆sit4∆, isc1∆sch9∆ cells and to a lesser extent, in isc1∆tor1∆ 
cells (Figure 3.S4). Together, these results are consistent with the idea that the 
protein machinery involved in vesicular trafficking events plays an important role in 
the modulation of autophagy in the mutant strain.   
 We have previously shown that isc1∆ mutants have increased levels of 
some ceramide species coupled with the activation of Sch9p and Sit4p and we 
proposed that the TORC1-Sch9p signalling pathway acts as a central axis to 
integrate upstream Isc1p-driven ceramide signalling signals to downstream 
effectors Sch9p and Sit4p (Teixeira et al., 2014). Combined with the results 
presented here, this suggests that ceramide plays a regulatory role in autophagy. 
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Figure 3.3. The deletion of SIT4 suppressed Pep4p-dependent vacuolar proteolysis 
and the vacuolar protein sorting defects in isc1Δ cells. 
A. BY4741, isc1Δ, sit4Δ and isc1Δsit4Δ cells carrying GFP-Atg8p were grown in            
SC-medium to exponential phase and treated with either DMSO (vehicle) or rapamycin 
(200 ng/mL) for 3h. Proteins were analyzed by immunoblotting, using anti-GFP antibody. 
The quantification of autophagic flux (GFP/(GFP+GFP-Atg8p)) is shown. ****p<0.0001; 
A 
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***p<0.001; **p<0.01. B. The processing of the Cvt pathway prApeI to mApeI was 
analyzed by immunoblotting in BY4741, isc1Δ, sit4Δ and isc1Δsit4Δ cells treated as 
described in 3A. C. Specific Pep4p activity was measured in protein extracts of BY4741, 
isc1Δ, sit4Δ and isc1Δsit4Δ cells grown to exponential phase in SC-medium. Values were 
normalized to parental cells (set as 100%). Values are mean ± SD of at least three 
independent experiments. ***p<0.001; **p<0.01. D. CPY secretion was analyzed in 
BY4741, isc1Δ, sit4Δ and isc1Δsit4Δ cells as described in figure 3.2.D. E. Vacuolar 
acidification of isc1Δsit4Δ cells was analyzed using quinacrine staining, as described in 
3.2.E. Unprobed and probed cells are depicted in red and blue, respectively. 
Representative histograms are shown.   
 
To explore this hypothesis, we enzymatically decreased ceramide load in isc1Δ 
cells by ectopically increasing YPC1 ceramidase expression (Mao et al., 2000). 
Overexpression of YPC1 efficiently restored Pep4p activity in isc1∆ cells to that of 
WT values (Figure 3.S5.A), but did not suppress the CPY vacuolar protein sorting 
defect (Figure 3.S5.B). This indicates that decreasing ceramide substrates of 
Ypc1p can overcome some but not all the mechanisms deregulated in the isc1Δ 
mutant. Taken together, our data suggest that ceramide species increased in 
isc1∆ cells signal through Sit4p and the TORC1-Sch9p pathways and impair 
vesicular trafficking, vacuolar function (proteolysis and acidification) and 
morphology, ultimately contributing to reduced autophagic flux in the mutant strain. 
 Mechanisms other than autophagy are involved in cellular protein turnover. 
It is well known that autophagy is coordinated with proteasomal degradation and 
the unfolded protein response (UPR) signalling to govern cell fate, either by 
restoring protein homeostasis or inducing cell death when the folding capacity is 
overwhelmed (Korolchuk et al., 2010, Salminen & Kaarniranta, 2010). Isc1p-
deficient cells are sensitive to tunicamycin (Kim et al., 2012), a hallmark of defects 
in ER stress response. We evaluated the activation of an UPRE::LacZ reporter in 
cells exposed to tunicamycin and DTT, two well-established ER stress inducers. 
The isc1Δ cells showed an UPRE-regulated induction comparable to the observed 
in parental cells (Figure 3.S6.A).  
 It was previously reported that the ceramide-activated protein phosphatase 
Sit4 negatively regulates the UPR in response to ceramide (Mousley et al., 2008). 
Since very long chain ceramide species levels increased during aging in isc1Δ 
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cells, which were previoulsy implicated in the activation of Sit4p, we hypothesized 
that UPR could be innapropriately downregulated in isc1Δ cells by activating Sit4p. 
We observed that UPR signalling was decreased both in exponential phase and 
during aging by a Sit4p-dependent mechanism (Figure 3.S6.B). However, the 
overexpression of HAC1 (encoding for the transcription factor that regulates the 
UPR) had minor effects on isc1Δ CLS and failed to abolish the hydrogen peroxide 
sensitivity of these mutants (Figure 3.S6.C-D). It is unlikely that lower UPR levels 
during aging of isc1Δ cells are associated with lower ER stress since the 
overexpression of HAC1 partially extended the CLS of isc1Δ cells. Instead, the 
results suggest that failure to induce UPR during aging results from inapropriate 
activation of Sit4p in response to deranged ceramide levels (Barbosa et al., 2011). 
In addition, the ER-associated degradation mechanism (ERAD) was not 
compromised in isc1Δ cells (Figure 3.S6.E). These results suggest that changes in 
the UPR do not significantly contribute to isc1Δ phenotypes. 
 
3.2.3. Mitophagy is hyperactivated in Isc1p-deficient cells  
 
 Since isc1Δ cells present mitochondrial dysfunction and fragmentation 
(Teixeira et al., 2014), we hypothesized that mitophagy is triggered to counteract 
mitochondria loss-of-function in the mutant. The induction of mitophagy was 
quantitatively measured by employing a modified alkaline phosphatase (mtPho8) 
assay (Sampaio-Marques et al., 2012). First, we have monitored mitophagy in 
cells incubated in lactate medium (post-log phase), as described (Kanki et al., 
2009b). The growth defect of isc1∆ cells in this medium is less pronounced than 
that observed in acetate or glycerol medium and cells are still able to grow within 
this period of time (48 hours), as reported (Vaena de Avalos et al., 2004) (and our 
observations). In parental cells, alkaline phosphatase activity increased 2-fold after 
shifting cells from glucose to lactate medium. This variation was higher (3-fold) in 
isc1∆ cells (Figure 3.4.A). This indicates that mitophagic activity (the uptake of 
mitochondria through mitophagy) is enhanced in isc1∆ cells. We also observed 
mitochondrial fragmentation and reduced oxygen consumption in isc1∆ cells under 
the same conditions (Figure 3.S7).  
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Figure 3.4. The hyperactivation of mitophagy was correlated with decreased cell 
viability in isc1Δ cells.  
A. Mitophagic activity was measured by performing the alkaline phosphatase assay. 
BY4741 and isc1Δ cells expressing inactive Pho8 proenzyme targeted to the 
mitochondrial matrix (mtPho8) were grown in SC-glucose (OD600=0.1, T0) and either 
maintained in the same medium or shifted to SC-lactate medium for 48 h. Alkaline 
phosphatase activity was measured in glucose (before the shift) and in glucose or lactate-
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growing cells after 2 days. Values are mean ± SD of at least three independent 
experiments. ****p<0.0001; **p<0.01. B. BY4741 and isc1Δ cells carrying mtPho8 were 
grown in SC-glucose to PDS phase, washed twice, and incubated in water during aging. 
Mitophagy activity was measured as described. Values are mean ± SD of at least three 
independent experiments. C. BY4741 and isc1Δ cells carrying mtPho8 were grown as 
described in 4C. Cell viability was expressed as the percentage of the colony-forming 
units (aged cells versus day 0 cells at PDS phase). Values are mean ± SD of at least 
three independent experiments. D. Mitochondrial Por1p protein levels were monitored by 
immunoblotting in BY4741 and isc1Δ cells grown as described in 4C, using anti-Por1p 
(top panel). Pgk1p was used as loading control. A representative blot of at least three 
independent experiments is shown. E. Growth curves of BY4741, isc1Δ, atg32Δ and 
isc1Δatg32Δ cells grown in SC-glucose medium. Values are mean ± SD of three 
independent experiments.  
 
 We have monitored mitophagy induction during aging (in CR conditions by 
shifting to water). We observed a slight increase in alkaline phosphatase activity in 
parental cells at day 5; however, mitophagy was induced more than 2-fold in isc1Δ 
cells already at day 3 and remained at higher steady levels up to day 7 (Figure 
3.4.B). This shows that higher induction of mitophagy is also observed at post-log 
phase in CR condtions (water) in isc1Δ cells. Importantly, this was correlated with 
loss of cell viability in isc1Δ cells (Figure 3.4.C).  
 We have also analyzed total levels of Por1p (Figure 3.4.D), a mitochondrial 
outer membrane protein, as a means to monitor mitochondrial turnover during 
aging. We observed increased Por1p levels already at PDS phase (T0) in isc1Δ 
cells, which correlates with increased mitochondrial mass measured by flow 
cytometry (Figure 3.S8). At day 5, there was a slight decrease in Por1p content in 
parental cells, which related well with the induction of mitophagy (Figure 3.4.D). 
However, the decrease in Por1p levels was more pronounced in isc1Δ cells, which 
is consistent with higher induction of mitophagy within the same period of time 
(Figure 3.4.B).  
 To evaluate if the hyperactivation of mitophagy is advantageous for the 
mutant strain, we analyzed if abolishing this process by deleting ATG32 affected 
cell growth of Isc1p-deficient cells. As shown in Figure 3.4.E, the growth defect of 
isc1Δ cells upon transition to the PDS phase was significantly exacerbated in 
isc1Δatg32Δ cells. The deletion of ATG32 also shortened the CLS of isc1∆ cells 
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(Figure 3.S9). These results indicate a negative genetic interaction between ISC1 
and ATG32 (Figure 3.4.E), and suggest that mitophagy is required to transiently 
counteract mitochondria loss of function in isc1Δ cells. 
 
3.2.4. Mitochondrial fragmentation is associated with increased            
Dnm1p-dependent fission in isc1Δ cells 
 
 We next sought to assess changes in mitochondrial dynamics, which may 
contribute to the mitochondrial fragmentation and dysfunction of isc1Δ cells. We 
first analyzed whether mitochondrial fusion was affected by performing a standard 
mitochondrial yeast mating assay (Jensen et al., 2000). Mata cells expressing 
mtDsRed were mated with Matα cells expressing mtGFP and the formation of 
diploids was monitored by microscopy (Figure 3.5.A). In parental cells, we 
observed a complete sumperimposition of both mitochondrial networks in the 
diploid cell, rendering a yellow signal. In the mutant strain, we observed that the 
majority of cells presented an almost complete merge of mitochondrial networks 
but some cells exhibited small portions that remained green or red, suggesting that 
mitochondrial fusion is slightly impaired in isc1Δ cells. The overexpression of 
FZO1, which encodes for a mitochondrial fusion protein, in isc1∆ cells partially 
restored a tubular shape (circa 50% of the analyzed cell population), resembling 
the normal mitochondrial network of parental cells (Figure 3.S10). We have also 
monitored the fission machinery by assessing Fis1p and Dnm1p levels in parental 
and isc1Δ cells grown to PDS phase (Figure 3.5.B). Although Fis1p levels were 
similar in both strains, Dnm1p levels were increased in isc1Δ cells compared to 
WT cells. These observations suggest that mitochondrial fragmentation in isc1Δ 
cells is due to mild defective fusion concomitant with enhanced Dnm1p-mediated 
fission events.  
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Figure 3.5. Mitochondrial fragmentation occurs by Dnm1p-dependent mechanisms 
and the deletion of TOR1, SCH9 and SIT4 suppressed mitochondrial fragmentation 
and this was correlated with proper restoration of mitophagy in isc1Δ cells under 
respiratory conditions. 
A. Haploid BY4741 and isc1Δ cells with different mating types carrying mitochondrial-
targeted GFP (pVT100U) and mtDsRed proteins were grown to the exponential phase 
and mated. The fusion of the mitochondrial networks was analyzed by fluorescence 
microscopy. Representative images are shown. Scale bar: 5 µm. B. Fis1p and Dnm1p-
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GFP protein levels were monitored by immunoblotting in BY4741 and isc1Δ cells grown to 
PDS phase, using anti-Fis1p and anti-GFP, respectively (top panel). Pgk1p was used as 
loading control. A representative blot of at least three independent experiments is shown. 
C. BY4741, isc1Δ, sit4Δ and isc1Δsit4Δ cells carrying mtDsRed were grown to PDS 
phase and mitochondrial network was analyzed by fluorescence microscopy. 
Representative images are shown. Scale bar: 5 µm. D. BY4741, isc1Δ, sit4Δ, isc1Δsit4Δ, 
tor1Δ, isc1Δtor1Δ, sch9Δ and isc1Δsch9Δ cells carrying mtPho8 were grown as described 
in figure 3.4.A. Mitophagy activity was measured by the alkaline phosphatase assay in 
glucose (open bars) or lactate-growing cells (closed bars) after 48 hours. Values are 
mean ± SD of at least three independent experiments. **p<0.01. E. BY4741, isc1Δ, sit4Δ, 
isc1Δsit4Δ, tor1Δ, isc1Δtor1Δ, sch9Δ and isc1Δsch9Δ cells carrying mtPho8 were grown 
in SC-glucose to PDS phase, washed twice, and incubated in water during aging. 
Mitophagy activity was measured as described in D. Values are mean ± SD of at least 
three independent experiments.  
 
3.2.5. Deletion of SIT4, TOR1 and SCH9 suppresses mitochondrial 
fragmentation and deregulated mitophagy in isc1Δ cells 
 
 Apart from TOR1 and SCH9 disruption (Teixeira et al., 2014), the deletion 
of SIT4 also abolished mitochondrial fragmentation in isc1Δ cells (Figure 3.5.C). 
Sch9p acts upstream of Hog1p in response to ceramide signalling and the deletion 
of HOG1 restores proper mitochondrial function to the mutant strain (Barbosa et 
al., 2012). Moreover, Hog1p has been implicated in the regulation of mitophagy 
(Mao et al., 2011). Thus, we also analyzed whether the Hog1p kinase contributes 
for these phenotypes. We observed that the normal tubular mitochondrial network 
of parental cells was restored in isc1∆hog1∆ cells (Figure 3.S11.A). Next, we 
monitored mitophagy in lactate-grown cells. Mitophagy was induced to lower 
extent in isc1∆sit4∆, isc1∆tor1∆, isc1∆sch9∆ cells (Figure 3.5.D) and isc1∆hog1∆ 
mutants (Figure 3.S11.B) compared to isc1∆ cells, suggesting that mitochondrial 
dynamics and mitophagy are coupled in isc1∆ cells upon respiratory conditions. 
We have also analyzed mitophagy during aging of these mutants in water (Figure 
3.5.E and 3.S11.C). Though the individual kinetics varied, it was apparent that the 
induction of mitophagy was lower at late stages of the aging process (after 5 days) 
in isc1∆sch9∆ and isc1∆sit4∆ cells but not in isc1∆tor1∆ and isc1∆hog1∆ cells 
(Figure 3.5.E and 3.S11.C) relative to isc1∆ single mutants. 
Chapter III 
	   	   142	  
 
3.2.6. The deletion of DNM1 abolishes mitochondrial fragmentation, impaired 
mitophagy, mitochondrial dysfunction, hydrogen peroxide sensitivity and 
shortened CLS of isc1Δ cells 
 
 To provide more evidence that mitochondrial fragmentation and the 
hyperactivation of mitophagy are coupled in response to mitochondrial loss-of-
function in isc1Δ cells, we assessed how the deletion of DNM1 affected isc1Δ 
phenotypes. The deletion of DNM1 suppressed mitochondrial fragmentation in 
Isc1p-deficient cells (Figure 3.6.A) to a hyperfused-like mitochondrial network 
similar to that of dnm1∆ cells. The induction of mitophagy was lower in lactate-
grown isc1∆dnm1∆ cells relative to isc1Δ cells (Figure 3.6.B), suggesting that 
Dnm1p-associated mitochondrial fragmentation leads to the activation of 
mitophagy in the mutant under respiratory conditions. To uncover if DNM1 deletion 
suppressed other mitochondrial-related isc1Δ phenotypes, oxidative stress 
resistance and CLS were characterized. Notably, dnm1∆ mutants were more 
resistant to hydrogen peroxide and DNM1 disruption suppressed the sensitivity of 
isc1∆ cells to this oxidant (Figure 3.6.C). The deletion of DNM1 also promoted 
CLS extension in both parental and isc1Δ cells (Figure 3.6.D). The suppression of 
isc1Δ phenotypes by DNM1 disruption was related to improved mitochondrial 
fitness. Indeed, the growth defect of isc1Δ cells on glycerol medium was also 
suppressed (Figure 3.6.E), both oxygen consumption and COX activity were 
increased in isc1Δdnm1Δ cells by 6- and 17-fold, respectively (Figure 3.6.F-G) 
compared to isc1Δ cells, and the hyperpolarization of the isc1∆ mitochondria was 
abolished (Figure 3.6.H). 
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Figure 3.6. The deletion of DNM1 abolishes the shortened CLS, oxidative stress 
sensitivity and mitochondrial dysfunctions displayed by isc1Δ cells. 
A. BY4741, isc1Δ, dnm1Δ and isc1Δdnm1Δ cells carrying mtDsRed were grown to PDS 
phase and mitochondrial network was analyzed by fluorescence microscopy. A detailed 
image of hyperfused mitochondria in dnm1Δ mutant is shown. Representative images are 
shown. Scale bar: 5 µm. B. Cells carrying mtPho8 were grown as described in figure 
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3.4.A. Mitophagy activity was measured by the alkaline phosphatase assay. Values are 
mean ± SD of at least three independent experiments. ****p<0.0001; **p<0.01; *p<0.05. 
C. Cells were grown in SC-medium to the exponential phase and exposed to 1.5 mM 
H2O2 for 60 min. Cell viability was expressed as the percentage of the colony-forming 
units (treated cells versus untreated cells). Values are mean ± SD of at least three 
independent experiments. ****p<0.0001; ***p<0.001; **p<0.01. D. Cells were grown in SC-
glucose and kept in the medium at 26°C. The viability was determined as the percentage 
of the colony-forming units at time T in relation to T0. Values are mean ± SD of at least 
three independent experiments. E. Cells were grown in SC-glucose to the exponential 
phase and then diluted to OD600=0.1. Fivefold dilution series were spotted on YPD 
(glucose) or YPG (glycerol) medium and grown at 26°C for 4 days. F. Oxygen 
consumption rate was measured in cells grown to PDS phase. Values are mean ± SD of 
at least three independent experiments. ****p<0.0001; **p<0.01. G. Cytochrome c oxidase 
(COX) activity was determined in cells grown to the PDS phase. Values are mean ± SD of 
at least three independent experiments. ****p<0.0001; ***p<0.001. H. Cells were grown in 
SC-glucose to the PDS phase, stained with the potential-sensitive dye 3,3-
dihexyloxacarbocyanine iodide [DiOC6(3)] for 30 min and analyzed by flow cytometry. 
Treatment of the parental strain (BY4741) with FCCP (carbonyl cyanide 4-
(trifluoromethoxy)phenylhydrazone, 10 mM) was used as a positive control (depolarizing 
event). Values are mean ± SD of at least three independent experiments. ***p<0.001; 
**p<0.01; *p<0.05. 
 
 3.2.7. Isc1p interacts with Dnm1p 
 
 Our data showing that Isc1p regulates mitochondrial dynamics and function 
in a Dnm1p-dependent manner led us to investigate whether these proteins 
interact. For this purpose, we overexpressed FLAG-tagged Isc1p (under GAL1 
promoter) in yeast cells expressing endogenously C-terminally GFP-tagged 
Dnm1p and cells were grown under respiratory conditions (galactose, for 16-18h 
hours), where Isc1p is translocated from the ER to the mitochondria (Vaena de 
Avalos et al., 2004). In fact, FLAG-Isc1p is localized at the ER after incubation for 
4-6 hours on galactose, whereas longer incubation (24 h) leads to the 
mitochondrial localization of Isc1p (Vaena de Avalos et al., 2004). 
Immunoprecipitation with a FLAG antibody co-precipitated Dnm1p-GFP in cells 
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expressing FLAG-Isc1p but not in cells expressing untagged Isc1p (Figure 3.7), 
indicating that Isc1p interacts with Dnm1p in vitro. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7. Isc1p interacts with Dnm1p in vitro. Lysates from cells expressing      
Dnm1p-GFP and FLAG-tagged Isc1p proteins were used for immunoprecipitation with 
either anti-GFP or anti-FLAG protein G beads. Cells were grown in SC-Galactose to 
induce FLAG-Isc1p and to monitor the interaction between these proteins under 
respiratory conditions, where Isc1p is known to translocate from the ER to mitochondria. 
Immunoprecipitated fractions were analyzed by SDS-PAGE and Western blotting. Lysate 
from untagged BY4741 (lane 2) and G protein beads (lane 3) were used as controls to 
evaluate unspecific binding of antibodies and beads to lysate proteins.  
 
3.3. Discussion 
 
 The role of sphingolipids in aging and age-associated pathologies, such as 
neurodegenerative diseases and cancer, has been extensively reported. In fact, it 
is well established that alterations on sphingolipid rheostat have significant impact 
on cell growth and survival and general stress response with impact on the onset 
of these diseases. However, the molecular mechanisms by which signalling 
pathways are activated in response to alterations in sphingolipid biosynthesis or 
turnover are not yet fully understood. This clarification is pivotal to understand 
sphingolipid functions in more detail and define new strategies to improve human 
health and extend lifespan.  
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 In this work, we report that Isc1p-driven ceramide signalling regulates 
macroautophagy and the Cvt pathway, mitophagy and mitochondrial dynamics. 
We show that isc1Δ cells present defects in autophagy flux, exacerbated 
mitophagy and increased mitochondrial fission, leading to mitochondrial network 
fragmentation. The impairment in autophagy was not associated with changes in 
vesicle nucleation. Instead, it resulted from primary defects observed in the mutant 
strain at later stages of autophagy, namely defective vesicular trafficking and 
Pep4p-mediated vacuolar proteolysis. The impairment of vesicular trafficking 
results from a general vacuolar protein sorting defect, since isc1Δ cells displayed 
aberrant secretion of CPY and disturbed processing of ApeI through the Cvt 
pathway. The lower Pep4p activity could be due to the lower vacuolar acidification 
and V-ATPase activity of isc1Δ cells, since Pep4p is not mislocalized in this 
mutant (our unpublished data). Notably, PEP4 overexpression ameliorated 
impaired autophagic flux in isc1Δ cells, indicating that Pep4p-mediated vacuolar 
proteolysis is a limiting factor in the mutant. Consistent with a role in autophagy, 
Isc1p has been reported to interact with Aut5p, a protein involved in the lysis of 
intravacuolar vesicles (Epple et al., 2003). 
 We have observed that the induction of GFP-Atg8p (in rapamycin treated 
cells) and basal Atg13p phosphorylation are not significantly altered in isc1Δ cells 
(Figure 3.3.A and 3.S12). Nevertheless, we cannot discard the possibility that 
autophagic induction may be altered in isc1Δ cells due to the hyperactivation of 
the TORC1 signalling pathway. It is possible that hyperactive TORC1 may target 
the Atg1p kinase activity, which is required for efficient association of Atg1p with 
Atg17p and Atg13p (Atg1p kinase complex) during autophagy. Moreover, Sch9p 
activation, which is increased in isc1Δ cells (Teixeira et al., 2014), was shown to 
contribute to the inhibition of autophagy independently of phosphorylation of 
Atg13p (Yorimitsu et al., 2007), which possibly accounts for reduced autophagic 
activity in isc1Δ cells. Yamagata et al. have recently reported that MIPC or 
M(IP)2C complex sphingolipids are not required for autophagy but reduced IPC 
causes autophagic defects, as the inhibtion of IPC synthesis by aureobasidin A 
(AbA) causes a reduction in autophagic activity (Yamagata et al., 2011). Since 
Isc1p-deficient cells accumulate these sphingolipids, we may discard the 
possibility that complex sphingolipids may play a key role for the defects in 
autophagy observed in isc1Δ cells. 
Chapter III 
	   	   147	  
 Our results show that the TORC1-Sch9p and Sit4p-mediated signalling 
pathways impair autophagic flux in isc1Δ cells since the deletion of TOR1, SCH9 
and SIT4 suppressed the defects on vesicular trafficking, vacuolar proteolytic 
capacity, vacuolar acidification and the vacuolar fragmentation phenotype, 
ultimately contributing to restore proper autophagic flux and the integrity of the Cvt 
pathway in isc1Δ cells. We therefore provide novel evidence that ceramide may 
constitute a quality control reporter in the process via the ceramide-activated Sit4p 
protein phosphatase and the activation of the TORC1-Sch9p pathway in response 
to Isc1p-driven ceramide signalling. Consistently, alterations in ceramide turnover 
promoted by ectopic overexpression of ceramidase YPC1 in isc1Δ cells improved 
vacuolar proteolysis. Recently, Sit4p was shown to interact with autophagy 
effectors, namely Atg18p (Ho et al., 2002). 
 In this work, we also implicate ceramide as a signal that contributes to UPR 
silencing observed in isc1Δ cells, due to activation of Sit4p. This is supported by 
the restoration of the UPR in the double mutant isc1Δsit4Δ strain during aging. 
Together, these results demonstrate that Sit4p links ceramide homeostasis to ER 
stress response and autophagy in isc1Δ cells by acting as a ceramide sensor 
whose result is the innapropriate downregulation of these important biological 
processes, in part due to derranged ceramide metabolism, which then alter cell 
signaling through Sit4p and the TORC1-Sch9p pathway. More recently, Sit4p has 
been shown to be present in different protein complexes. Indeed, Sit4p activity is 
regulated by TORC1 in a Tip41p/Tap42p manner by phosphorylation  (Jacinto et 
al., 2001) whereas it can be activated by ceramide in a Isc1p-dependent manner 
(Barbosa et al., 2011). Luke et al. (Luke et al., 1996) and Woodacre et al.  
(Woodacre et al., 2013) have demonstrated that Sit4p also interacts with SAP 
proteins (SIT4-associated proteins), indicating some degree of response 
specificity. We propose that ceramide signalling acts as a quality control reporter 
ideally suited to sense the functional status of autophagy and the ER stress 
response via Sit4p-mediated mechanisms. Sit4p likely integrates signalling derived 
from both TORC1 and Isc1p-mediated ceramide homeostasis to regulate these 
processes and the response specificity may be acquired by interacting with 
different protein subunits, depending on the stimulus. 
 Importantly, Swinnen et al. have recently reported that ceramide levels are 
regulated by the TORC1-Sch9p signalling pathway at a transcriptional level 
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(Swinnen et al., 2014). In particular, sch9Δ cells exhibit increased expression of 
YPC1. Therefore, the suppression of isc1Δ phenotypes imparted by SCH9 
deletion can be associated with decreased ceramide levels due to upregulation of 
YPC1, similarly to the supression of some autophagic defects by ectopic 
expression of YPC1 reported in this study. We thus propose that Sit4p acts as a 
ceramide "sensor" and Sch9p may control the phosphatase activity by adjusting 
ceramide levels (through Ypc1p).  
 The molecular mechanisms underlying the regulation of mitophagy in 
response to alterations in sphingolipid metabolism remain largely unknown. We 
provide evidence that mitophagic activity is increased and associated with 
mitochondrial fragmentation and impaired mitochondrial function in isc1∆ cells 
when respiration is induced (lactate-growing conditions). This is consistent with an 
adaptive response to counteract mitochondrial dysfunction. The induction of 
mitophagy is increased during aging of isc1∆ cells, a phenotype that was 
associated with shortened CLS of the mutant strain. The deletion of ATG32 
aggravated the growth defect of isc1∆ cells, particularly upon the transition to PDS 
phase (respiratory metabolism), and further shortened its CLS, indicating that 
Atg32p is required for isc1∆ cell growth and that mitophagy contributes to survival 
of isc1∆ cells during stationary phase. Sentelle et al. have recently reported an 
interaction between ceramide and LC3B-II upon DNM1L/DRP1-dependent 
mitochondrial fission, which ultimately contributes to impaired mitochondrial 
function by inducing mitophagic cell death (Sentelle et al., 2012). Isc1p-deficient 
cells also exhibit mitochondrial fragmentation associated with Dnm1p-dependent 
mechanisms and with the activation of Sit4p and the TORC1-Sch9p pathways in 
response to derranged ceramide load, leading to mitochondrial dysfunction.  
 Since mitophagy is hyperactivated in isc1∆ cells, could mitophagy be acting 
as an adaptive clearance mechanism in response to the segregation of 
dysfunctional mitochondria promoted by mitochondrial fragmentation? We 
observed that lactate-growing isc1∆ cells present mitochondrial fragmentation and 
mitochondrial dysfunction associated with increased induction of mitophagy. 
Importantly, the deletion of TOR1, SCH9, SIT4 and HOG1 lowers the induction of 
mitophagy when respiration is induced in isc1Δ cells (lactate) and this is 
associated with the restoration of mitochondrial network integrity and improvement 
of the organelle function (Barbosa et al., 2011, Barbosa et al., 2012, Teixeira et al., 
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2014). Altogether, the results point out to a molecular mechanism in which the 
impairment of mitochondrial dynamics leads to the segregation of dysfunctional 
and damaged mitochondria, in a Dnm1p-dependent manner, to be degraded by 
mitophagy in isc1Δ cells upon respiratory metabolism (post-log phase, lactate). 
This hypothesis is supported by the fact that the deletion of DNM1 reverted the 
mitochondrial fragmentation of isc1∆ cells, which was associated with lower 
activation of mitophagy in lactate-growing cells and overall improvement of 
mitochondrial function. Therefore, we propose that Dnm1p-mediated alterations in 
mitochondrial dynamics promote mitophagy, thus tipping the balance in favour of 
fission and thereby enforcing segregation of damaged/dysfunctional mitochondria 
to be removed by mitophagy in isc1Δ cells under respiratory conditions. This 
supports a functional link between mitophagy and mitochondrial dynamics and 
gives new insights on the role of ceramide in the crosstalk between these 
important mitochondrial quality control mechanisms. In fact, our data supports that 
Isc1p-driven ceramide signaling also plays a regulatory role in the regulation of 
mitophagy and mitochondrial dynamics in yeast by modulating the activation of the 
TORC1-Sch9p pathway, Sit4p and the HOG pathway, which responds to ceramide 
in a Sch9p-dependent manner, under respiratory conditions (post-log phase). We 
propose that, when Isc1p is post-translationally activated during the transition to a 
respiratory metabolism and relocalizes to mitochondria, the protein may adjust 
ceramide pools to regulate the activation of these signalling pathways and 
therefore contribute to proper mitochondrial function and network organization in 
yeast. 
 During aging, the induction of mitophagy further increased in isc1Δtor1Δ 
and isc1Δhog1Δ cells, comparing with isc1Δ cells. In contrast, it was decreased in 
isc1Δsit4Δ and isc1Δsch9Δ cells at late stages of the aging process (in water), 
rendering the strongest phenotypes, which is consistent with the fact that Sch9p 
and Sit4p integrate ceramide signalling with TORC1 readouts. Nevertheless, these 
results do not allow to clearly assess the role of mitophagy in aging of isc1∆ cells. 
 We also demonstrate, for the first time, that a protein involved in 
sphingolipid metabolism, namely Isc1p, interacts with the mitochondrial fission 
machinery protein Dnm1p under respiratory growth conditions. We speculate that 
Isc1p-driven ceramide signalling may regulate Dnm1p expression and activity. 
This is supported by the fact that ISC1 disruption leads to the fragmentation of the 
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network by Dnm1p-dependent mechanisms, as demonstrated in this study. 
Kitagaki et al. have reported that a decrease in the levels of α-hydroxylated 
phytoceramide was associated with mitochondrial dysfunction in isc1∆ cells 
(Kitagaki et al., 2007). Therefore, we hypothesize that alterations in ceramide 
content (dependent of Isc1p activity) leading to dysfunction of mitochondria may 
constitute a signal that promotes the recruitment of Dnm1p, leading to the 
segregation and degradation of damaged mitochondria by mitophagy in yeast. In 
agreement with this hypothesis, Parra et al. have reported that C2-ceramide 
induced mitochondrial fragmentation associated with increased mitochondrial 
DRP1 and FIS1 content, DRP1 colocalization with FIS1, and early activation of 
apoptosis (Parra et al., 2008). 
 In mammalian cells, ceramide triggers autophagy by inactivating the 
mTOR-signalling pathway downstream of AKT/PKB (Ravikumar et al., 2004). 
Furthermore, ceramide also acts by activating the c-Jun N-terminal kinase 1 
(JKAMP/JNK1), an orthologue of yeast Hog1p (Galcheva-Gargova et al., 1994), 
which phosphorylates BCL-2 leading to its dissociation from BECN1/BECLIN1 
(Pattingre et al., 2009). C2-Cer has also been shown to relieve IL-13-mediated 
inhibition of autophagy, whose mechanism appears to be mediated by the class I 
PI3K/AKT pathway (Petiot et al., 2000). Additionally, recent work has shown that 
amino acid deprivation caused an increase in acid sphingomyelinase activity 
leading to enhanced ceramide content, which in turn promoted the PP1/PP2A-
dependent inactivation of mTOR to induce autophagy (Taniguchi et al., 2012). Our 
data supports that Isc1p-driven ceramide signalling is also important for proper 
induction of autophagy; however, autophagy is inhibited upon increased ceramide 
content observed in isc1Δ cells. Importantly, ceramide acts by downregulating the 
mTOR signalling in mammals, whereas the TORC1 pathway is hyperactive in 
isc1Δ cells, contributing to impaired autophagy induction and flux, in parallel to 
ceramide-mediated activation of Sit4p and Sch9p. One explanation for the 
apparently divergent regulation of autophagy between mammalian and yeast cells 
may rely on the fact that specific ceramide species are altered in Isc1p-deficient 
cells, namely very long chain ceramide species (Barbosa et al., 2011), which in 
turn inappropriately activates signalling pathways responsive to these particular 
ceramide pools. Yeast and mammals, however, appear to retain similar molecular 
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mechanisms regarding the regulation of mitophagy and mitochondrial dynamics in 
response to ceramide signalling, as suggested by our study.  
 Overall, our results implicate Isc1p and ceramide signalling in the regulation 
of autophagy and support a model in which ceramide load promotes Dnm1p-
driven mitochondrial fragmentation, therefore contributing to mitochondrial 
dysfunction and cell death in yeast. Importantly, our study provides mechanistic 
details and novel evidence that the modulation of ceramide metabolism by 
targeting these ceramide-responsive signalling pathways, which are conserved in 
mammals, could represent a novel strategy to improve lifespan and human health. 
 
 
3.4. Experimental Procedures 
 
3.4.1. Yeast strains and growth conditions 
 
  S. cerevisiae BY4741 was the parental strain of all haploid derivatives used 
in this study (Table 3.5.1). Yeast cells were grown aerobically at 26°C in a gyratory 
shaker (at 140 r.p.m.), with a ratio of flask volume/medium volume of 5:1. The 
growth media used were YPD [1% (w/v) yeast extract, 2% (w/v) bactopeptone and 
2% (w/v) glucose], YPL [1% (w/v) yeast extract, 2% (w/v) bactopeptone and 2% 
(w/v) lactate, pH 5.5], YPGlycerol [1% (w/v) yeast extract, 2% (w/v) bactopeptone, 
4% (v/v) glycerol], synthetic complete (SC) drop-out medium containing 2% (w/v) 
glucose, 0.67% yeast nitrogen base without amino acids (Difco Laboratories) and 
supplemented with appropriate amino acids (80 mg histidine L-1 (Sigma-Aldrich), 
400 mg leucine L-1 (Sigma-Aldrich), 80 mg tryptophan L-1 (Sigma-Aldrich) and 80 
mg uracil L-1, (Sigma-Aldrich), SC drop-out medium containing 3% (v/v) glycerol 
and SC drop-out medium containing 2% (v/v) lactate, pH 5.5. Gene disruption was 
done by conventional methods and the proper integration of the cassettes was 
confirmed by PCR. The double mutant isc1Δatg32Δ was generated by sporulation 
of the diploids resultant from mating atg32Δ::KanMX4 carrying pISC1 and 
isc1Δ::LEU2 strains, followed by tetrad dissection on SC-URA medium to select 
for spores carrying pISC1, by standard techniques. The identities of the resulting 
strains were confirmed by growth on respective selective media. 
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3.4.2. Stress resistance and chronological lifespan 
 
 For H2O2 resistance assay, cells were grown to the exponential phase 
(OD600 = 0.6) and exposed to 1.5 mM H2O2 (Merck) for 60 min. The CLS assay 
was performed as described (Teixeira et al., 2014). 
 
3.4.3. Enzymatic activities and oxygen consumption 
 
 For the alkaline phosphatase assay, cells were harvested and 
ressuspended in 200 µL assay buffer [250 mM Tris (AMRESCO), 10 mM MgSO4 
(Sigma-Aldrich), 10 mM ZnSO4 (Prolabo), pH 9.0 containing protease inhibitors 
(Complete Mini EDTA-free protease cocktail inhibitor tablets, Boehringer 
Mannhein). The cells were lysed by vortexing with glass beads and cell debris was 
removed by centrifugation at 13,000 r.p.m. for 15 min. 10 µg of extract was added 
to a final volume of 500 µL (assay buffer containing 1.13 mM 
nitrophenylphosphate (Sigma Fast, Sigma-Aldrich), and samples were incubated 
for 15 min at 30°C before terminating the reaction by adding 500 µL of stop buffer 
[2 M glycine (Nzytech)/NaOH (Merck), pH 11.0]. Production of nitrophenol was 
monitored spectrophotometrically (UV Mini 1240, Shimadzu), and its concentration 
was calculated using ε400 = 18,000 M-1.cm-1. The activity of COX (Poyton et al., 
1995), β-galactosidase (Teixeira et al., 2014) and Pep4p (Jones et al., 1982) was 
determined as previously described. For ER stress assays, tunicamycin (Sigma-
Aldrich) and DTT (Nzytech) were used at indicated concentrations. For V-ATPase 
activity, ATP-dependent proton uptake activity was assayed by spectrophotometry 
using acridine orange (Sigma-Aldrich) (491-540 nm). Protein (15 µg) of isolated 
vacuoles were added to the reaction mixture containing 20 mM MOPS (Sigma-
Aldrich)-Tris pH 7.0, 15 mM KCl (VWR), 135 mM NaCl (Merck) and 15 mM 
acridine orange followed by addition of 0.1 mM MgATP (Sigma-Aldrich). The 
reaction was stopped by the addition of 10 µL of 1 mM carbonyl cyanide p-
(trifluoromethoxy)phenylhydrazone (FCCP, Sigma-Aldrich). Concanamycin A (0.1 
µM, Enzo) was used a control to assess that V-ATPase was the main source of 
the vacuolar proton motive force. Protein content was determined by the method 
of Lowry, using bovine serum albumin (Nzytech) as a standard. Oxygen 
consumption rate was measured for 3 x 108 cells in PBS buffer (pH 7.4), using an 
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oxygen electrode (Oxygraph, Hansatech). Data was analyzed using the Oxyg32 
V2.25 software.  
 
3.4.4. Western Blot analysis  
 
 Cells were harvested and then ressuspended in 50 mM potassium 
phosphate buffer (pH 7.0) containing protease inhibitors and phosphatase 
inhibitors [50 mM sodium fluoride (Merck), 5 mM sodium pyrophosphate (Fluka 
Biochemika), 1 mM sodium orthovanadate (Sigma, Aldrich)]. Total protein extracts 
were lysed and centrifuged at 13,000 r.p.m. for 15 min and protein content was 
determined by the method of Lowry. Proteins were then analyzed by SDS-PAGE 
using 10% polyacrylamide (Sigma-Aldrich) gels and blotted onto a nitrocellulose 
membrane (GE Healthcare) and the Lumigen HRP chemiluminescent substrate 
(GE Healthcare). Assay for ERAD was done as reported (Ellis et al., 2004). To 
evaluate Dnm1p-GFP protein levels and Atg13p phosphorylation, cells were 
harvested and subjected to alkaline lysis. Proteins (50 µg) were resolved by     
SDS-PAGE using 8.5% polyacrylamide gels. The primary antibodies used were 
rabbit anti-Atg13p and rabbit anti-ApeI (kindly provided by Dr. Klionsky), mouse 
anti-GFP (Roche, Basel, 11 814 460 001), mouse anti-CPY (Molecular Probes), 
mouse anti-Pgk1p (Invitrogen), rabbit anti-HA (Sigma-Aldrich), rabbit anti-actin 
(Sigma-Aldrich), mouse anti-Por1p (Molecular Probes) and rabbit anti-Fis1p 
(Santa Cruz Biotechnology, Inc.). The secondary antibodies used were anti-mouse 
IgG-peroxidase (Molecular Probes) and goat anti-rabbit IgG-peroxidase (Sigma-
Aldrich).  
 
3.4.5. Protease protection assay 
 
 Rapamycin-treated cells (40 OD600 units) were harvested at 4,000 r.p.m. for 
5 min, washed twice with water, and incubated for 20 min at 30ºC in 4 mL of buffer 
A [100 mM Tris/H2SO4 (Sigma-Aldrich), pH 9.4] containing 20 mM dithiothreitol 
(DTT, Sigma-Aldrich). The cells were then pelleted, ressuspended in 4 mL of 
zymolyase buffer [1 M sorbitol (Sigma-Aldrich), 20 mM PIPES (AMRESCO), pH 
6.8 containing 1.2 mg zymolyase 20T (Amsbio)] and spheroplasted for 30 min at 
30°C. The spheroplasts were harvested at 2,000 r.p.m. for 5 min and hypotonically 
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lysed in PS200 buffer (200 mM sorbitol, 5 mM MgCl2, 20 mM PIPES pH 6.8). The 
lysis solution was twice pre-cleared at 500 rcf at 4°C, and the supernatant was 
divided into three 300 µL aliquots. The aliquots were mixed with 300 µL of PS200, 
PS200 with 10 µg/mL trypsin (Sigma-Aldrich), and PS200 buffer supplemented 
with 10 µg/mL trypsin and 0.4% Triton X-100 (Sigma-Aldrich). After 30 min of 
incubation, the digestion was halted through trichloroacetic acid (TCA, Merck) 
precipitation and the pellet was washed twice with acetone (Vidrolab 2). The 
pellets were dissolved in 50 µL of Laemmli buffer. In the case of prApeI protease 
protection assay, the total lysate (after spheroplast lysis) was divided into a 13,000 
x g supernatant and pellet fraction after cell debris was pre-cleared at 500 rcf at 
4°C. This procedure was used to obtain highly enriched membrane fractions. 
 
3.4.6. CPY colony blot assay  
 
 The CPY colony blot assay was done as described (Kojima et al., 2012) 
with some modifications. Briefly, cells were grown to exponential phase and then 
diluted to 0.02 OD600, and 3 µL of each dilution was spotted on a YPD plate. After 
48 hours of incubation, spots were covered with a 0.45 µm nitrocellulose filter for 
an additional day. The filter was then removed from the plate, cells were washed 
off three times with PBS pH 7.4 and the presence of CPY was done by 
immunoblotting. 
 
3.4.7. Quinacrine staining, mitochondrial mass determination and 
mitochondrial membrane potential 
  
 Vacuolar acidification was measured using quinacrine (Sigma-Aldrich) 
staining (Seol et al., 2001). Fluorescence was measured on a Becton Dickinson 
FACS Canto II Analytic Flow cytometer with excitation and emission settings of 
405 nm and 515–545 nm, respectively. Mitochondrial mass determination was 
performed using MitoTracker Green FM (Molecular Probes) according to the 
manufacturer. Fluorescence was measured by flow cytometry with 
excitation/emission settings of 488/525 nm (FL-1 channel). The mitochondrial 
membrane potential was measured as described (Teixeira et al., 2014). Data 
treatment was performed using the FlowJo software (Tree Star). 
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3.4.8. Fluorescence microscopy 
 
 To monitor GFP-Atg8p processing, cells were grown in SC-medium to the 
exponential phase and treated with either rapamycin (200 ng/mL, Sigma-Aldrich) 
or DMSO (vehicle, Sigma-Aldrich) for 3 hours. To analyze vacuolar morphology, 
cells were grown in YPD to the exponential phase. Cells (20-40 OD600 units. mL-1 
in YPD) were then incubated with 4.8 µM FM4-64 dye (Molecular Probes) for 30 
min and washed twice with YPD. Videos were collected in Spinning Disk Confocal 
System Andor Revolution XD (ANDOR Technology, UK) using iXonEM+DU-897 
with 2x port coupler (ANDOR Technology, UK). For mitochondrial morphology 
analysis, cells carrying pYX222-mtDsRed were grown in SC-medium to the PDS 
phase. For the mitochondrial fusion during mating, MATa strains carrying 
mtDsRed (pYX222-mtDsRed) and MATa strains carrying pmtGFP (pVT100U) 
were grown to the exponential phase in SC-medium lacking histidine and uracil, 
respectively, pelleted by centrifugation, washed twice with YPD, and 
ressuspended in 1 mL of YPD medium. Same OD600 units of both cells were mixed 
and collected by centrifugation. Live cells were observed by fluorescence 
microscopy (AxioImager Z1, Carl Zeiss). Data image stacks were deconvolved by 
QMLE algorithm of Huygens Professional v3.0.2p1 (Scientific Volume Imaging 
B.V.). Maximum intensity projection was used to output final images using ImageJ 
1.45v software.   
 
3.4.9. Vacuoles isolation 
 
 Cells grown to the exponential phase were ressuspended in assay buffer 
(100 mL of 100 mM Tris-HCl, 10 mM DTT pH 9.5) and incubated at 30ºC for 30 
min while shaking at 75 r.p.m. Cells were centrifuged at 4,000 r.p.m. for 5 min, 
washed with 100 mL of water followed by a wash with 1.1 M sorbitol and 
ressuspended in 50 mL of 1.1 M sorbitol/20 g cells. The cell wall was 
enzymatically digested with 1 mL of glusulase (glucuronidase (90,000 units/mL) 
and sulfatase (19,000 units/mL) (PerkinElmer Life Sciences), 3 mg of zymolyase 
20T and 3 mg of Glucanex (Sigma-Aldrich) per 10 mL suspension supplemented 
with 5 mM DTT. The suspension was incubated for 2.5 h at 30ºC while shaking at 
60 r.p.m. Light microscopy was used to evaluate the extent of spheroplast 
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formation. Spheroplasts were then cooled in ice and each 25 mL of suspension 
was pipetted on top of a layer of 25 mL of buffer F [7.5% Ficoll (GE Healthcare) 
containing 1.1 M sorbitol]. The spheroplasts were washed through this Ficoll-
sorbitol layer by centrifugation at 4,000 r.p.m. for 20 min at 4ºC. Samples of 20 mL 
were transferred to a centrifuge tube and overlaid with 10 mL of lysis buffer [10 
mM Tris-MES (Sigma-Aldrich), pH 6.9, 12% Ficoll, 0.1 mM MgCl2 and 0.1 mM 
PMSF]. Centrifugation was performed in a swing-out bucket rotor (Sorvall Ultra 
Pro 80, Rotor TH641) at 17,000 r.p.m. (50,000 gavg) for 30 min at 4ºC. Vacuoles 
were collected from the fraction floating on top of the tube, and ressuspended in 
10 mL of lysis buffer/ 2-3 mL of crude vacuoles by homogenization with a 
micropipette. The homogenized crude vacuoles were overlaid in a centrifuge tube 
with a layer of 10 mL Tris-MES pH 6.9, 8% Ficoll, 0.5 mM MgCl2 and 0.1 mM 
PMSF and a second layer of 10 mL of the same buffer containing 4% Ficoll 
instead. Upon centrifugation at 17,000 r.p.m. (50,000 gavg) for 45 min at 4ºC, intact 
vacuoles were obtained on top of 4% Ficoll solution. Purified vacuoles were 
collected with a spoon-shaped spatula prewetted in 4% Ficoll buffer.  
 
3.4.10. Co-IP assay 
 
 For Isc1p–Dnm1p interaction experiments, a Dnm1p GFP-tagged BY4741 
strain carrying FLAG-Isc1p was used. 30 OD600 cell equivalents were harvested 
and ressuspended in 500 µL IP buffer (0.5% Triton X-100, 150 mM NaCl, 1 mM 
EDTA (Merck), 50 mM Tris, pH 7.4, supplemented with protease and phosphatase 
inhibitors). Cells were lysed with glass beads and cleared by centrifugation at 
13,000 g for 15 min. 250 µL of supernatant was incubated with 25 µL of anti–
FLAG (Sigma-Aldrich) for 2 h followed by incubation with protein G Sepharose 
beads (Protein G Sepharose 4 Fast Flow, GE Healthcare Life Sciences) for 1 h at 
4°C. The beads were collected and washed 4 times in washing buffer (1× 
phosphate-buffered saline [PBS], 2 mM Na3VO4, 50 mM KF, 15 mM Na2H2P2O7, 
15 mM p-nitrophenylphosphate (p-NPP), 0.1% Triton X-100 and protease inhibitor 
cocktail). The bound proteins were released by incubating the beads in 40 µL in 
Laemmli buffer. Immunoprecipitated proteins were analyzed by SDS-PAGE using 
8.5% polyacrylamide gels, and immunodetection was performed with both anti-
GFP and anti-FLAG antibodies. 
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3.4.11. Statistical analysis 
 
 Data are expressed as mean values ± SD of at least three independent 
experiments. Values were compared by Student’s t-test. The 0.05 probability level 
was chosen as the point of statistical significance throughout. Statistical analyses 
were carried out using GraphPad Prism Software v5.01 (GraphPad Software).  
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3.5. Supplementary Information  
 
Table 3.5.1. Saccharomyces cerevisiae strains used in this study. 
Strain Genotype Source 
BY4741 Mata his3Δ1, leu2Δ0, met15Δ0, ura3Δ0 EUROSCARF 
BY4741 
Mata his3Δ1, leu2Δ0, met15Δ0, ura3Δ0 
[pYX222-mtDsRed, pRS413TEFpr-PEP4, 
pRS416-GFP-ATG8, pJT30, pDN436 
(CPY*-HA), pRS315-HAC1i,pRS426-VAM3, 
YEp352-YKT6, YEp24-YPC1,	  pJDCEX2] 
This study 
Dilcher et al.  (2001) 
Darsow et al.  (1997) 
Ellis et al.  (2004) 
Escobar-Henriques et 
al.  (2006) 
BY4742 Matα his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0  EUROSCARF 
VT1 BY4742 isc1Δ::LEU2  [pVT100U] This study 
BY4741 
Dnm1-GFP 
BY4741 DNM1-GFP::HisMX6 
 [pFLAG-ISC1] 
Life Technologies 
This study 
TYY172 W303-1B pho13Δ::kan pho8Δ60::HIS3 Yorimitsu et al.  (2007) 
TYY181 
W303-1B pho13Δ::kan pho8Δ60::HIS3 
atg1Δ::URA3 
Yorimitsu et al.  (2007) 
TYVT1 
W303-1B pho13Δ::kan pho8Δ60::HIS3 
isc1Δ::LEU2 
This study 
vac8Δ BY4741 vac8Δ::KanMX4  This study 
isc1Δ 
BY4741 isc1Δ::KanMX4 [pYX222-mtDsRed 
pRS413TEFpr-PEP4, pRS416-GFP-ATG8, 
pJT30, pDN436 (CPY*-HA), pRS315-
HAC1i,pRS426-VAM3, YEp352-YKT6, 
YEp24-YPC1, pJDCEX2] 
EUROSCARF 
This study 
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isc1Δ 
Dnm1-GFP 
BY4741 DNM1-GFP isc1Δ::LEU2 This study 
isc1Δvac8Δ BY4741 isc1Δ::LEU2 vac8Δ::KanMX4  This study 
VT2 
isc1Δ::KanMX4 pho8Δ::HPH  [pYX242-
mtPho8] 
This study 
tor1Δ BY4741 tor1Δ::KanMX4 Teixeira et al.  (2014) 
 
VT3 
tor1Δ::KanMX4 pho8Δ::HPH  
 [pYX242-mtPho8] 
This study 
isc1Δtor1Δ BY4741 isc1Δ::LEU2 tor1Δ::KanMX4 Teixeira et al.  (2014) 
VT4 
BY4741 isc1Δ::URA3 tor1Δ::KanMX4 
pho8Δ::HPH [pYX242-mtPho8] 
This study 
sch9Δ BY4741 sch9Δ::KanMX4 EUROSCARF 
VT5 
sch9Δ::KanMX4 pho8Δ::HPH  [pYX242-
mtPho8] 
This study 
isc1Δsch9Δ BY4741 isc1Δ::LEU2 sch9Δ::KanMX4 Teixeira et al.  (2014) 
VT6 
BY4741 isc1Δ::URA3 sch9Δ::KanMX4 
pho8Δ::HPH [pYX242-mtPho8] 
This study 
sit4Δ 
BY4741 sit4Δ::KanMX4 
 [pYX222-mtDsRed, pRS416-GFP-ATG8] 
EUROSCARF 
This study 
VT7 
sit4Δ::KanMX4 pho8Δ::HPH  [pYX242-
mtPho8] 
This study 
isc1Δsit4Δ 
BY4741 isc1Δ::LEU2 sit4Δ::KanMX4 
[pYX222-mtDsRed, pRS416-GFP-ATG8] 
This study 
VT8 
BY4741 isc1Δ::URA3 sit4Δ::KanMX4 
pho8Δ::HPH  [pYX242-mtPho8] 
This study 
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hog1Δ 
BY4741 hog1Δ::KanMX4 
 [pYX222-mtDsRed] 
EUROSCARF 
This study 
VT9 
hog1Δ::KanMX4 pho8Δ::HPH  [pYX242-
mtPho8] 
This study 
isc1Δhog1Δ 
BY4741 isc1Δ::URA3 hog1Δ::KanMX4 
[pYX222-mtDsRed] 
This study 
VT10 
BY4741 isc1Δ::URA3 hog1Δ::KanMX4 
pho8Δ::HPH  [pYX242-mtPho8] 
This study 
dnm1Δ 
BY4741 dnm1Δ::KanMX4 
 [pYX222-mtDsRed] 
EUROSCARF 
This study 
VT11 
dnm1Δ::KanMX4 pho8Δ::HPH  [pYX242-
mtPho8] 
This study 
isc1Δdnm1Δ 
BY4741 isc1Δ::URA3 dnm1Δ::KanMX4 
[pYX222-mtDsRed] 
This study 
VT12 
BY4741 isc1Δ::URA3 dnm1Δ::KanMX4 
pho8Δ::HPH  [pYX242-mtPho8] 
This study 
atg32Δ 
BY4741 atg32Δ::KanMX4 
 [pISC1] 
EUROSCARF 
This study 
isc1Δatg32Δ Matα isc1Δ::LEU2 atg32Δ::KanMX4 This study 
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Figure 3.S1. Defective vacuolar proteolysis contributed to reduced autophagic flux 
in isc1Δ cells. BY4741 and isc1Δ cells were grown to exponential phase in SC-medium 
and treated with rapamycin (200 ng/mL) for 3h. Lysed spheroplasts of rapamycin-treated 
cells were trypsin-digested with and without detergent (Triton X-100). Immunoblots were 
performed with anti-GFP antibody.  
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Figure 3.S2. Overexpression of VAM3 or YKT6 does not suppress the Cvt pathway 
and CPY protein sorting defects in isc1Δ cells. 
A. BY4741 and isc1Δ cells overexpressing VAM3 or YKT6 were grown to exponential 
phase in SC-medium and treated with either DMSO (vehicle) or rapamycin (200 ng/mL) 
for 3h. The processing of the Cvt pathway marker prApeI to mApeI was analyzed by 
immunoblotting using anti-ApeI. B. Cells were grown on SC-medium plates in contact with 
a nitrocellulose filter. Secreted CPY was immunodetected with anti-CPY. 
 
 
 
 
 
A 
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Figure 3.S3. The deletion of TOR1 and SCH9 suppressed the Cvt pathway and 
vacuolar protein sorting defects in isc1Δ cells. 
A. The processing of the Cvt pathway marker prApeI to mApeI was analyzed by 
immunoblotting in BY4741, isc1Δ, tor1Δ, isc1Δtor1Δ, sch9Δ and isc1Δsch9Δ cells treated 
with either DMSO (vehicle) or rapamycin (200 ng/mL) for 3h. B. Specific Pep4p activity 
was measured in protein extracts of BY4741, isc1Δ, tor1Δ, isc1Δtor1Δ, sch9Δ and 
isc1Δsch9Δ cells. Values were normalized to parental cells (set as 100%). Values are 
mean ± SD of at least three independent experiments. ****p<0.0001. C. CPY secretion 
was analyzed in BY4741, isc1Δ, tor1Δ, isc1Δtor1Δ, sch9Δ and isc1Δsch9Δ cells as 
described in figure 3.2.D. D. Vacuolar acidification of isc1Δtor1Δ and isc1Δsch9Δ cells 
was analyzed using quinacrine staining. Unprobed and probed cells are depicted in red 
and blue, respectively. Representative histograms are shown.   
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Figure 3.S4. The deletion of TOR1, SCH9 and SIT4 suppressed vacuolar 
fragmentation in isc1Δ cells. BY4741, isc1Δ, isc1Δtor1Δ, isc1Δsch9Δ and isc1Δsit4Δ 
cells were grown to exponential phase and incubated with FM 4-64 for 30 min. Vacuoles 
were observed by fluorescence microscopy. Scale bar: 5 µm.  
 
 
Figure 3.S5. Ectopic overexpression of YPC1 abolishes Pep4p-dependent vacuolar 
proteolysis but not the vacuolar protein sorting defect in isc1Δ cells. A. BY4741 and 
isc1Δ cells carrying either YEp24 (empty vector) or overexpressing YPC1 were grown to 
exponential phase in SC-medium. Specific Pep4p activity was measured and values were 
normalized to parental cells (set as 100%). Values are mean ± SD of at least three 
independent experiments. *p<0.05. B. BY4741 and isc1Δ cells carrying either YEp24 
(empty vector) or overexpressing YPC1 were grown on SC-medium plates in contact with 
a nitrocellulose filter. Secreted CPY was immunodetected with anti-CPY. 
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Figure 3.S6. The UPR response is downregulated by a Sit4p-dependent mechanism 
in isc1Δ cells. 
A. BY4741 and isc1Δ cells carrying an UPRE-lacZ reporter (pJT30) were grown in SC-
medium to the exponential phase and treated with either tunicamycin (2 µg/mL, vehicle 
DMSO) or DTT (6 mM, vehicle water) for 1 h. β-galactosidase activity was determined. 
Values represent the fold induction between untreated and treated cells and are means ± 
SD of at least three independent experiments. B. BY4741, isc1Δ, sit4Δ and 
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isc1Δsit4Δcells carrying an UPRE-LacZ reporter (pJT30) were grown in SC-medium to the 
exponential (B1) or stationary phase (B2) and kept in the medium overtime.                      
β-galactosidase activity was determined. Values are means ± SD of at least three 
independent experiments. ***p<0.001; **p<0.01; *p<0.05. C. Isc1p-deficient cells carrying 
the empty vector (pRS315) and expressing the intron-less form of the HAC1 gene (pHACi) 
were grown to PDS phase in SC-medium and kept in the medium overtime. The viability 
was expressed as the percentage of the colony-forming units as compared to time T0.     
D. BY4741 and isc1Δ cells carrying pRS315 or pHACi were grown in SC-medium to the 
exponential phase and exposed to 1.5 mM H2O2 for 60 min. Cell viability was expressed 
as the percentage of the colony-forming units (treated cells versus untreated cells). 
Values are mean ± SD of at least three independent experiments. ***p<0.001. E. BY4741 
and isc1Δ cells carrying CPY*–HA were treated with cycloheximide (to block protein 
synthesis) for 1h and aliquots were collected at the indicated times. Immunoblotting was 
performed using anti-HA or anti-actin as primary antibodies. The CPY*-HA band 
intensities were normalized to actin bands. Data was expressed as the percentage 
relative to time zero.  
 
Figure 3.S7. Isc1p-deficient cells exhibit mitochondrial fragmentation and reduced 
oxygen consumption in lactate-growing conditions. BY4741 and isc1Δ cells carrying 
mtDsRed were grown in SC-glucose (OD600=0.1) and shifted to SC-lactate medium for 48 
h. The mitochondrial network was analyzed by fluorescence microscopy (scale bar: 5 µm) 
(A) and oxygen consumption rate was measured (B).  
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Figure 3.S8. The mitochondrial mass is increased in isc1Δ cells at PDS phase. 
BY4741 and isc1Δ cells were grown in SC-medium to PDS phase and ressuspended in 
10 mM HEPES buffer, pH 7.4, containing 5% glucose (106 cells/mL). The probe 
MitoTracker Green FM was added to a final concentration of 100 nM and cells were 
incubated at 26ºC for 30 minutes. Representative histograms are shown.   
 
 
 
 
 
 
 
 
 
 
Figure 3.S9. The deletion of ATG32 shortened the CLS of isc1Δ cells. Cells were 
grown in SC-glucose to the PDS phase (T0) and kept in the medium at 26°C. The viability 
was determined as the percentage of the colony-forming units at time T in relation to T0. 
Values are mean ± SD of at least three independent experiments. 
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Figure 3.S10. Overexpression of FZO1 partially abolishes mitochondrial 
fragmentation of isc1Δ cells. BY4741 and isc1Δ cells carrying FLAG-FZO1 (pJDCEX2) 
and mtDsRed were grown in SC-glucose lacking leucine and histidine in the presence of 
50 mM CuSO4 (to induce FZO1 expression) and the mitochondrial network was observed 
by fluorescence microscopy. Scale bar: 5 µm. 
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Figure 3.S11. The deletion of HOG1 suppressed mitochondrial fragmentation and 
this was correlated with lower induction of mitophagy in isc1Δ cells in lactate-
growing conditions. 
A. BY4741, isc1Δ, hog1Δ and isc1Δhog1Δ cells carrying mtDsRed were grown to PDS 
phase and mitochondrial network was analyzed by fluorescence microscopy. 
Representative images are shown. Scale bar: 5 µm. B. BY4741, isc1Δ, hog1Δ and 
isc1Δhog1Δ cells carrying mtPho8 were shifted from glucose (OD600=0.1) to lactate 
medium for 48 h. Mitophagy activity was measured by the alkaline phosphatase assay in 
glucose (open bars) or lactate-growing cells (closed bars) after 48 hours. Values are 
mean ± SD of at least three independent experiments. ****p<0.0001; **p<0.01; *p<0.05. 
C. BY4741, isc1Δ, hog1Δ and isc1Δhog1Δ cells carrying mtPho8 were grown in SC-
glucose to PDS phase, washed twice, and incubated in water during aging. Mitophagy 
activity was measured as described in figure 3.4.A. Values are mean ± SD of at least 
three independent experiments.  
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Figure 3.S12. Atg13p phosphorylation is similar in parental and isc1Δ cells in 
vegetative conditions. BY4741 and isc1Δ cells were grown to exponential phase in SC-
medium. The phosphorylation status of endogenous Atg13p was analyzed by 
immunoblotting using anti-Atg13p antibody. The dephosphorylated form of Atg13p was 
discriminated after treatment with rapamycin (200 ng/mL) for 3 h. 
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 The most beautiful thing we can experience is the mysterious. It is the 
source of all true art and all science. He to whom this emotion is a stranger, who 
can no longer pause to wonder and stand rapt in awe, is as good as dead: his 
eyes are closed. 
                    Albert Einstein 
CHAPTER IV 
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lifespan in yeast by regulating sphingolipid signalling in a Snf1p-
dependent manner 
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Abstract 
 
 Sphingolipids are essential components of membranes and play an 
important role in several biological functions, namely cell growth, stress response 
and longevity. In this study, we show that cells lacking Sit4p, a ceramide-activated 
protein phosphatase orthologue to human protein phosphatase PP6, are sensitive 
to myriocin and phytosphingosine, indicating alterations in sphingolipid 
homeostasis. We also demonstrate that Sit4p regulates sphingolipids biosynthetic 
pathway by a transcriptional regulatory mechanism involving the ceramide 
synthase LAG1 and the phytoceramidase YPC1. Importantly, myriocin sensitivity 
is correlated with alterations in Ypk1p-Orm signalling in sit4Δ cells. Moreover, the 
LCBs responsive Pkh1/2p-Sch9p pathway is downregulated in sit4Δ cells by a 
Snf1p-dependent mechanism, a phenotype that contributes to improved 
mitochondrial function and lifespan extension displayed by sit4Δ cells. These 
results provide evidence that Sit4p is not only an effector but also a key regulator 
of sphingolipid metabolism and integrates signals derived from TORC1-mediated 
nutrient sensing with sphingolipid metabolism to regulate longevity in yeast. 
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4.1. Introduction 
 
 Ceramides and sphingoid long-chain bases (LCBs) are sphingolipid 
metabolites that play important roles in cell signalling and intracellular trafficking 
(Cowart et al., 2006, Hannun & Obeid, 2008, Liu et al., 2013, Rego et al., 2014). 
Conserved biosynthetic pathways in yeast are responsible for the formation of 
bioactive metabolites, such as LCBs, which are represented by phytosphingosine 
(PHS) and dihydrosphingosine (DHS), the phosphorylated forms of LCBs 
(LCBPs), namely DHS-1-P and PHS-1-P, and ceramide species, represented by 
dihydroceramides, phytoceramides and α-hydroxylated phytoceramides (Hannun 
& Obeid, 2008, Rego et al., 2014). In yeast, they play a crucial role in the 
regulation of cell growth, endocytosis, actin cytoskeleton organization, protein 
trafficking, cell wall integrity, nutrient uptake, stress response and importantly 
longevity (Cowart et al., 2006, Dickson, 2008, Liu et al., 2013, Rego et al., 2014).  
 Several studies in mammalian and yeast systems have unraveled an 
interplay between sphingolipid dynamics and the Target of Rapamycin (TOR) 
signalling pathway to regulate aging. The TOR complex 1 (TORC1) and the TOR 
complex 2 (TORC2) play a wide spectrum of cellular activities that are crucial for 
proper regulation of spatial and temporal aspects of cell growth and recently both 
branches were implicated in the regulation of sphingolipid metabolism (de Virgilio 
& Loewith, 2006, Evans et al., 2011, Kim & Guan, 2011, Loewith & Hall, 2011, 
Laplante & Sabatini, 2012, Johnson et al., 2013). Both are involved in the 
regulation of sphingolipid homeostasis by modulating the activity of Orm1p and 
Orm2p, two evolutionary conserved proteins located in the endoplasmic reticulum 
(ER) (Roelants et al., 2011, Liu et al., 2012, Shimobayashi et al., 2013). In 
particular, TORC1 negatively controls the synthesis of complex sphingolipids from 
ceramide by inhibiting its downstream effector, the PP2A-like protein phosphatase 
Sit4p. As a result, the Npr1p kinase is no longer activated and Orm1/2p are not 
phosphorylated and activated, impeding the flux of ceramide to drive the synthesis 
of complex sphingolipids (Shimobayashi et al., 2013).  
 TORC2, on the other hand, stimulates the de novo biosynthesis of 
sphingolipids upon sphingolipid depletion (e.g., by myriocin treatment) via 
phosphorylation and activation of Ypk1p, which then phosphorylates and 
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inactivates Orm1/2p (Roelants et al., 2011, Berchtold et al., 2012). Since Orm1/2p 
bind to and inhibit the serine palmitoyl-coenzyme A transferase (SPT) (Breslow et 
al., 2010), which catalyzes the first step in sphingolipid biosynthesis, their 
inactivation by Ypk1p-dependent phosphorylation alleviates SPT inhibition and 
boosts sphingolipid production (Breslow et al., 2010, Roelants et al., 2011, 
Berchtold et al., 2012). In addition, TORC2 stimulates ceramide synthase by a 
Ypk2p-dependent mechanism (Ypk2p is a paralog of Ypk1p), which is antagonized 
by calcineurin (Aronova et al., 2008). It also inhibits Isc1p, an homologue of 
mammalian neutral sphingolmyelinase 2 (nMase2), via modulation of Slm1/2p 
(Tabuchi et al., 2006). The phosphorylation of Slm1/2p by TORC2 promotes their 
recruitment to the plasma membrane, where they play an essential role in the 
regulation of Ypk1p activation by increasing the phosphorylation efficiency of 
Ypk1p by TORC2 (at the HM site) and by Pkh1p kinase (at the A-loop) (Tabuchi et 
al., 2006, Berchtold et al., 2012, Niles & Powers, 2012). Thus, Slm1/2p are 
involved in the regulation of both ceramide biosynthesis, via the TORC2-Ypk1p-
SPT-ceramide synthase cascade, and ceramide generation by hydrolysis of 
complex sphingolipids mediated by Isc1p. Importantly, TORC1 regulates Orm 
phosphorylation by molecular mechanisms dissimilar from TORC2, as Orm 
phosphorylation sites are distinctly regulated by TORC1 and TORC2 (Huber et al., 
2009, Soulard et al., 2010). 
 Apart from sensing nutrient signalling (aminoacids), early studies have 
shown that the TORC1 downstream effector and S6K1 homologue, Sch9p, is also 
responsive to LCBs (PHS) (Liu et al., 2005). Like Ypk1p, Sch9p is phosphorylated 
by Pkh1/2p at its PDK1 site located in the activation loop (Roelants et al., 2004, 
Urban et al., 2007), which is indispensable for proper activity. The dual regulation 
of Sch9p by TORC1 and Pkh1p is crucial for proper integration of nutrient and 
sphingolipid signalling impacting on cell growth and survival (Huang et al., 2012, 
Huang et al., 2013). In fact, reducing the rate of the sphingolipid biosynthetic 
pathway by myriocin treatment leads to chronological lifespan (CLS) extension 
and improvement of stress response by downregulating the Pkh1/2p-Sch9p 
pathway, although Sch9p-independent mechanisms are also implicated (Huang et 
al., 2012). More recently, Sch9p was shown to be a key regulator of sphingolipid 
metabolism as the LCBs/ceramide rheostat is altered in sch9Δ mutants in favor of 
increased survival (Swinnen et al., 2014).   
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 On the other hand, the deletion of both TOR1 and SCH9 also improves 
mitochondrial function and oxidative stress response by an intrinsic mechanism 
involving enhanced mitochondrial membrane potential and superoxide production, 
which pre-conditions cells to better survive at the stationary phase and extends 
CLS in yeast (Bonawitz et al., 2007, Wei et al., 2008, Wei et al., 2009, Pan et al., 
2011). Such mechanisms are highly conserved from yeast to mammals (Swinnen 
et al., 2013). More recently, we have proposed that Sch9p also integrates nutrient 
signals from TORC1 with Isc1p-driven ceramide signalling in the regulation of 
mitochondrial function, oxidative stress resistance and CLS in yeast (Teixeira et 
al., 2014).  
 The TORC1 downstream effector Sit4p is the catalytic subunit of the 
ceramide-activated protein phosphatase (CAPP), a heterotrimeric complex that 
also includes Tpd3p and Cdc55p as regulatory subunits (Nickels & Broach, 1996). 
Sit4p was also shown to associate with a set of proteins collectively denominated 
SIT4-associated proteins (SAP), which positively regulates Sit4p activity (Luke et 
al., 1996). Sit4p is a serine-threonine protein phosphatase related to type 2A 
family of protein phosphatases (PP2A), with high homology to human protein 
phosphatase 6 (Bastians & Ponstingl, 1996, Morales-Johansson et al., 2009). 
Sit4p regulates several biological processes, such as the cell wall integrity (CWI) 
pathway, cytoskeleton organization and ribosomal gene expression (Angeles de la 
Torre-Ruiz et al., 2002). It also modulates the cell cycle by regulating the Swi4p-
mediated transcription of G1 cyclin genes (Fernandez-Sarabia et al., 1992, Di 
Como et al., 1995, Angeles de la Torre-Ruiz et al., 2002), ion tolerance (Masuda 
et al., 2000), multidrug resistance (Chen, 2001), the ubiquitin-proteasome system 
(Singer et al., 2003), endocytosis (McCourt et al., 2009) and TORC1 readouts, 
namely on nutrient signalling (Rohde et al., 2004, Tate et al., 2006, Tate et al., 
2009) and sphingolipid metabolism (Barbosa et al., 2011, Shimobayashi et al., 
2013). In response to nutrient signals, TORC1 modulates the interaction of Sit4p 
with its essential effector Tap42p and thereby controls Gcn2p-regulated 
translation, expression of the nitrogen catabolite-repressed (NCR) and retrograde 
response genes (Beck & Hall, 1999, Bertram et al., 2000, Torres et al., 2002, 
Kubota et al., 2003, Rohde et al., 2004). Importantly, Sit4p is also involved in the 
regulation of mitochondrial function. In fact, sit4Δ cells present a growth defect on 
respiratory substrates by shunting the carbohydrate metabolism flux into 
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gluconeogenesis and glycogen storage, therefore depleting the Krebs cycle 
intermediates (Jablonka et al., 2006). In addition, Sit4p participates in the catabolic 
derepression of mitochondria. In glucose-growing cells, both Mig1p and 
hexocinase Hxk2p are dephosphorylated by the Reg1p-Glc7p protein 
phosphatase complex and form a complex in the nucleus to repress the 
expression of genes associated with growth on non-fermentable carbon sources 
(Ahuatzi et al., 2004, Ahuatzi et al., 2007). The interaction between Hxk2p and 
Mig1p under repressing conditions inhibits Mig1p phosphorylation at Ser311 by 
the Snf1p protein kinase, a homologue of mammalian AMPK, and its export from 
the nucleus into the cytosol in a Msn5p-dependent manner (Ahuatzi et al., 2007). 
Under these conditions, Snf1p is dephosphorylated and inhibited by Reg1p-Glc7p 
and Sit4p protein phosphatases (Ruiz et al., 2011). 
We have previously reported that cells lacking Isc1p exhibit mitochondrial 
dysfunctions, oxidative stress sensitivity and premature aging associated with the 
activation of Sit4p in response to increased levels of very long chain ceramide 
species during aging (Almeida et al., 2008, Barbosa et al., 2011). Although Sit4p 
functions downstream of Isc1p (Barbosa et al., 2011), the phosphatase is also 
downregulated by TORC1 (Di Como & Arndt, 1996, Jacinto et al., 2001, de Virgilio 
& Loewith, 2006) and Sit4p controls the turnover of complex sphingolipids in 
response to TORC1 in a Npr1p-dependent manner (Shimobayashi et al., 2013). In 
addition, a reduction in Orm1p phosphorylation was observed in sit4Δ cells at 
basal conditions and in response to myriocin, indicating that Sit4p is also an 
effector of sphingolipid signalling (Liu et al., 2012). Notably, SIT4 (Barbosa et al., 
2011) and TOR1 (Bonawitz et al., 2007, Pan et al., 2011) deletion extends lifespan 
by boosting mitochondrial function and stress responses in yeast. 
How Sit4p integrates nutrient and sphingolipid signalling to regulate lifespan 
remains poorly understood. This works aimed to establish a functional association 
between Sit4p and sphingolipid metabolism and evaluate the impact on cell 
survival. Here, we show that Sit4p regulates the sphingolipid biosynthetic pathway 
by a transcriptional regulatory mechanism involving LAG1 (encoding for ceramide 
synthase) and YPC1 (encoding for phytoceramidase) expression. Importantly, 
decreased Orm phosphorylation (Liu et al., 2012) and ceramide levels (Vilaça, 
2014) in sit4Δ cells correlate with alterations in Ypk1p-Pkh1p-Orm signalling. 
Moreover, the activation of the Pkh1p-Sch9p pathway is mostly abolished in sit4Δ 
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cells by a Snf1p-dependent mechanism and this is associated with improved 
mitochondrial function, oxidative stress resistance and extended CLS displayed by 
Sit4p-deficient cells. 
 
4.2. Results 
 
4.2.1. Sit4p-deficient cells display alterations in sphingolipid metabolism 
 
 To investigate the role of Sit4p in the modulation of sphingolipid 
biosynthesis, we have analyzed the sensitivity of sit4Δ cells to myriocin, an 
inhibitor of SPT that catalyzes the condensation of palmitoyl-CoA and serine in the 
de novo biosynthetic pathway (Hanada et al., 2000). The analysis was also 
performed with different selection markers used for the deletion of SIT4 to exclude 
possible marker effects. The results show that sit4Δ cells exhibited myriocin 
sensitivity and are more sensitive to the growth-inhibitory effect of PHS (Figure 
4.1). Overall, the results suggest that Sit4p fulfills a regulatory role within the 
sphingolipid biosynthetic pathway.  
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 4.1. Sit4p-deficient cells are sensitive to myriocin and phytosphingosine 
(PHS). BY4741 and sit4Δ cells were grown in SC medium to exponential phase, diluted to 
OD600=0.1 and spotted in five-dilution series onto YPD plates supplemented with either 
ethanol 95% and DMSO (vehicle for myriocin and PHS treatment, respectively) or 
myriocin (0.35 µg/mL) and PHS (25 µM). A representative image out of three is shown. 
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 Consistent with this hypothesis, Sit4p-deficient cells exhibit significant 
changes in the levels of sphingolipids (Vilaça, 2014). The levels of C14-, C16- 
C18-, C20-, C22-, C24- and C26-phytoceramides and C14- and C16 
dihydroceramides were increased whereas the levels of C18-, C20- and C22-
dihydroceramide were decreased in sit4Δ cells, indicating some substrate 
specificity regarding the sphingoid base. Overall, total ceramide content was 
decreased in sit4Δ cells. Moreover, the PHS levels remained unaltered whereas 
the levels of DHS were increased in sit4Δ cells (Vilaça, 2014). The higher levels of 
LCBs may explain the increased sensitivity to PHS displayed by the mutant strain. 
Furthermore, Sit4p-deficient cells present higher levels of PHS-1-P and DHS-1-P 
and lower LCBs/LCBPs ratios compared to parental cells (Vilaça, 2014), 
suggesting that LCBs are preferentially shunted towards LCBPs formation. These 
results exclude the possibility that defective ceramide production results from 
limiting amounts of LCBs.  
 High levels of LCBPs have been associated with cell growth inhibition (Kim 
et al., 2000, Zhang et al., 2001). However, the accumulation of LCBPs does not 
contribute to reduced growth rate of sit4Δ cells since the deletion of LCB4, which 
encodes for the major LCB kinase responsible for the synthesis of LCBPs, did not 
improve cell growth (Figure 4.2).  
 
  
 
 
 
 
 
 
 
 
 
 
Figure 4.2. The deletion of LCB4 does not suppress the growth defect of sit4Δ cells. 
Growth curves of BY4741, sit4Δ, lcb4Δ and sit4Δlcb4Δ cells grown in SC-glucose 
medium. Values are mean ± SD of three independent experiments.  
Chapter IV 
	   	   180	  
4.2.2. Sit4p controls ceramide levels via transcriptional regulation 
mechanisms 
 
 Sit4p deficiency alters the LCBPs/ceramide rheostat and favors the 
production of phytoceramide and α-hydroxylated phytoceramides and the 
accumulation of LCBPs (Vilaça, 2014). Thus, we have also considered that Sit4p 
could play a regulatory role on sphingolipid biosynthesis and turnover. Since Sit4p 
is involved in transcriptional programs (Di Como & Arndt, 1996, Crespo et al., 
2002, Shirra et al., 2005), we have analyzed the expression of YDC1 and YPC1 
genes (encoding for ceramidases) and LAG1 and LAC1 (encoding for ceramide 
synthase) in parental and sit4Δ cells transformed with LacZ reporters under the 
control of the promoter of each gene (Swinnen et al., 2014). The analysis of β-
galactosidase activity showed that YPC1 expression decreased and LAG1 
expression increased whereas YDC1 and LAC1 expression remained unchanged 
in sit4Δ cells (Figure 4.3). Our results point to the existence of a transcriptional 
regulation mechanism in which Sit4p acts to promote the induction of YPC1 
ceramidase and the repression of LAG1 expression in the sphingolipid 
biosynthetic pathway.  
 
 
 
 
  
 
 
 
 
 
 
 
 
Figure 4.3. The deletion of SIT4 decreases the expression of ceramidase YPC1 and 
increases ceramide synthase LAG1 expression in yeast.  BY4741 and sit4Δ cells 
carrying LacZ reporter fusions with the promoters of LAG1, LAC1, YDC1 or YPC1 in the 
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multicopy plasmid YEp357 were grown in SC-medium to exponential phase. β-
galactosidase activity was determined. Values are means ± SD of at least three 
independent experiments. *p<0.05. 
 
4.2.3. Snf1p regulates the TORC2-Ypk1p and the Pkh1p-Sch9p signalling 
pathways in sit4Δ cells  
 
 Accumulating evidence has demonstrated a functional convergence 
between the activities of Snf1p and Sit4p in yeast, particularly on reciprocal effects 
on transcription (Shirra et al., 2005). Ruiz et al. reported that Sit4p contributes to 
the inactivation of Snf1p by dephosphorylating Thr210 (Ruiz et al., 2011). To 
assess the role of Snf1p in sit4Δ phenotypes, we have firstly analyzed myriocin 
resistance of sit4Δsnf1Δ cells. Remarkably, the deletion of SNF1 weakly conferred 
myriocin resistance to parental cells (Yucel & Ulgen, 2013) and abolished myriocin 
sensitivity of sit4Δ cells (Figure 4.4).  
 
  
 
 
 
 
 
 
 
 
Figure 4.4. The deletion of SNF1 suppresses myriocin sensitivity of sit4Δ cells. 
BY4741, sit4Δ, snf1Δ and sit4Δsnf1Δ cells were grown in SC medium to exponential 
phase, diluted to OD600=0.1 and spotted in five-dilution series onto YPD plates 
supplemented with either ethanol 95% (vehicle) or myriocin (0.35 µg/mL). A 
representative image is shown.  
 
 The TORC2-dependent phosphorylation of Ypk1p upon myriocin treatment 
and the consequent inhibition of Orm1/2p alleviates SPT repression and enable 
cells to respond to sphingolipid depletion (Niles & Powers, 2012). It was previously 
reported that sit4Δ cells exhibit decreased Orm1p phosphorylation in response to 
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myriocin (Liu et al., 2012) and our results show that this mutant strain displayed 
myriocin sensitivity. We therefore investigated whether the TORC2-Ypk1-Orm 
pathway is altered in Sit4p-deficient cells in a Snf1p-dependent manner. For this 
purpose, we have analyzed the TORC2-mediated phosphorylation of Ypk1p at the 
HM site (T662), which is responsive to alterations in sphingolipid levels (Berchtold 
et al., 2012, Niles & Powers, 2012). The results show that the phosphorylation of 
T662-Ypk1p was not affected in sit4Δ cells but it was increased in snf1Δ and 
sit4Δsnf1Δ cells (Figure 4.5).  
   
Figure 4.5. Ypk1p signalling is diminished in sit4Δ cells by a Snf1p-dependent 
mechanism. BY4741, sit4Δ, snf1Δ and sit4Δsnf1Δ cells were grown to exponential phase 
in YPD and the TORC2-dependent and Pkh1p-mediated phosphorylation of Ypk1p were 
analyzed by immunoblotting, using anti-T662-Ypk1p (top panel), anti-T504-Ypk1p (top 
panel), respectively, and anti-Pgk1p (loading control) as primary antibodies. A 
representative blot out of at least three is shown. The quantification was done by 
densitometry. The TORC2-dependent phosphorylation was quantified by normalization to 
Pgk1p levels. **p<0.01; *p<0.05. 
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 The current model for sphingolipid regulation by TORC2 activity proposes 
that Pkh1p also phosphorylates Ypk1p at the A-loop and is essential for its full 
activation (Berchtold et al., 2012, Niles & Powers, 2012). Therefore, we analyzed 
the activity of Pkh1p by monitoring the phosphorylation of T504 in Ypk1p (Huang 
et al., 2012). We observed that the Pkh1p-mediated phosphorylation of Ypk1p was 
decreased in sit4Δ cells and partially restored upon deletion of SNF1 in the mutant 
strain (Figure 4.5). We also took advantage a mutant allele of YPK1, YPK1D242A, 
which is constitutively active in the absence of TORC2 function but still requires 
Pkh1p activity (Roelants et al., 2011, Niles & Powers, 2012). In principle, the 
expression of this allele would not completely rescue the myriocin sensitivity of 
sit4Δ cells since it still requires functional Pkh1p. In agreement, we observed that 
the expression of Ypk1pD242A did not suppress myriocin sensitivity of sit4Δ cells 
(Figure 4.6.A), likely due to dependence in Pkh1p-dependent phosphorylation for 
full activation of Ypk1p. We also observed that myriocin sensitivity could not be 
suppressed by increasing PKH1 copies (Figure 4.6.B), indicating that the 
activation of Pkh1p rather than Pkh1p protein levels is likely a limiting factor. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6. Bypassing TORC2 signalling or increased expression of PKH1 do not 
suppress myriocin sensitivity of sit4Δ cells. BY4741 and sit4Δ cells carrying an 
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hyperactive mutant allele of YPK1, YPK1D242A (A) or pRS316-PKH1 (B) or the 
corresponding empty vectors were grown in SC medium to exponential phase, diluted to 
OD600=0.1 and spotted in five-dilution series onto YPD plates supplemented with either 
ethanol 95% (vehicle) or myriocin (0.35 µg/mL). A representative image out of three is 
shown.  
 
 Taken together, our results show that TORC2-dependent phosphorylation 
of Ypk1p is not altered in sit4Δ cells but Ypk1p signalling is diminished due to 
decreased activity of Pkh1p. This is consistent with decreased Orm 
phosphorylation and myriocin sensitivity. Importantly, the deletion of SNF1 
increased the activation of TORC2-Pkh1p-Ypk1p axis in parental cells, which may 
explain the mild resistance of snf1Δ cells to myriocin. In agreement, the deletion of 
YPK1 confers myriocin sensitivity to parental cells and suppressed myriocin 
resistance of Snf1p-deficient cells (Figure 4.7). Importantly, SNF1 deletion partially 
restored the activation of this pathway in sit4Δ cells by increasing the TORC2 and 
the Pkh1p-mediated phosphorylation of Ypk1p, which correlates with enhanced 
TORC2-Pkh1p-Ypk1p signalling and increased resistance to myriocin displayed by 
sit4Δsnf1Δ cells compared to sit4Δ cells. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7. The deletion of YPK1 confers myriocin hypersensitivity to parental and 
snf1Δ cells. BY4741, snf1Δ, ypk1Δ and snf1Δypk1Δ were grown in SC medium to 
exponential phase, diluted to OD600=0.1 and spotted in five-dilution series onto YPD plates 
supplemented with either ethanol 95% (vehicle) or myriocin (0.02 µg/mL). A lower 
concentration was used due to the hypersensitivity of ypk1Δ cells to myriocin. A 
representative image out of three is shown.  
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4.2.4. The deletion of SIT4 downregulates the Pkh1p-Sch9p pathway to 
extend lifespan in yeast 
 
 Several studies have demonstrated the important role of sphingolipids in 
the regulation of stress response and lifespan, in part via the activation of 
sphingolipid-responsive pathways, such as the Pkh1/2p-Sch9p pathway (Liu et al., 
2005, Huang et al., 2012). The decreased Pkh1p activity in sit4Δ cells prompted us 
to monitor the phosphorylation of residue T570 in Sch9p (Huang et al., 2012). 
Notably, both T570-Sch9p phosphorylation and Sch9p levels were decreased in 
sit4Δ cells and partially restored upon deletion of SNF1, suggesting that Sit4p 
activates the Pkh1p-Sch9p pathway in part by inhibiting Snf1p (Figure 4.8).  
 Since the deletion of SIT4 (Barbosa et al., 2011) and SCH9 (Fabrizio et al., 
2001, Bonawitz et al., 2007) also extend CLS and stress response in yeast, we 
aimed to investigate if the downregulation of the Pkh1p-Sch9p pathway is related 
to sit4Δ phenotypes. According to our hypothesis, the deletion of SNF1 should be, 
in principle, deleterious since it partially restores the activation of the Pkh1p-Sch9p 
pathway by increasing Pkh1p activity and Sch9p total protein levels in sit4Δ cells 
(Figures 4.5 and 4.8).  
 
 
 
 
 
 
 
 
 
 
Figure 4.8. The activation of Pkh1p-Sch9p signalling pathway is decreased in sit4Δ 
cells in a Snf1p-dependent manner. BY4741, sit4Δ, snf1Δ and sit4Δsnf1Δ cells were 
grown to exponential phase in YPD and the Pkh1p-mediated phosphorylation of Sch9p 
was analyzed by immunoblotting, using anti-T570-Sch9p (top panel), anti-Sch9p (middle 
panel) and anti-Pgk1p (loading control) as primary antibodies. A representative blot out of 
at least three is shown.  
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 In agreement, the deletion of SNF1 in sit4Δ cells leads to decreased cell 
growth, hydrogen peroxide sensitivity, abolishes CLS extension and promotes 
impaired mitochondrial function (Pereira et al., unpublished results). To provide 
further evidence that the restoration of Sch9p levels contribute to these 
phenotypes in sit4Δsnf1Δ cells, SCH9 was overexpressed in sit4Δ cells. In fact, 
the overexpression of SCH9 impaired cell growth, particularly in the stationary 
phase (Figure 4.9.A), abolished hydrogen peroxide resistance (Figure 4.9.B) and 
reduced oxygen consumption (Figure 4.9.C) and glycogen storage (Figure 4.9.D) 
in sit4Δ cells. Importantly, we also observed that the overexpression of SCH9 
partially shortened the CLS extension of Sit4p-deficient cells (Figure 4.9.E).  
 
 
4.3. Discussion 
 
 The role of sphingolipids in aging and age-associated pathologies, such as 
neurodegenerative diseases and cancer, has been extensively reported. In fact, 
alterations on sphingolipids metabolism deregulate cell growth and survival and 
general stress responses with impact on the onset of these diseases (Kolter, 
2011). However, the molecular mechanisms by which signalling pathways are 
activated in response to alterations in sphingolipid biosynthesis or turnover are not 
yet fully understood. This clarification is pivotal to understand sphingolipid 
functions in more detail and define new strategies to improve human health and 
extend lifespan. 
  In this study, we report that Sit4p, the yeast orthologue of human 
phosphatase PP6, is not only an effector but also a regulator of sphingolipids 
metabolism. Our results show that Sit4p is required for proper regulation of 
sphingolipid metabolism, which is consistent with Sit4p-deficient cells presenting 
higher LCBPs/LCBs ratio and reduced ceramide content during exponential 
growth (Vilaça, 2014). Regarding the sphingolipids biosynthetic pathway, we 
provide evidence that Sit4p takes part of a novel mechanism in which this 
phosphatase plays a key role in the regulation of the YPC1 and LAG1 expression, 
since YPC1 expression was decreased and LAG1 expression was increased in 
sit4Δ cells.  
 
Chapter IV 
	   	   187	  
 
Chapter IV 
	   	   188	  
Figure 4.9. The overexpression of SCH9 abolishes hydrogen peroxide resistance, 
increased oxygen consumption and the glycogen storage phenotype of sit4Δ cells. 
A. Growth curves of BY4741 and sit4Δ cells carrying the empty vector (YEp13) or 
overexpressing SCH9 (YEp13-SCH9) grown in SC-glucose to early exponential phase 
and maintained overtime. The OD600 values read after 40 hours of incubation is depicted 
on the right. Values are mean ± SD of three independent experiments. **p<0.01 B. 
BY4741 and sit4Δ cells carrying the empty vector (YEp13) or overexpressing SCH9 
(YEp13-SCH9) were grown in SC-medium to the exponential phase and exposed to 1.5 
mM H2O2 for 60 min. Cell viability was expressed as the percentage of the colony-forming 
units (treated cells versus untreated cells). Values are mean ± SD of at least three 
independent experiments. ***p<0.001; **p<0.01. C. Oxygen consumption rate was 
measured in cells grown to PDS phase. Values are mean ± SD of at least three 
independent experiments. **p<0.01; *p<0.05. D. Analysis of glycogen content in BY4741 
and sit4Δ cells carrying the empty vector (YEp13) or overexpressing SCH9 (YEp13-
SCH9). Cells were grown in SC-medium to exponential phase, diluted to OD600=0.1 and 
spotted onto YPD agar. After 3 days of growth, iodine staining was performed by exposing 
cells to iodine vapor. A representative image out of three is shown. E. Analysis of 
chronological lifespan in BY4741 and sit4Δ cells carrying the empty vector (YEp13) or 
overexpressing SCH9 (YEp13-SCH9). Values are mean ± SD of at least three 
independent experiments. 
 
 The downregulation of the phytoceramidase YPC1 gene may account for 
the specific accumulation of phytoceramides observed in sit4Δ cells, which then 
becomes the substrate for the synthesis of α-hydroxylated phytoceramides 
(Vilaça, 2014). Importantly, the induction of the ceramide synthase LAG1 gene 
may occur either as a feedback loop mechanism in response to reduced ceramide 
levels observed in sit4Δ cells. A reduction in ceramide synthase activity predicts 
an increase in LCBs, as observed in avo3-30 (Aronova et al., 2008) and sit4Δ cells 
(Vilaça, 2014). More recently, Ypk1p was shown to activate Lac1p and Lag1p by 
phosphorylation at Ser23 and Ser24 (catalytic domain), which is antagonized by 
calcineurin (Muir et al., 2014). It would be interesting to assess ceramide synthase 
activity, and the Ypk1p-mediated phosphorylation of the catalytic domain of 
ceramide synthase to establish a connection between the activity of ceramide 
synthase and a reduction in ceramide content observed in Sit4p-deficient cells 
(Vilaça, 2014). It is noteworthy that calcineurin appears to act in parallel to these 
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pathways since FK506-induced inhibition of calcineurin further enhances the 
myriocin sensitivity of sit4Δ cells (Figure 4.S1).  
 In cells devoid of Sit4p, sphingolipid flux is preferentially shunted to favor 
the accumulation of phytoceramides and drive the synthesis of α-hydroxylated 
phytoceramide species (Vilaça, 2014). Importantly, the levels of α-hydroxylated 
phytoceramides were previously associated with proper mitochondrial function in 
yeast (Kitagaki et al., 2007). Thus, the observed increase in the content of α-HO 
phytoceramide species may account for improved mitochondrial function displayed 
by sit4Δ cells already at log phase (Jablonka et al., 2006, Barbosa et al., 2011, 
Vilaça, 2014).  
 It was previously reported that the phosphorylation of Orm1p but not Orm2p 
was decreased in sit4Δ cells in response to both rapamycin and myriocin (Liu et 
al., 2012). According to the model proposed by Shimobayashi et al., 
(Shimobayashi et al., 2013), the downregulation of TORC1 relieves Sit4p inhibition 
and therefore Npr1p kinase becomes activated to phosphorylate and activate 
Orm1p, thus stimulating complex sphingolipid biosynthesis. Here we demonstrate 
that decreased Orm phosphorylation in sit4Δ cells may also be attributed to 
decreased Ypk1p signalling. Although the phosphorylation of Ypk1p by TORC2 
was unaltered in Sit4p-deficient cells, full activation of Ypk1p still requires its 
phosphorylation by Pkh1p. In this study, we provide evidence that overall 
activation of Ypk1p is decreased in sit4Δ cells. In agreement, we showed that 
Pkh1p-driven phosphorylation of Ypk1p at T504 is decreased in sit4Δ cells. It was 
previously reported that the phosphorylation of Ypk1p by Pkh1p at T504 is also 
required for efficient endocytosis (deHart et al., 2002). In this scenario, reduced 
phosphorylation of Ypk1p-T504 may also explain defective endocytosis previously 
reported for sit4Δ cells (Burston et al., 2009).  
 We also show that a hyperactive form of Ypk1p, which bypasses TORC2 
signalling, was unable to suppress myriocin sensitivity because it likely requires 
the Pkh1p-dependent phosphorylation for full activation of Ypk1p. Furthermore, 
decreased Ypk1p activation in sit4Δ cells correlates well with reduced Orm 
phosphorylation observed in the mutant strain at basal conditions and in response 
to myriocin (Liu et al., 2012). Consistently, ypk1Δ cells are more sensitive to 
myriocin (Roelants et al., 2004, Tanoue et al., 2005), a feature that is shared with 
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Sit4p-deficient cells. In addition, sit4Δ cells are more sensitive to heat stress (Ruiz-
Roig et al., 2010) (and our observations, data not shown), which promotes the de 
novo sphingolipid biosynthesis, and Ypk1p-Orm signalling is required for heat 
stress adaptation (Sun et al., 2012). Overall, decreased Ypk1p-dependent 
inhibition of Orm1/2p in sit4Δ cells favors SPT inhibition, likely contributing to 
downregulate sphingolipid biosynthesis. In agreement, ceramide production is 
decreased in this mutant (Vilaça, 2014).  
 Altogether, we propose that Sit4p is a master regulator of sphingolipid 
biosynthesis and metabolism by integrating signalling derived from TORC1 and 
TORC2 branches. TORC1 inhibits Sit4p, which in turn decreases Npr1p activity. 
As a result, Orm1/2p phosphorylation decreases and they become less active, 
thus reducing the flux of ceramide and complex sphingolipid synthesis in the Golgi 
apparatus (Shimobayashi et al., 2013). Our study provides evidence that deletion 
of SIT4 also decreases de novo sphingolipids biosynthesis pathway by decreasing 
Pkh1p-Ypk1p signalling (by Snf1p-dependent mechanisms), which reduces Orm 
phosphorylation. Therefore, SPT is inhibited and the biosynthesis of ceramide is 
diminished (Vilaça, 2014). Interestingly, it was shown that Sit4p co-purifies with 
Tor2p (Yan et al., 2006), which further supports a regulatory role of Sit4p in TOR 
readouts. Additional studies are required to demonstrate if Sit4p physically 
interacts with Tor2p to specifically regulate TORC2 functions, since Tor2p can also 
be present on the TORC1 protein complex (Loewith & Hall, 2011). 
 Mechanistically, we demonstrate that Snf1p is required for the regulation of 
these molecular events. In fact, we provide evidence that the deletion of SNF1 
increases the TORC2-Pkh1p-Ypk1p signalling in parental cells, likely contributing 
to mild myriocin resistance. In agreement, the deletion of YPK1 conferred myriocin 
hypersensitivity to Snf1p-deficient cells, further demonstrating that Snf1p is 
epistatically upstream of Ypk1p. Notably, the pathway is also upregulated in 
snf1Δsit4Δ cells since TORC2-Pkh1p-Ypk1p signalling is increased compared to 
sit4Δ cells. As a result, snf1Δsit4Δ cells became more resistant to sphingolipid 
depletion induced by myriocin in relation to sit4Δ cells.    
 Huang et al. demonstrated that sphingolipids regulate CLS by modulating 
the activation of the Pkh1/2p-Sch9p pathway, which responds to LCBs (Huang et 
al., 2012). In this study, we demonstrated that Sit4p controls the Pkh1p-Sch9p 
pathway by regulating Pkh1p activity and Sch9p protein levels, the latter either by 
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expression or turnover. Importantly, the deletion of SIT4 promotes CLS extension 
and improves stress response and mitochondrial function in yeast (Barbosa et al., 
2011). We propose that the downregulation of the Pkh1p-Sch9p pathway also 
contribute to these phenotypes in sit4Δ cells. This is supported by the fact that the 
activation of the pathway promoted by the deletion of SNF1, which increases 
Pkh1p activity and partially restores Sch9p levels, abolished oxidative stress 
resistance, mitochondrial function and the extended CLS exhibited by sit4Δ cells 
(Pereira et al., unpublished results). Notably, Snf1p physically interacts with Sin4p 
(Kuchin et al., 2000), a subunit of the RNA polymerase II mediator complex that 
may regulate SCH9 expression. Further studies are necessary to test this 
hypothesis.  
 Nevertheless, we may not exclude possible effects related to Snf1p 
functions, which is essential for the metabolic adaptation upon glucose starvation 
and induction of respiration (Young et al., 2003, Hardie, 2007). Moreover, the 
overexpression of SCH9 in sit4Δ cells produced similar effects as observed for 
sit4Δsnf1Δ double mutants. We thus conclude that Sit4p modulates the activation 
of the Pkh1/2p-Sch9p pathway by a Snf1p-dependent mechanism to regulate 
stress response and lifespan in yeast.   
 Sit4p-deficient cells accumulate LCBPs and present decreased ceramide 
levels during exponential phase (Vilaça, 2014), which corresponds to the 
sphingolipid profile exhibited by stationary phase-grown cells (Lester et al., 2013). 
This may indicate that Sit4p deficiency may reprogram sphingolipid metabolism 
already during growth to precondition cells to better survive in the stationary phase 
and extend CLS. Although the link between the accumulation of LCBPs and 
lifespan is not yet fully understood (Lester et al., 2013), a recent study 
demonstrated that knocking out LCB4 abolished the anti-aging effect of CR (Tang 
et al., 2008), which indicates that the formation of LCBPs is important for lifespan 
extension. Apart from it, sit4Δ cells present several characteristics of stationary 
phase-grown cells already during exponential growth, namely derepression of 
mitochondrial function (Jablonka et al., 2006), enhanced oxidative stress 
resistance (Barbosa et al., 2011) and glycogen storage (Jablonka et al., 2006), 
which has been associated with longevity in yeast. As a result, sphingolipid 
metabolism is redirected and overall cell fitness is improved upon Sit4p deficiency 
already during growth, contributing to extend CLS in yeast. Our results support a 
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model in which Sit4p is activated by ceramide but also regulates sphingolipids 
metabolism by integrating molecular events involving the TORC2-Ypk1p signalling 
and Orm phosphorylation to modulate the sphingolipid biosynthetic pathway.  
 
 
4.4. Experimental Procedures 
 
4.4.1. Yeast strains and growth conditions 
 
 S. cerevisiae BY4741 was the parental strain of all haploid derivatives used in 
this study (Table 4.5.1). Yeast cells were grown aerobically at 26°C in a gyratory 
shaker (at 140 r.p.m.), with a ratio of flask volume/ medium volume of 5:1. The 
growth media used were YPD [1% (w/v) yeast extract, 2% (w/v) bactopeptone, 2% 
(w/v) glucose] and synthetic complete (SC) drop-out medium containing 2% (w/v) 
glucose, 0.67% yeast nitrogen base without amino acids and supplemented with 
appropriate amino acids (80 mg histidine L-1, 400 mg leucine L-1, 80 mg tryptophan 
L-1 and 80 mg uracil L-1). Gene disruption was done by conventional methods and 
the proper integration of the cassettes was confirmed by PCR.  
 
4.4.2. Stress resistance and chronological lifespan 
 
 For H2O2 resistance assay, cells were grown to the exponential phase 
(OD600 = 0.6) and exposed to 1.5 mM H2O2 (Merck) for 60 min. The CLS assay 
was performed as described (Fabrizio & Longo, 2003). Briefly, overnight cultures 
were diluted to OD600 = 0.6, grown for 72 h (to stationary phase; considered T0 in 
the CLS assay) and kept in medium at 26°C. For both assays, cell viability was 
determined by standard dilution plate counts on YPD medium containing 1.5 % 
(w/v) agar and expressed as the percentage of the colony-forming units after 
growth at 26ºC for 3 days (time T vs. T0 (when viability was considered 100%) for 
the CLS assay; treated vs. untreated cells for H2O2 resistance). Values are mean ± 
SD of at least three independent experiments. To assess cellular resistance to 
myriocin (Sigma-Aldrich) or phytosphingosine (Sigma-Aldrich), yeast cells were 
grown in SC-medium to exponential phase, diluted to OD600=0.1, spotted onto 
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YPD plates containing these compounds at the indicated concentrations and 
incubated at 26ºC for 2-3 days. 
 
4.4.3. Sphingolipid profiling  
 
          Yeast cells were grown in SC-glucose medium and 1.9 × 109 cells were 
collected at exponential phase. Cell pellets were ressuspended in 1 mL of lipid 
extraction solvent: 50% (v/v) iso-propanol, 10% (v/v) diethyl ether, 2% (v/v) 
pyridine, 25% (v/v) ammonia. A 200 µL volume of glass beads were added into a 
screw cup 2 mL plastic tubes. Tubes were shaken in a bead better five times, 3 
min on, 1 min off at 4°C. The content of the tubes was poured into a 13 × 100 mm 
glass tubes. An additional 1 mL solvent was used to wash the plastic tubes and 
was added into the glass tubes. The tubes containing 2 mL solvent with cells and 
glass beads were dried in an analytical nitrogen evaporator (N-EVAP). The dried 
samples were sent to the Lipidomic Core at the Medical University of South 
Carolina for lipid analysis. Levels of ceramide, long-chain sphingoid bases and 
their phosphorylated forms were measured by the high-performance liquid 
chromatography/mass spectrometry (LC-MS/MS) methodology as previously 
described (Bielawski et al., 2010). Analytical results of lipids were expressed as 
pmol sphingolipid/total cell number. 
 
4.4.4. Enzymatic activities and oxygen consumption 
 
 The activity of β-galactosidase was determined as previously described 
(Teixeira et al., 2014). Oxygen consumption rate was measured for 3 x 108 cells in 
PBS buffer (pH 7.4), using an oxygen electrode (Oxygraph, Hansatech). Data was 
analyzed using the Oxyg32 V2.25 software.  
 
4.4.5. Western Blot analysis  
 
 To evaluate the TORC2-dependent phosphorylation (T662) and the Pkh1p-
mediated phosphorylation (T504) of Ypk1p, the Pkh1p-mediated activation of 
Sch9p (T570) and total Sch9p protein levels, cells were harvested and subjected 
to alkaline lysis. Proteins (50 µg) were resolved by SDS–PAGE using 8.5% 
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polyacrylamide gels and blotted onto a nitrocellulose membrane (GE Healthcare). 
The primary antibodies used were mouse anti-phospho-T662-Ypk1p (kindly 
provided by Dr. Robbie Loewith, 1:500), rabbit anti-phospho-T504 Ypk1p 
(Phospho-PKC (pan) zeta Thr410 (190D10)); Cell Signalling Technology, 1:1,000), 
rabbit anti-phospho-T570-Sch9p (kindly provided by Dr. Robbie Loewith, 
1:10,000), rabbit anti-Sch9p (kindly provided by Dr. Robert Dickson, 1:1,000) and 
mouse anti-Pgk1p (Invitrogen, 1:30,000). Subsequently, the membrane was 
incubated with the secondary antibody anti-mouse IgG-peroxidase (Molecular 
Probes) or anti-rabbit (Sigma) at a 1:5,000 dilution. Immunodetection was done 
using the Lumigen HRP chemiluminescent substrate (GE Healthcare).  
 
4.4.6. Glycogen content 
 
 Yeast cells were grown in SC-medium to exponential phase, diluted to 
OD600=0.1, spotted onto YPD plates and incubated for 3 additional days. The 
iodine staining was performed by exposing cells to iodine vapor (Sigma-Aldrich) 
(Wilson et al., 2002). 
 
4.4.7. Statistical analysis 
 
 Data are expressed as mean values ± SD of at least three independent 
experiments. Values were compared by Student’s t-test. The 0.05 probability level 
was chosen as the point of statistical significance throughout. Statistical analyses 
were carried out using GraphPad Prism Software v5.01 (GraphPad Software).  
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4.5. Supplementary Information  
 
Table 4.5.1. Saccharomyces cerevisiae strains used in this study. 
Strain Genotype Source 
BY4741 
Mata his3Δ1, leu2Δ0, met15Δ0, ura3Δ0 
[YEp357-YPC1, YEp357-YDC1, YEp357-
LAG1, YEp357-LAC1, p416MET25- 
YPK1D242A, pRS316, pRS316-PKH1, 
YEp13,YEp13-SCH9] 
EUROSCARF 
This study 
 
sit4Δ::KanMX4 
BY4741 sit4Δ::KanMX4 [p416MET25- 
YPK1D242A, pRS316, pRS316-PKH1, 
YEp13,YEp13-SCH9] 
EUROSCARF 
 This study 
sit4Δ::HIS3MX6 
BY4741 sit4Δ::HIS3MX6 [YEp357-YPC1, 
YEp357-YDC1, YEp357-LAG1, YEp357-
LAC1] 
Vilaça, 2014 
This study 
snf1Δ BY4741 snf1Δ::KanMX4  EUROSCARF 
sit4Δsnf1Δ BY4741 sit4Δ::HIS3MX6 snf1Δ::KanMX4 Pereira et al. 
lcb4Δ BY4741 lcb4Δ::KanMX4 EUROSCARF 
sit4Δlcb4Δ BY4741 sit4Δ::HIS3MX6 lcb4Δ::KanMX4 This study 
ypk1Δ BY4741 ypk1Δ::KanMX4 EUROSCARF 
snf1Δypk1Δ BY4741 snf1Δ::LEU2 ypk1Δ::KanMX4 This study 
 
Harboring plasmids are shown in square brackets.  
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Figure 4.S1. Calcineurin inhibition further increases the myriocin sensitivity of 
Sit4p-deficient cells. BY4741 and sit4Δ cells with different selection markers were grown 
in SC medium to exponential phase, diluted to OD600=0.1 and spotted in five-dilution 
series onto YPD agar supplemented with either ethanol 95% (vehicle) or myriocin (0.35 
µg/mL) and calcineurin inhibitor FK506 (1 µg/mL) as indicated. A representative image out 
of three is shown. 
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5.1. General discussion and future perspectives 
 
 Sphingolipids have come to the foreground of research area in the past few 
years due to the recognition of their importance as bioactive molecules involved in 
the regulation of overall cellular metabolism and fate (Cowart et al., 2006, Hannun 
& Obeid, 2008, Liu et al., 2013, Rego et al., 2014). Their importance is reinforced 
by the fact that sphingolipid metabolism is highly conserved among eukaryotes, 
ranging from yeast to mammals (Cowart et al., 2006, Hannun & Obeid, 2008, Liu 
et al., 2013, Rego et al., 2014). Most importantly, subtle variations in the 
"sphingolipid rheostat" have a significant impact in cell physiology and fate 
(Cowart et al., 2006, Hannun & Obeid, 2008, Liu et al., 2013, Rego et al., 2014). 
As a result, sphingolipid metabolism is tightly regulated. In addition, sphingolipids 
actively modulate important cellular processes, such as cell cycle arrest, 
apoptosis, differentiation, senescence and stress responses, and also contribute 
to the etiology of several human disorders (Dickson, 2008, Hannun & Obeid, 2008, 
Young et al., 2013).  
 In S. cerevisiae, the homologue of mammalian neutral sphingomyelinase 
type 2, Isc1p, is required for proper oxidative stress resistance and chronological 
lifespan. In fact, isc1Δ cells exhibit severe mitochondrial dysfunction, hydrogen 
peroxide hypersensitivity and premature aging, which is, in part, associated with 
increased intracellular levels of iron and Yca1p-mediated cell death by apoptosis 
(Kitagaki et al., 2007, Almeida et al., 2008, Kitagaki et al., 2009). The activation of 
the ceramide-activated protein phosphatase Sit4p and the Hog1p protein kinase in 
response to ceramide signalling, are associated with these phenotypes, as the 
deletion of SIT4 (Barbosa et al., 2011) and HOG1 (Barbosa et al., 2012) 
suppresses isc1Δ associated phenotypical traits.  
 The role of the sphingomyelinase Isc1p in signalling transduction involved 
in stress response and chronological aging is yet not fully understood. The 
knowledge of the involvement of Isc1p-driven ceramide signalling in the regulation 
of fundamental biological processes, such as autophagy and related mechanisms, 
is also still scarce.  
 This thesis aimed to explore the involvement of the nutrient-sensing Target 
Of Rapamycin Complex 1 (TORC1) and its downstream effector, the AGC protein 
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kinase Sch9p, in isc1Δ phenotypes. This work demonstrates that the TORC1-
Sch9p pathway is activated in cells lacking Isc1p and contributes to isc1Δ 
phenotypes since the deletion of TOR1 or SCH9 suppresses the premature aging, 
oxidative stress sensitivity and mitochondrial dysfunctions displayed by isc1Δ 
cells. Importantly, this is correlated with autophagic defects exhibited by the 
mutant strain.  
 More work is required to characterize the molecular mechanism(s) by which 
Isc1p regulates the activation of the TORC1-Sch9p pathway. TORC1 activity is 
highly sensitive to nutrient availability but also integrates signals from various 
stresses and growth factors. In yeast and mammals, TORC1 is activated by 
aminoacid availability. Withdrawal of branched-chain amino acids, in particular 
leucine, leads to a strong reduction of TORC1 activity, implying that leucine is the 
most potent activator of TORC1 (Binda et al., 2009). In yeast, TORC1 activity can 
also be stimulated by addition of other nitrogen sources, such as ammonium ions, 
albeit with different efficiencies. Interestingly, depletion of intracellular glutamine 
levels mimics inactivation of TORC1, suggesting a direct role for glutamine in the 
activation of TORC1 (Crespo et al., 2002, Binda et al., 2009). In yeast and 
mammals, various direct activators of TORC1 have also been identified, namely 
the small GTPase Rheb, which is required for the activation of TORC1 in response 
to growth factors and possibly by aminoacids (Sancak et al., 2008). In addition, 
some studies have also shown that sphingolipids, especially ceramide, alters 
nutrient sensing and internalization (Guenther et al., 2008). Since TORC1 is 
responsive to aminoacids, the deregulation of nutrient sensing may affect the 
activation of the TORC1-Sch9p pathway in isc1Δ cells.   
 Interestingly, inhibition of translation with cycloheximide causes a 
pronounced increase in TORC1 activity presumably by triggering an increase in 
the concentration of free aminoacids in the cytoplasm (Urban et al., 2007). 
Interestingly, reduced ribosome biogenesis results in a dramatic increase in 
TORC1 activity (Lempiainen et al., 2009). In Isc1p-deficient cells, it was observed 
reduced expression of genes encoding for ribosomal proteins and corresponding 
subunits (Almeida et al., 2008). Therefore, it is possible that blocking ribosome 
biogenesis, like translation and protein synthesis inhibition, may lead to an 
increase in free aminoacids that subsequently activates TORC1 in isc1Δ cells. 
This hypothesis needs further clarification.  
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 Apart from TORC1, Sch9p is also responsive to LCBs and this study shows 
that it also senses ceramide signalling to regulate Hog1p. As a result, Sch9p 
activity is responsive to nutrient-derived TORC1 and Isc1p-driven ceramide 
signalling inputs to regulate mitochondrial function, oxidative stress sensitivity and 
lifespan in yeast. Overall, our data support a model in which Isc1p regulates 
mitochondrial function and chronological lifespan in yeast through the TORC1-
Sch9p pathway, which acts as a central axis to integrate upstream Isc1p-driven 
ceramide signalling signals to downstream effectors Sch9p and Sit4p. 
 Although the role of Snf1p, the yeast homologue of AMPK, as a 
downstream target of TORC1 is still controversial (Zhang et al., 2011), the 
hyperactivation of the TORC1 could then lead to the downregulation of Snf1p. The 
assumption of decreased activation of Snf1p could also explain phenotypic 
similarities between strains lacking Isc1p and Snf1p, namely the inability to grow 
on non-fermentable carbon sources, decreased ion tolerance, aberrant cell wall 
characteristics and increased ROS accumulation (Kuchin et al., 1993, Alepuz et 
al., 1997, Tabuchi et al., 2006, Weinberger et al., 2010, Barbosa et al., 2012). In 
addition, downregulation of Snf1p could also account for autophagic defects, as 
Snf1p is a positive regulator of autophagy (Jewell et al., 2013). These hypothesis 
need to be clarified in more detail. 
 Macroautophagy plays an important regulatory role in mitochondrial 
function, stress response and aging (Seo et al., 2010). Since these processes are 
compromised in Isc1p-deficient cells, this thesis also aimed to evaluate the impact 
of Isc1p-driven ceramide signalling on macroautophagy and crucial mitochondrial 
quality control mechanisms, namely mitochondrial dynamics and mitophagy. 
Reduced autophagic flux displayed by isc1Δ cells is attributed to primary defects in 
vesicular trafficking and vacuolar proteolysis and morphology and ability to 
maintain the proton motive force in the vacuole. These phenotypes were abolished 
by downregulation of TORC1 and its downstream effectors, Sch9p and Sit4p, 
which integrate nutrient and stress signals from TORC1 with ceramide signalling 
from Isc1p. As a result, it is conceivable to assume that these proteins kinases and 
the Sit4p protein phosphatase regulate the phosphorylation status or the catalytic 
activity of proteins involved in vesicular trafficking, such as Rab GTPases, 
tethering factors, and SNAREs protein machinery (Cai et al., 2007). In addition, 
alterations in sphingolipid profiling previously reported (Barbosa et al., 2011) could 
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also impair vesicular trafficking in isc1Δ cells. In this case, it would be important to 
determine which sphingolipid species could possibly play a key role in this 
process.  
 On the other hand, we show that the deletion of ISC1 leads to the 
hyperactivation of mitophagy, presumably as an adaptive response to 
mitochondrial dysfunction since this was correlated with loss of cell viability of 
isc1Δ cells. Importantly, the deletion of TOR1, SCH9, SIT4 and HOG1 attenuated 
the induction of mitophagy in respiratory conditions and this was correlated with 
the suppression of mitochondrial fragmentation and improvement of mitochondrial 
function. This could possibly indicate that, when Isc1p is translocated to the 
mitochondria upon the transition to respiratory conditions (PDS phase), the 
regulation of sphingolipid metabolism by Isc1p at this organelle may be important 
to modulate ceramide pools and control the activation of the TORC1-Sch9p, Sit4p 
and Hog1p signalling pathways, contributing to maintain proper mitochondrial 
function and dynamics and oxidative stress resistance. As a result, cells are better 
conditioned to endure the stationary phase. 
  Isc1p-deficient cells also displayed higher levels of mitochondrial fission 
protein Dnm1p associated with unbalanced mitochondrial fission, contributing to 
mitochondrial fragmentation, oxidative stress sensitivity and shortened lifespan of 
isc1Δ cells. How Isc1p regulates Dnm1p protein levels (which are increased in 
isc1Δ cells) and activity remains to be understood. According to our hypothesis, in 
respiratory conditions, mitochondrial fragmentation leads to the hyperactivation of 
mitophagy, presumably in response to mitochondrial dysfunction. Importantly, 
mitochondrial dysfunction is associated with apoptotic cell death in isc1Δ cells. 
Since Dnm1p is also involved in apoptosis (Frank et al., 2001), the recruitment of 
Dnm1p and impairment of mitochondrial dynamics may constitute one of the 
primary events leading to apoptosis in isc1Δ cells. Supporting a regulatory role in 
mitochondrial dynamics, we show that Isc1p and Dnm1p physically interacted in 
vitro. It is possible that alterations in ceramide content (dependent of Isc1p activity) 
leading to dysfunction of mitochondria may constitute a signal that promotes the 
recruitment of Dnm1p, leading to the segregation and degradation of damaged 
mitochondria by mitophagy as an adapative response to cope with mitochondrial 
dysfunction. Further studies are needed to test this hypothesis.  
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 Our lab was able to show that the deletion of SIT4 extends lifespan in yeast 
by boosting mitochondrial function (mitochondrial catabolic derepression) and 
stress response (Barbosa et al., 2011). Although Sit4p functions downstream of 
Isc1p (Barbosa et al., 2011), the phosphatase is also downregulated by TORC1 
(Di Como & Arndt, 1996, Jacinto et al., 2001, de Virgilio & Loewith, 2006). In 
addition, Sit4p was recently linked to sphingolipid metabolism, as TORC1 controls 
the turnover of complex sphingolipids in a Sit4p-dependent manner (Shimobayashi 
et al., 2013). However, how TORC1 effector Sit4p integrates nutrient and 
sphingolipid signalling to regulate lifespan is not yet established. On this basis, the 
work aimed to establish a functional association between Sit4p and sphingolipid 
metabolism and evaluate the impact on cell survival. This work demonstrates that 
Sit4p regulates the sphingolipid biosynthetic pathway by a transcriptional 
regulatory mechanism involving the ceramide synthase LAG1 and the ceramidase 
YPC1. Importantly, increased LCBPs/LCBs ratio and the preferential shunting of 
sphingolipid metabolism towards the synthesis of α-hydroxylated phytoceramide 
species (Vilaça, 2014), which have been implicated on proper mitochondrial 
function (Kitagaki et al., 2007), are possible traits associated with CLS extension 
imparted by SIT4 deletion. Overall ceramide production is decreased in sit4Δ cells 
(Vilaça, 2014) and this was correlated with reduced activation of the Pkh1p-Ypk1p 
pathway and decreased Orm phosphorylation by a Snf1p-dependent mechanism. 
Moreover, the Pkh1/2p-Sch9p pathway is significantly downregulated in this 
mutant and Snf1p also mediates this effect. How Snf1p, which is involved in 
glucose sensing (Hardie, 2007), regulates sphingolipid metabolism needs to be 
clarified in more detail at a molecular level. At the cellular level, it has been 
demonstrated that ceramides impair insulin signalling and intracellular handling of 
glucose and lipids with resulting deleterious effects on cellular metabolism (Larsen 
& Tennagels, 2014). Therefore, Snf1p may constitute an additional level of 
regulation to couple sphingolipid signalling with glucose metabolism, which is 
particularly relevant in a therapeutic context (chronic hyperglycemia or 
hyperlipidemia or inflammatory diseases) (Larsen & Tennagels, 2014). Therefore, 
further studies could be useful to discriminate possible regulatory roles of Snf1p in 
sphingolipid and glucose metabolism and how they are coupled at a cellular level.  
 Importantly, the downregulation of the Pkh1/2p-Sch9p pathway was 
associated with improved mitochondrial fitness and extended CLS upon Sit4p 
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deficiency. Since Sit4p integrates TORC1-associated nutrient signalling with 
Isc1p-driven ceramide signalling and also regulates the activation of the Pkh1/2p-
Sch9p pathway, our results provide evidence that Sit4p is not only an effector but 
also a key regulator of sphingolipid metabolism and is involved in a regulatory 
network of interacting pathways that integrate signals from TORC1-mediated 
nutrient sensing with sphingolipid metabolism to regulate cell growth and longevity.  
 The deletion of SIT4 increases the activation of Snf1p, which in turn 
decreases Ypk1p-Orm signalling to inhibit the de novo biosynthetic pathway by 
possibly reducing SPT activity. As a result, the activation of Sit4p is expected to 
activate the TORC2-Ypk1p-Orm signalling to stimulate ceramide synthesis through 
the biosynthetic pathway. On the other hand, Shimobayashi et al. showed that 
TORC1 inhibition activates the kinase Npr1p (by promoting the activation of Sit4p) 
that directly phosphorylates and activates the Orm proteins. Npr1p-phosphorylated 
Orm1p and Orm2p stimulate de novo synthesis of complex sphingolipids 
downstream of SPT. As a result, the activation of the TORC2-Ypk1p-Orm 
mediated ceramide biosynthesis pathway by Sit4p may be coupled to the 
stimulation of complex sphingolipids when TORC1 activity is inhibited (which 
relieves the inhibition of Sit4p) to maintain sphingolipid homeostasis. Further 
studies are required to test this hypothesis. The interplay between ceramide and 
nutrient signalling is shown in Figure 5.1.  
 In conclusion, this thesis provides new insights on the molecular 
mechanisms by which cellular signalling pathways are activated in response to 
alterations in sphingolipid metabolism and the impact on crucial cellular functions 
and metabolism (Figure 5.1). This clarification is pivotal to understand sphingolipid 
functions in more detail and define new strategies to improve human health and 
extend lifespan.  
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Figure 5.1. Cross talk between ceramide and signalling transduction in the 
regulation of cell metabolism and longevity. In response to Isc1p-driven ceramide 
signalling and TORC1-mediated nutrient sensing, the ceramide activated protein 
phosphatase Sit4p and the AGC protein kinase Sch9p integrate these signals to regulate 
mitochondrial function, oxidative stress resistance and chronological lifespan in yeast. 
Additionally, Sit4p emerges as a key regulator of sphingolipid metabolism by integrating 
TORC1- and TORC2 signalling to regulate complex sphingolipid turnover (TORC1-Sit4p-
Npr1p-Orm signalling pathway) and the de novo biosynthetic pathway of sphingolipids 
(TORC2-Pkh1p-Ypk1p-Orm signalling pathway in a Snf1p-dependent manner).  
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Enquanto existir vida em mim, não deixarei de te procurar. Anseio por aquele 
abraço único e intransmissível. Porque cada abraço é anatomicamente distinto; 
aquele instante em que os braços anseiam por aquela fusão de corpos e almas é 
invariavelmente singular. Aquele abraço é como uma partitura musical que só 
aqueles dois corpos sabem tocar. Adiante, esses corpos comprimem-se num 
encaixe apertado e característico de uma fusão perfeita de curvas e 
concavidades. E nesse instante, transportamo-nos no tempo e passamos a viver 
numa mesma dimensão, onde os desejos se fundem numa dança em ritmo 
próprio, sublime. Num abraço, naquele momento alígero, roubamos à realidade a 
distância da saudade, seguramos o tempo num fio invisível, um fragmento do 
tempo resumido na eternidade de um abraço. 
Vitor Teixeira 
